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It is becoming increasingly evident that cell signaling is much more complex than originally 
perceived and involves crosstalk of different signaling pathways to define the cellular response to 
multiple simultaneous signals. The gonadotropin-releasing hormone (GnRH) receptor (GnRHR), 
a plasma membrane G protein-coupled receptor, is the primary regulator of mammalian 
reproduction. The glucocorticoid receptor (GR), a cytosolic or nuclear steroid receptor, plays a 
central role in various processes of mammalian physiology, by maintaining homeostasis of basal 
and stress-related conditions through modulation of a vast array of metabolic and immune 
functions. Some of the effects of stress on reproduction are mediated via glucocorticoids (GCs) 
from the adrenal gland as part of a crosstalk mechanism between the hypothalamic-pituitary-
adrenal axis (HPA) and hypothalamic-pituitary-gonadal (HPG) axis. A recent study from the 
Hapgood laboratory demonstrated the presence of a novel crosstalk mechanism between the GR 
and GnRHR, indicating an additional direct mechanism for the effects of stress on reproduction. 
The present study investigated whether this crosstalk between the GR and GnRHR involves the 
co-localization of these receptors to lipid rafts, providing a specialized distinct region where the 
receptors can be in close proximity and reciprocally modulate each other’s signaling pathways. 
Specific aims of the present study included confirming the GnRH and synergistic transcriptional 
responses with dexamethasone (Dex) and GnRH induced by crosstalk between the GR and 
GnRHR.  This study investigated whether this reciprocal modulation involves co-localization and 
an interaction of these receptors in lipid rafts, while also investigating a functional role for lipid 
rafts in GR and GnRHR signaling. Using promoter-reporter assays, the results showed that 
GnRH was able to activate the unliganded GR, to a similar extent as Dex to transactivate via a 
GRE-reporter gene in LβT2 cells. Co-stimulation with Dex and GnRH synergistically enhanced 
the transcriptional activity of the GRE-reporter gene in these cells. Modulations of the GnRHR 
signaling pathway by the GR on other cis-elements were also investigated. Dex enhanced the 
GnRH-induced transcriptional activity of a minimal activator protein-1 (AP-1)-reporter gene, but 
had no effect on the GnRH-induced activation of a minimal nuclear factor-kappa B (NF-κB)-
reporter gene in LβT2 cells. The novel finding that GnRH induced GR protein degradation is 
supporting evidence for the activation of the GR with GnRH in LβT2 cells. Both the GR and 
GnRHR appeared to co-localize to lipid rafts containing Flot-1 at the plasma membrane of LβT2 
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cells, as shown by immunoflorescence and density-gradient analysis. Interestingly, the lipid raft 
association of the GR was found to be independent of 30 min treatment with Dex, GnRH or both 
together. Co-immunoprecipitation assays showed that the GR interacts with Flot-1 in a complex 
that is independent of ligands, supporting the results of the immunoflorescence and density-
gradient experiments. Although results using cholesterol depletion agents suggest that lipid rafts 
are not required for the hormone-induced transcriptional response on a GRE or the GC-
independent phosphorylation of the GR in LβT2 cells, they were inconclusive. However, siRNA 
knock down experiments revealed that Flot-1 appeared to be required for the Dex-induced 
transcriptional response and the synergistic transcriptional response with Dex and GnRH on a 
GRE in LβT2 cells. The results suggests a novel mechanism for the crosstalk between the GR 
and GnRHR signaling pathways involving co-localization of both receptors to lipid rafts 
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Chapter 1: Literature review 
 
1.1 Glucocorticoid receptor 
 
1.1.1 Physiological function in the pituitary 
 
The endogenous ligand for the glucocorticoid receptor (GR) in humans, namely cortisol, is 
synthesized in the adrenal cortex and its release is under the control of the hypothalamic-
pituitary-adrenal axis. Corticotrophin-releasing hormone (CRH) secretion from the hypothalamus 
regulates glucocorticoid (GC) synthesis by controlling the release of adrenocorticotropin 
hormone (ACTH) (Chrousos, 1995). The GR plays a vital role in the control of homeostasis and 
adaptive processes including immune, metabolic, neural and behavioral systems (Bloom et al., 
1982; Wiegers and Reul, 1998). Given the fundamental role of GCs, they are extensively utilized 
as therapeutical drugs in many inflammatory and immune diseases as well as in certain cancer 
treatments (Rhen and Cidlowski, 2005).  
 
Chronic and acute stress have been implicated in the regulation of mammalian reproduction 
although the underlying mechanisms are not well understood. While chronic stress primarily 
reduces gonadotropin secretion and reproduction, the effects of acute stress are variable with both 
positive and negative effects reported in the literature (Brann and Mahesh, 1991; Tilbrook et al., 
2000). The effects of stress on reproduction are mediated via GCs from the adrenal gland as part 
of a crosstalk mechanism between the hypothalamic-pituitary-adrenal (HPA) and hypothalamic-
pituitary-gonadal (HPG) axis (Rivier and Rivest, 1991). The pulsatile administration of 
gonadotropin-releasing hormone (GnRH) to rat pituitary cells was shown to increase GnRH 
receptor (GnRHR) mRNA levels, an effect that was further increased with dexamethasone (Dex) 
(Rosen et al., 1991). Furthermore, in cultured rat pituitary cells (Baldwin et al., 1991; Brann and 
Mahesh, 1991; Kilen et al., 1996; McAndrews et al., 1994; D'Agostino et al., 1990), GCs 
increased the secretion of follicle-stimulating hormone (FSH), while having no effect or 
decreasing luteinizing hormone (LH) secretion. In addition, the activated GR was shown to 
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enhance expression of the glycoprotein hormone α-subunit gene in the immortalized gonadotrope 
cell line, LβT2 (Sasson et al., 2008). In contrast, some of the effects of stress on reproduction 
have been shown to involve a GC-dependent decrease in LH secretion in primary rat pituitary 
cultures (Kamel and Kubajak, 1987), resulting from a decrease in pituitary responsiveness to 
GnRH (Breen and Karsch, 2004). Furthermore, cortisol was shown to inhibit the estrogen-
induced increase of GnRHR mRNA, suggesting a repressive role for GCs in GnRHR expression 
(Adams et al., 1999). The results from pituitary cells strongly support a mechanism of GCs 
affecting mammalian reproduction through either increasing GnRHR levels or directly 
influencing gonadotropin levels. The physiological role of the GC-dependent increase in FSHβ 
secretion was proposed to protect and maintain the health of the follicle for the next reproductive 
cycle (Kilen et al., 1996). The expression of functional GR protein has previously been reported 
in primary mouse pituitary cells and conditional knockout mice with a deletion of the GR in the 
pituitary impaired the GC-mediated negative feedback on the HPA axis (Schmidt et al., 2009).  
 
1.1.2 Structural organization 
 
Steroid hormone receptors such as the GR, progesterone receptor (PR), androgen receptor (AR), 
mineralocorticoid receptor (MR) and the estrogen receptor (ER) belong to the nuclear receptor 
subfamily 3 (Nuclear Receptors Nomenclature Committee, 1999). The human GR gene 
comprises of 10 exons spanning a region of 110 kb while alternative splicing of exons 9α and 9β 
results in two GR isoforms, namely GRα and GRβ, respectively (Zhou and Cidlowski, 2005). 
These two proteins contain the same functional domains, except GRβ has a truncated C-terminal 
domain that prevents it from binding to ligands. In the absence of ligand, the GRα is mainly 
cytoplasmic, while GRβ is nuclear and represses the expression of certain cytokine genes (Kelly 
et al., 2008). In addition, the GRβ isoform can form heterodimers with GRα, acting as a 
dominant-negative for the transcriptional activity of GRα (Oakley et al., 1999; Bamberger et al., 
1995). Furthermore, a recent study was the first to report GRβ mRNA and protein expression in 
mice, which displayed similar properties to the human GRβ (Hinds et al., 2010). Increased GRβ 
expression with its dominant negative effect on the transcriptional activity of GRα could result in 
GC resistance that is associated with various diseases (Hamilos et al., 2001). Three additional GR 
splice variants have been identified in various tissue types, namely GRγ, GR-A and GR-P. 
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Besides the above mentioned isoforms, alternative translation initiation of GRα and GRβ results 
in multiple GRα and GRβ isoforms. All of the translational GR isoforms are expressed in mouse 
and rat tissues, although they were differentially expressed compared to human tissues (Lu and 
Cidlowski, 2005). The existence of various GR isoforms can be a mechanism for the differential 
cellular responsiveness to GC. 
 
The GRα protein consists of 777 amino acids and can be divided into three independent 
functional domains, namely a variable N-terminal domain (NTD), a central highly conserved 
DNA-binding domain (DBD) and a C-terminal ligand-binding domain (LBD) (Griekspoor et al., 
2007) (Figure 1.1.1). The NTD is the most variable region with respect to sequence homology 
and size between different species of GR, while containing a region required for maximal 
transcriptional activity, known as the transcriptional activation function-1 (AF-1). The AF-1 
region has been shown to interact directly with components of the basal transcription machinery 
and many co-factors involved in the regulation of transcription (Kumar and Thompson, 2005; 
Heitzer et al., 2007). Mutational studies have shown that the NTD is a constitutive activator of 
transcription in the absence of the LBD (Godowski et al., 1987). Furthermore, the NTD is a 
major target for post-translational modifications such as phosphorylation and sumoylation (Faus 
and Haendler, 2006).  
 
The central DBD is the most conserved region consisting of two zinc-finger motifs where each 
zinc atom is coordinated by four cysteine residues in a tetrahedral conformation (Freedman et al., 
1998). The amino acids from the first zinc-finger interact with specific DNA sequences in the 
promoter of target genes while the second zinc-finger stabilizes the DNA-protein interaction and 
is important for receptor homodimerization (Dahlman-Wright et al., 1991). The DBD also 
interacts directly with other proteins modulating the transcriptional activity of the GR. The DBD 
Figure 1.1.1: Structural organization of the human GRα protein. AF-1, activation 
function 1; DBD, DNA-binding domain; LBD, ligand-binding domain. Taken and 
adapted from (Avenant, 2009). 
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is connected to the LBD by a flexible hinge region, allowing the receptor to change conformation 
and it contains a nuclear localization signal (Picard and Yamamoto, 1987). The LBD is located at 
the C-terminal end of the receptor and is responsible for recognition and binding of hormone 
ligands. The LBD consists of twelve amino acid residues and four β-strands that form a central 
hydrophobic ligand-binding pocket. Mutational studies have revealed that two residues within the 
LBD are very important for receptor homodimerization (Bledshoe et al., 2002). The LBD 
contains a second nuclear localization signal and the transcriptional AF-2 region, which plays a 
role in binding of heat shock proteins and recruitment of co-factors (Savory et al., 1999; 
Bledshoe et al., 2004).  
 
1.1.3 The classical ligand-dependent GR mechanism of action 
 
1.1.3.1 Ligand binding and activation 
 
In the absence of ligand, the GR exists in a multi-protein complex that is mainly cytoplasmic. 
The multi-protein complex maintains the GR in an inactive state and includes chaperones such as 
heat-shock protein 90 (HSP90), HSP70, HSP23, phosphatases such as protein phosphatase 5 
(PP5) and immunophilins like FK506 binding protein 51 (FKBP51) (Pratt and Toft, 1997; Wang 
et al., 2007; Kumar and Thompson, 2005). GCs are lipophillic hormones that enter the cell by 
passive diffusion across the plasma membrane (Lu et al., 2006). Upon ligand binding, the GR 
changes conformation and is released from the cytoplasmic chaperone proteins. The resulting 
change in conformation of the GR is accompanied by hyperphosphorylation of the receptor and 
exposure of the nuclear localization signals (Zhou and Cidlowski, 2005). 
 
1.1.3.2 Dimerization and nuclear translocation 
 
In the classical model of GR activation, after ligand binding the receptor homodimerizes through 
distinct hydrophobic regions in the LBD, followed by nuclear translocation where it regulates 
transcription of target genes (Luisi et al., 1991). A study by Savory et al. suggests that receptor 
dimerization occurs in the cytoplasm (Savory et al., 1999). Mutations of key residues in the DBD 
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and LBD that is important for homodimerization, still results in nuclear import and 
transrepression of target genes, but not transactivation (Bledshoe et al., 2002; Reichardt et al., 
1998). This suggests that receptor dimerization is not required for nuclear import or 
transrepression of GR target genes, but is important for transactivation. 
 
The GR contains two nuclear localization signals, one in the hinge region and one in the LBD, 
that are uncovered during the conformational change upon ligand-binding (Savory et al., 1999). 
Not all chaperone proteins are released upon ligand-binding and the resulting conformational 
change of the GR, such as HSP90, which has been shown to play an important role in the 
mobility of the GR within the nucleus (Elbi et al., 2004). Furthermore, a recent finding 
demonstrated that FKBP51 and FKBP52 are involved in GR nuclear localization through direct 
binding of HSP90 (Banerjee et al., 2008; Zhang et al., 2008). The same study showed that when 
the unliganded GR exists in the same complex with FKBP52, the GR is mostly nuclear, but in 
contrast the GR is mostly cytoplasmic when in the same complex with FKBP51 (Banerjee et al., 
2008). Additionally, it was previously shown that ligand-binding induces a switch from an 
inactive GR protein complex with FKBP51 to an active GR protein complex with FKBP52 and 
subsequent nuclear translocation (Davies et al., 2002). The mechanism of nuclear import involves 
FKBP52 interacting with dynein, which can move along the microtubule network to the nuclear-
pore (Silverstein et al., 1999). The nuclear translocation signals of the GR are recognized by 
proteins involved in nuclear import known as importins, which are responsible for translocation 
of the GR through nuclear pores into the nucleus (Freedman and Yanamoto, 2004).  
 
In contrast to the important role FKBP52 appears to play in nuclear import of the GR, no defects 
in GR-regulated physiology were detected in FKBP52 knockout mice. However, embryonic 
fibroblast cells from these animals had a 70% reduction in the transcriptional activity of the GR, 
suggesting that FKBP52 is important for the ability of the GR to regulate expression of target 
genes. In addition, the same study reported different effects on the expression of endogenous GR 
target genes, with reduced expression of the glucocorticoid-inducible leucine zipper (GILZ) gene, 
but no effect on the Dex-induced expression of serum- and glucocorticoid-induced protein kinase 
(SGK) gene (Wolf et al., 2009). The results from Wolf et al. suggest that FKBP52 is a gene-
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specific modulator of GR activity and that alternative pathways of nuclear import could exist for 
the GR.  
 
1.1.3.3 Transcriptional regulation of gene expression 
 
 1.1.3.3.1 Direct DNA binding 
 
In the nucleus, the GR can enhance transcription by binding to regulatory elements within the 
promoters of target genes, a process called transactivation. The activated GR binds as a 
homodimer to specific DNA sequences located in the regulatory elements of GC-responsive 
genes, called glucocorticoid-response-elements (GRE), as shown in Figure 1.1.2. The GRE 
consists of two conserved six-base pair half sites separated by a non-conserved three-base pair 
spacer: 5’-GGTACAnnnTGTTCT-3’ (Comings et al., 1995; Nordeen et al., 1990). The 15 base 
pair consensus sequence has been found to vary slightly between different GR target genes, but 




Figure 1.1.2: GR mechanism of action. Diverse mechanisms for GR transactivation or 
transrepression are demonstrated. HOP, heat shock protein 90/70 organizing protein; NGRE, 
negative glucocorticoid-response-element; KB, nuclear factor-kappa B; AP-1, activator 
protein-1. Taken from (Japiassu et al., 2009). 
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When bound to the DNA, activated GR serves as a platform for the recruitment of transcription 
factors and the basal transcription machinery to induce transcription (Ford et al., 1997). The NTD 
of ligand-activated GR has been shown to interact with the transcription factor II D (TFIID) and 
TATA-box binding protein (TBP), resulting in recruitment of chromatin-remodeling complexes 
(Ford et al., 1997). The GR has been shown to interact with brahma-related gene 1 (BRG1), a 
component of the human switch/sucrose non-fermentable (SWI/SNF), ATP-dependent 
chromatin-remodeling complex, which leads to relaxation of heterochromatin allowing access for 
the basal transcription machinery and transcription factors to the regulatory regions within the 
promoter (Fryer and Archer, 1998). Furthermore, the AF domains of the GR interact in a ligand-
dependent manner with many co-factors involved in regulation of transcription (Gronemeyer et 
al., 2004), which in turn recruit additional co-factors such as cAMP response element binding 
protein (CREB)-binding protein (CBP), adenovirus E1A binding protein 300 (p300) and 
p300/CBP associated factor (p/CAF). These co-factors possess histone acetyltransferase (HAT) 
activity (McKenna et al., 1999). The acetylation of lysine residues within histone tails involves 
neutralization of the charges, resulting in dissociation of the DNA from the histones allowing 
binding of transcription factors and increasing the efficiency of transcription (Eberharter and 
Becker, 2002).  
 
The most well known and extensively studied GR co-factors are members of the steroid receptor 
co-activator (SRC) family, also known as the p160 family. Members of this family include SRC-
1 (also known as NcoA-1), SRC-2 (also known as GRIP-1 or TIF-2) and SRC-3 (also known as 
p/CIP, RAC3, ACTR or AIB1) (Carapeti et al., 1998; Ning et al., 1999; Anzick et al., 1997). The 
SRC family of proteins interact with steroid receptors in a ligand-dependent manner through a 
LXXLL (L = leucine, X = any amino acid) motif that is present within the nuclear receptor 
interaction domains (Heery et al., 1997; Voegel et al., 1998). The N-termini of the SRC proteins 
contain a basic-helix-loop-helix (bHLH) domain that has been shown to interact with the coiled-
coil co-activator (CoCoA) (Kim et al., 2003), while the C-termini has been shown to recruit the 
arginine methyltransferase CARM1 as well as HATs like p300/CBP and p/CAF (Lee et al., 2002; 
Lee et al., 2005; Vottero et al., 2002). Furthermore, all the members of the SRC family of co-
factors possess weak HAT activity themselves, resulting in decondensation of chromatin 
providing access on the DNA for additional co-factors (Chen et al., 1997; Goel and Janknecht, 
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2004; Spencer et al., 1997). It is clear that GC-induced transcriptional regulation of gene 
expression by the GR involves multiple mechanisms to achieve the desired responses. A few 
examples of well-studied genes that contain GREs in their promoters and are induced by GCs to 
result in transactivation by the GR are the tyrosine aminotransferase (TAT) and 
phosphoenolpyruvate carboxykinase (PEPCK) genes (Schmid et al., 1987; Hanson and Reshef, 
1997).  
 
In some promoters the activated GR can bind to an undefined non-consensus negative GRE 
(NGRE) resulting in transrepression, of which the osteocalcin gene is a good example (Meyer et 
al., 1997). Another well-studied example is the CRH gene that contains three NGRE half sites 
with an adjacent activator protein-1 (AP-1) site, of which both are required for GR-mediated 
repression in mouse corticotroph AtT-20 cells (Malkoski and Dorin, 1999; Drouin et al., 1998). 
Additionally, the GR can inhibit transcription by competing with transcription factors for DNA 
binding, which involves a GRE overlapping a transcription factor binding site in the promoter 
(Kassell and Herrlich, 2007; Schoneveld et al., 2004). The GR has also been shown to bind as a 
monomer to GRE half sites in the promoter of certain genes resulting in transactivation, such as 
the relaxin gene that contains multiple GRE half sites and encodes for the insulin-related peptide 




The GR can regulate gene transcription without direct binding of DNA, but rather through a 
tethering mechanism and modulation of the activity of several transcription factors, such as AP-1, 
nuclear factor-kappa B (NF-κB) and signal transducer and activator of transcription 5 (STAT-5) 
(De Bosscher and Haegeman, 2009; Stoecklin et al., 1997; Doppler et al., 2001). The effects of 
this crosstalk can either be positive or have a suppressive role on transcription (Kassel and 
Herrlich, 2007). A study by Heck et al. showed that the DBD of the GR is required for this 
modulation in transcription factor activity by a mechanism involving a direct physical interaction 
with AP-1 (Heck et al., 1994). The same study showed that homodimerization of the GR was not 
required for the repression of AP-1 regulated genes in CV-1 and COS-7 cells (Heck et al., 1994). 
Therefore, it appears that the activated GR functions as a GR monomer forming hetero-
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complexes with other transcription factors to regulate transcription. Target genes that are 
negatively regulated by this tethering mechanism of the GR have been shown to involve 
transcription factors such as AP-1 and NF-κB, involved in regulating the pro-inflammatory 
response (De Bosscher and Haegeman, 2009). It has been reported that tethering of GR to AP-1 
proteins does not alter the composition or decrease the binding of c-Jun and c-Fos to the AP-1 
site in the promoter of the collegenase gene in U2-OS cells (Kassel et al., 2004; Rogatsky et al., 
2001). Distinct domains of the NF-κB protein, namely p65, are required for binding of the GR 
and the resulting transrepression in COS-1 cells (Wissink et al., 1997). Only a few examples of 
transactivation by the GR through a tethering mechanism have been described, including an 
interaction with STAT-5 on the promoter of the β-casein gene in CV-1 and COS-7 cells 
(Stoecklin et al., 1997; Doppler et al., 2001), and c-Jun on the promoter of the α-2 macroglobulin 
gene in H35 cells (Lerner et al., 2003).  
 
Both positive and negative effects have been reported for the tethering of GR to AP-1 proteins 
(De Bosscher and Haegeman, 2009). In successive chromatin immunoprecipitation (ChIP) 
experiments the GR and AP-1 were shown to be recruited to the same collegenase-1 promoter, 
resulting in transrepression in HeLa cells (Kassel et al., 2004). c-Fos was reported  to be the 
major target of GR tethering in the inhibition of AP-1 target genes in vitro (Kerppola et al., 
1993). In contrast to the inhibition of AP-1-regulated genes by the GR such as interleukin (IL) 6, 
8 and the collegenase (Lerner et al., 2003; Kassell and Herrlich, 2007), some studies have 
reported an increase in transcription by tethering of the GR to an AP-1-containing promoter. Rani 
et al. showed that Dex treatment resulted in increased expression of the rat tyrosine hydrolase 
gene via an AP-1 site located in the promoter in PC12 cells (Rani et al., 2009). Dex also 
increased expression via an AP-1 site in the GnRHR gene in a GR-dependent manner by 
recruitment of GRIP-1, although not via a minimal AP-1-reporter gene, indicating that additional 
cis-elements in the GnRHR gene are required for the Dex-mediated increase in GnRHR gene 
expression in LβT2 cells (Kotitschke et al., 2009). Transactivation via the ligand-activated GR by 
tethering to AP-1 is also supported by Rogatsky et al. showing that GRIP-1, recruited by the 
ligand-activated GR, could activate or repress transcription via an AP-1 site, depending on the 
composition of the c-Jun/c-Fos dimer in U2-OS cells (Rogatsky et al., 2001 and 2002). Thus, 
transcriptional regulation by the GR through tethering to transcription factors involves 
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recruitment of co-factors, although the precise mechanisms that result in a positive or negative 
response remain to be determined.  
 
1.1.4 Post-translational modifications 
 
Several reports in the literature have shown that post-translational modifications of the GR 
(Figure 1.1.3) play an important role in modulating its biological function, including 
transcriptional regulation, protein-protein interactions, receptor degradation and sub-cellular 
localization (Faus and Haendler, 2006). The process of sumoylation is similar to ubiquitination 
and involves the covalent attachment of a small-ubiquitin-related modifier-1 (SUMO-1) peptide 
to lysine residues by the SUMO conjugase Ubc9 (Le Drean et al., 2002). Sumoylation of the GR 
appears to play a role in protein stability as over-expression of SUMO-1 enhanced GR 
degradation by the proteasome pathway (Tian et al., 2002). Three sumoylation sites (K277, K293 
and K703) have been identified in the human GR and if mutated simultaneously can enhance 
Dex-mediated transcription of simple GRE promoters (2 X GRE), but not complex GRE 
promoters (4 X GRE with additional cis-elements) like that of the TAT and mouse mammary 
tumor virus (MMTV) promoters, respectively (Holmstrom et al., 2003).  
 
Besides the well-described acetylation of lysine residues within histone tails, the acetylation of 
various transcription factors has been reported (Kouzarides, 2000). The lysine residues that serve 
as possible acetylation acceptor sites are conserved amongst related steroid receptors (Fu et al., 
2003). An acetylation motif (KXKK/RXKK) in the DBD of the GR corresponding to amino acids 
492 – 495 in the human GR has been reported. Ito et al. identified two residues, K495 and K496, 
within the DNA binding domain of the human GR that are acetylated after Dex-binding (Ito et 
al., 2006). They reported a decrease in the level of acetylated GR upon mutation of these two 
residues to alanine (Ito et al., 2006), although it did not result in a complete loss of acetylation 
detected, suggesting the presence of other acetylation sites not yet identified. They also 
established that acetylated GR is a substrate for histone deacetylase 2 (HDAC2) and 
deacetylation of the GR is required for its interaction with p65 and the resulting transrepression 
of inflammatory genes through a tethering mechanism (Ito et al., 2006). A previous study showed 
that the over-expression of p300 resulted in increased GR-mediated transactivation of the MMTV 
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promoter (Li et al., 2002). The same study showed that this mechanism involved GR binding to 
p300 with the increase in transcriptional activity dependent on the HAT activity of p300 (Li et 
al., 2002). However, a more recent study showed that over-expression of p300 in astrocytes 
decreased the transcriptional activity of GR on a simple GRE, while over-expression of CBP 
increased GR-mediated transactivation (Fonte et al., 2007). The results indicate that acetylation 
of the GR increases or decreases transcription of target genes in a cell- or promoter-specific 
manner. Taken together, the above findings suggest that the acetylation status of the GR plays an 











Early findings have shown that the GR exists as a phospho-protein in intact cells and becomes 
hyperphosphorylated at multiple residues upon hormone treatment (Singh and Moudgil, 1985; 
Orti et al., 1989; Housley and Pratt, 1983). Eight phosphorylation sites that are highly conserved 
between species have been identified in the mouse GR, most of which are serine residues located 
in the NTD (Galliher-Beckley and Cidlowski, 2009). Interestingly, three of the residues namely 
S212, S220 and S234 (corresponding to S203, S211 and S226 in the human GR) located in the 
AF-1 domain of the mouse GR, become hyperphosphorylated with Dex treatment, suggesting 
that phosphorylation of the GR may function to regulate transcription of target genes (Wang et 
al., 2002). The functional significance of the phosphorylation sites in the mouse GR was 
investigated by individual or simultaneous mutations of the phosphorylation residues to alanine. 
These unphosphorylated mutant receptors were compared to the wild type receptor for the ability 
to transactivate a MMTV reporter gene. The results showed that the mutated receptors had a 
similar ability compared to the wild type receptor for activating a GRE in COS-1 cells (Mason 
C N 
T8 S267 K277 
K495 
S45 S226 S404 S134 S203 
K293 
K419 K703 K494 
S211 
P P P P P P P P S S S U A A 
Figure 1.1.3: Post-translational modification of the human GR. P, phosphorylation; A, 
acetylation; S, sumoylation; U, ubiquitination. Taken and modified from (Galliher-Beckley and 
Cidlowski, 2009) and (Faus and Haendler, 2006). 
 12 
and Housley, 1993). More recent studies report an increase in the transcriptional activity of the 
mutated GR in HCT116 cells (Kino et al., 2007), while the combination of S212A, S220A and 
S234A corresponding mutations in the human GR decreased transactivation of a MMTV reporter 
gene in COS-1 cells (Avenant, 2009). These two findings suggest that phosphorylation of the GR 
regulates the transcriptional activity in a species- or cell-specific manner. 
 
Other studies have shown that the phosphorylation status of the GR plays a critical role in 
regulating various other GR properties. For instance, it was shown that phosphorylation of the 
mouse GR at all the abovementioned phosphorylation sites affects the stability of the GR protein 
by abolishing the ligand-induced GR protein degradation (Webster et al., 1997). However, a 
more recent study showed that single or a combination of mutations of the phosphorylation sites 
in the human GR has no effect on the ligand-induced degradation of the GR (Avenant, 2009). 
Additionally, it was shown that the phosphorylation status of the GR controls protein-protein 
interactions with co-factors such as GRIP-1 (Avenant, 2009) and p300/CBP (Galliher-Beckley et 
al., 2008) to regulate the transcriptional activity of the GR.   
 
Phosphorylation of the GR at a specific residue has been shown to affect the phosphorylation 
status at other sites, with an inverse relationship between the phosphorylation level at S203 and 
S226 of the human GR (Wang et al., 2007). The S203 phosphorylated GR is contained solely in 
the cytoplasm and the GRE-binding ability was abolished in the S203A mutant GR (Wang et al., 
2002; Blind and Garabedian, 2008). The inhibition of the extracellular-regulated kinase 1/2 
(ERK-1/2) reduces the level of GR phosphorylation at S203 and results in enhanced nuclear 
import with increased Dex-mediated regulation of GLUT5 mRNA expression,  supporting a role 
for phosphorylation in regulating GR transcription (Takabe et al., 2008). Together, these results 
suggest that when the GR is phosphorylated at S203, the receptor localizes to the cytoplasm and 
is transcriptionally inactive, while the level of phosphorylation at S211 of the GR directly 
correlates with the transcriptional activity of the GR as measured by gene reporter assays (Wang 
et al., 2002). In support, the S211 phosphorylated GR has been shown to be recruited to many 
GRE promoters and is thus considered a marker for GR activation (Blind and Garabedian, 2008). 
Although GR phosphorylated at S211 localized to both the nucleus and the cytoplasm of cells, 
the majority of the GR phosphorylated at S211 was found in the nucleus (Wang et al., 2002). The 
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amount of GR localizing to the nucleus is directly proportional to the level of S211 
phosphorylation (Chen et al., 2008), which has been shown to be mediated by the mitogen-
activated protein kinase (MAPK) p38 in 3T3-L1 cells (Miller et al., 2005; Nader et al., 2010). 
Taken together, the ligand-induced S211 phosphorylation of the GR is associated with nuclear 
import and transcriptional regulation of target genes and can be considered as a marker for GR 
activation. 
 
The human GR has been shown to be phosphorylated at S226 in vitro by the MAPKs, c-Jun N-
terminal kinase (JNK) and cyclin-dependent kinase 5 (CDK5) in a cell-specific manner, resulting 
in the reduced transcriptional activity of a GRE reporter gene (Avenant et al., 2010a; Itoh et al., 
2002; Kino et al., 2007; Rogatsky et al., 1998). The attenuation of GC signaling by JNK-
mediated phosphorylation of the GR at S226 resulted from enhanced nuclear export of the GR 
(Itoh et al., 2002). However, a more recent study showed that the S226 phosphorylated GR 
strongly associated with two different endogenous GRE-containing promoters, the TAT and 
sulfonyl transferase 1A1 genes (Blind and Garabedian, 2008), suggesting it is still 
transcriptionally active. In another report, Galliher-Beckley et al. showed that phosphorylation at 
S404 of the human GR occurs in response to Dex and is mediated by glycogen synthase kinase 
3β (GSK3β) in human osteosarcoma cells (Galliher-Beckley et al., 2008). Furthermore, 
constitutive phosphorylation at S404 decreased the stability of the GR protein and resulted in 
altered recruitment of co-factors (Galliher-Beckley et al., 2008). Taken together, the studies 
above suggest that the ligand-induced phosphorylation of the GR plays an important role in 
regulating GR transcription in a species-, cell- and promoter-specific manner.  
 
1.1.5 Protein degradation 
 
It has previously been shown that both GR protein and mRNA levels are down regulated in 
response to ligand (Okret et al., 1986; Dong et al., 1988; Hoeck et al., 1989; Burnstein et al., 
1994). The decrease in GR protein expression is a mechanism that may limit cellular 
responsiveness to GCs. The down regulation of GR protein levels with ligand is similar to other 
steroid receptors and involves degradation by the proteasome-ubiquitination pathway (Sheflin et 
al., 2000; Alarid et al., 1999; Lange et al., 2000).  The post-translational modification of a 
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protein by the covalent attachment of an ubiquitin protein is a process that involved three-steps. 
First, an E1 enzyme activates the 76-amino acid protein, ubiquitin, followed by transfer to a 
specific E3 ubiquitin ligase by E2 conjugating enzymes. Subsequently, the activated ubiquitin is 
covalently linked to lysine residues located within special degradation motifs of target proteins 
(Wallace and Cidlowski, 2001). As mentioned above, the human GR is ubiquitinated at K419, 
which is located in a PEST (amino acid sequence Pro (P) - Glu (E) - Ser (S) –Thr (T)) 
degradation motif (Hershko and Ciechanover, 1998; Dvorak et al., 2005). The importance of the 
E3 ubiquitin ligase CHIP (C-terminal of heat shock 70-interacting protein) for GR degradation 
was shown in HT22 hippocampal cells, which is naturally deficient in the expression of the CHIP 
E3 ligase. It was shown that over-expression of the CHIP E3 ligase in these cells restored the 
ligand-dependent degradation of the GR, resulting in reduced transactivation of a MMTV 
promoter (Wang and DeFranco, 2005). A recent study identified the calcium-activated cysteine 
protease, namely calpain, to be a protease involved in degradation of the ligand-activated GR 
(Kim et al., 2008).  
 
An early study by Dong et al. showed that the unliganded GR is gradually degraded over time 
with a half life of about 25 h, while stimulation with Dex significantly reduced the half-life to 
about 11 h in rat hepatoma cells (Dong et al., 1988). Interestingly, Hoeck et al. showed the Dex-
induced degradation of the GR to be a dose-dependent effect in NIH3T3 cells. Furthermore, the 
same study showed the unliganded GR having a half-life of about 8 h and that Dex stimulation 
decreased the half-life to about 3 h (Hoeck et al., 1989). The mutation of the ubiquitination site 
K419 in the PEST degradation motif of the human GR abolished the ligand-induced degradation, 
while increasing the transcriptional activity of the GR (Wallace et al., 2010). Furthermore, a few 
studies have shown proteasome inhibitors to have a positive effect on GR-mediated 
transactivation of various GRE promoters (Wallace and Cidlowski, 2001; Deroo et al., 2002; 
Garside et al., 2006). Taken together, the above studies suggest that the GR protein is targeted for 
degradation via the proteasome-ubiquitin pathway, while the ligand-induced degradation of the 
GR is a dose-dependent effect with the half-life varying in a cell-specific manner. The ligand-
dependent degradation of the GR could be a mechanism to prevent over-stimulation of the GR 
signaling pathway.  
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1.1.6 Rapid glucocorticoid-mediated non-genomic actions 
 
Since the early studies that investigated the mechanism of GC action, it became apparent that 
these steroid hormones could induce effects within a very short time (≤ 30 min) that occur in both 
in vitro, as well as in vivo systems. These rapid GC effects are not mediated by the delayed 
responses (hours) of the classical genomic model for steroid action, which involves nuclear 
translocation of the GR with regulation of gene expression and protein synthesis (Falkenstein et 
al., 2000). Rapid GC-mediated (non-genomic) effects are characterized by responses that do not 
directly influence gene expression initially, but result in the activation of signaling cascades that 
are not sensitive to protein synthesis inhibitors (Losel and Wehling, 2003). Therefore, the non-
genomic actions of GCs suggest that the GR has an additional mechanism to regulate gene 
transcription, which involves the reciprocal modulation of various receptors and signaling 
pathways (Tasker et al., 2006).  
 
Some of the non-genomic GC effects are mediated in a GR-independent manner through altering 
the physiochemical properties of the plasma- and mitochondrial membranes. These non-specific 
effects only occur at high concentrations of GCs, leading to the lipophillic ligands intercalating 
into the membranes, which affects the function of membrane-associated proteins (Buttgereit and 
Scheffold, 2002; Buttgereit et al., 2004). A few of these effects have previously been reported 
such as reduced transport of calcium (Ca
+2
) and sodium across the plasma membranes of immune 
cells and increased proton leakage in the mitochondrial membrane resulting in reduced levels of 
cellular ATP (Buttgereit and Scheffold, 2002; Stahn et al., 2007). However, the in vivo relevance 
of these membrane effects of GCs remains doubtful as the effects required high concentrations of 
GC (> 10 μM) in vitro, which are above the physiological and therapeutic range (Buttgereit and 
Scheffold, 2002). Another study showed that treatment of human primary bronchial epithelial 
cells with physiological concentrations (0.1 – 1 μM) of Dex rapidly reduced the level of intra-
cellular Ca
+2
 resulting in a decrease of ATP-induced secretion of Cl  ֿ . Furthermore, experiments 
with specific antagonists suggested that the Dex-induced non-genomic mechanism was 
independent of the classical GR, but rather through activation of the protein kinase A (PKA) 
signaling pathway (Urbach et al., 2002). However, showing that the rapid GC signaling is 
insensitive to the GR/PR antagonist RU486, is not evidence that the classical GR is not involved. 
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This is supported by the study of Kotitschke et al. showing that the rapid GnRH-induced 
activation of the GR was insensitive to RU486, but the classical GR was involved as determined 
by siRNA-mediated knockdown experiments in LβT2 cells (Kotitschke et al., 2009). This is 
supported by studies showing that the GnRH-induced activation of a progesterone-response-
element (PRE)-containing gene was insensitive to the PR antagonist RU486, but the PR was 
shown to be involved as determined by siRNA-mediated knockdown experiments in αT3-1 and 
LβT2 cells, respectively (An et al., 2006, 2009). Rapid GC effects can be mediated by the 
classical GR or a membrane-associated GR (Falkenstein et al., 2000; Buttgereit and Scheffold, 
2002; Lowenberg et al., 2008) as described below. 
 
1.1.6.1 Crosstalk of the classical GR with intracellular signaling 
pathways 
 
The majority of rapid GC-induced effects appear to be mediated via a crosstalk mechanism 
between the classical GR and other signaling pathways. Croxtall et al. reported that Dex could 
inhibit the rapid epidermal growth factor (EGF)-stimulated activation of phospholipase A2 
(PLA2) activation and subsequent release of arachidonic acid in A549 cells (Croxtall et al., 
2000). Additionally, the Dex-induced decrease of phosphorylation was shown to be unaffected by 
actinomycin D, an inhibitor of transcription, while specific antagonists showed the mechanism 
required the GR, JNK and ERK-1 (Croxtall et al., 2000). Interestingly, the liganded GR was 
shown to directly interact with JNK, reducing its activity and the resulting phosphorylation of c-
Jun (Caelles et al., 1997). Furthermore, GCs have been reported to rapidly activate p38 and JNK 
in PC12 cells and hippocampal neurons (Li et al., 2001; Qi et al., 2005). Taken together, these 
findings suggest that the GR signaling pathway can regulate transcription via a non-genomic 
crosstalk mechanism with members of the MAPK family. 
 
In addition to the MAPK signaling pathways, the GR has been shown to crosstalk with the Akt 
(protein kinase B) kinase signaling pathway. A recent study reported rapid Dex-induced 
phosphorylation and activation of Akt by c-src tyrosine kinase (c-src) in a GR-dependent manner 
in A549 cells (Matthews et al., 2008). Dex has been shown to rapidly activate the endothelial 
nitric oxide synthase (eNOS) enzyme in a GR-dependent and transcription-independent manner 
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(Hafezi-Moghadam et al., 2002), which was significantly reduced with specific inhibitors of 
phosphatidyl inositol 3-kinase (PI3K) and eNOS. Activation of the PI3K signaling pathway with 
Dex results in the activation of Akt, which phosphorylates and activates eNOS (Dimmeler et al., 
1999). Furthermore, a study by Solito et al. showed rapid GC-induced phosphorylation and 
membrane translocation of annexin-1, via a non-genomic GR-dependent mechanism involving 
the PI3K/Akt pathway and protein kinase C (PKC) in human folliculostellate cells (Solito et al., 
2003). Thus, these findings suggest that the GR can crosstalk with the PI3K signaling pathway 
via a non-genomic mechanism in different cells, resulting in the rapid activation of Akt that 
modulates the activity of various signaling molecules.  
 
Several studies have reported rapid GC effects can be mediated via the activation of various 
receptor tyrosine kinase (RTK) signaling pathways. As mentioned above, GCs have been shown 
to reduce the EGF stimulation of PLA2 activity by inhibiting the phosphorylation of MAPK/ERK 
kinase 1/2 (MEK1/2) in A549 cells (Malcher-Lopes et al., 2008). Another study showed GCs 
inhibiting insulin signaling in a GR-dependent non-genomic mechanism in T-lymphocytes and 
adipocytes (Lowenberg et al., 2006a). A few studies reported that the GR modulates T-cell 
signaling through a non-genomic crosstalk mechanism with members of the T-cell receptor 
(TCR) pathway (Lowenberg et al., 2005; Lowenberg et al., 2006b). The unliganded GR was 
shown to localize with the TCR at the plasma membrane in a protein complex that included 
HSP90, zeta-chain-associated protein kinase 70 (ZAP-70) and non-receptor tyrosine kinases, 
such as FYN kinase and leukocyte-specific protein tyrosine kinase (LCK). Short exposure of T-
cells to Dex impaired signaling by disruption of the membrane protein complex resulting in 
reduced activity of LCK and FYN kinases (Lowenberg et al., 2006b). Furthermore, the inhibition 
of LCK leads to a decrease in the activity of inositol-1, 4, 5-triphosphate (IP3) receptors, 
attenuating the signaling of intracellular Ca
+2
 (Harr et al., 2009). In addition, Bartis et al. showed 
rapid Dex-induced GR-dependent tyrosine phosphorylation of ZAP-70 in Jurkat cells (Bartis et 
al., 2007). These studies indicate that by inhibiting LCK through disruption of the TCR protein 
complex with the subsequent down regulation of IP3 receptors, GCs are able to suppress immune 
function by decreasing the response of the TCR. Besides modulating MAPK and PI3K/Akt 
kinase pathways, the GR appears to also modulate RTK signaling pathways upstream of MAPKs, 
such as those of the EGF, insulin and T-cell receptors. 
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Several reports in the literature suggest GR crosstalk with G-protein-coupled receptors (GPCRs) 
and G-proteins via rapid-non-genomic mechanisms (Tasker et al., 2006). Iwasaki et al. suggested 
the involvement of Gi proteins in the rapid GC-mediated inhibition of ACTH secretion (Iwasaki 
et al., 1997). Interestingly, Kino et al. reported that the activated GR directly interacts with Gβ 
proteins and co-migrates to the nucleus resulting in the repression of GR-mediated 
transactivation. In addition, the authors reported that stimulation of the somatostatin receptor, a 
GPCR, results in co-localization of the GR and Gβ at the plasma membrane in HTC116 cells 
(Kino et al., 2005). A recent study showed the involvement of a Gs-coupled receptor in the GC-
induced synthesis and release of encannabinoids from neuroendocrine cells (Malcher-Lopes et 
al., 2008). The reports described above indicate that the association of the GR with G-proteins 
could explain some of the rapid GC-mediated effects. A recent study performed by Kotitschke et 
al. demonstrated a crosstalk mechanism between the GR and the GnRHR that requires both 
receptors. The authors showed that GnRH rapidly induced site-specific phosphorylation at S234 
of the unliganded mouse GR, resulting in nuclear translocation and transactivation of a GRE 
reporter gene in LβT2 cells (Kotitschke et al., 2009). Furthermore, co-stimulation of the cells 
with Dex and GnRH resulted in a synergistic transcriptional activity of the GRE reporter gene 
(Kotitschke et al., 2009). 
 
1.1.6.2 Crosstalk of membrane-associated GR with intracellular 
signaling pathways 
 
It is possible that rapid non-genomic GC-induced effects are mediated via classical or novel GRs 
associated with the plasma membrane (mGR). A novel mGR may have several distinct 
differences from the classical receptor (Falkenstein et al., 2000; Levin, 2008). The existence of a 
63-kDa mGR was shown for the first time in amphibian neuronal membranes (Gametchu et al., 
1993), followed by identification in rat lymphoma and human leukemia cells (Gametchu et al., 
1999). Several studies have reported the mGR to be distinct from the classical cytoplasmic GR in 
several ways, including cell localization, molecular size and ligand-binding characteristics. 
However, the mGR has also been reported to have certain similarities with the cytoplasmic GR 
such as shared epitope recognition for antibodies, phosphorylation status and interactions with 
heat shock proteins (Gametchu et al., 1999; Powell et al., 1999). Furthermore, Barthalome et al. 
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showed the presence of a mGR, which was similar to the classical GR, in primary human 
monocytes and B cells with a high-sensitivity immunofluorescent staining technique (Barthalome 
et al., 2004). However, further work is required, such as cloning and functional domain analysis, 
to characterize and prove the identity of a mGR. Furthermore, whether such a cloned and 
expressed receptor binds to GCs and can mediate a non-genomic GC response remains to be 
determined.  
 
As mentioned above, rapid GC effects may be mediated via the classical GR acting at the plasma 
membrane. There have been several reports in the literature suggesting that the GR associates 
with lipid rafts, which are specialized plasma membrane microdomains that recruit various 
signaling proteins involved in coordinating the cellular response. Jain et al. showed that the 
classical GR localizes with HSP90 and STAT3 in caveolin-1-containing membrane 
microdomains, known as caveolae, in human liver Hep3B cells (Jain et al., 2005). This study 
further provided evidence for a functional role of the membrane-associated GR in Dex-mediated 
transcription, since Dex-induced GRE transactivation was significantly repressed in the presence 
of a lipid raft disrupter (Jain et al., 2005). A more recent study showed the unliganded GR 
localizing with c-src to caveolae to facilitate the rapid Dex-induced phosphorylation of Akt and 
caveolin-1 in A549 cells. Furthermore, the same study showed the loss of Dex-induced 
phosphorylation of Akt and caveolin-1 in the presence of a lipid raft disruptor, while the 
knockdown of caveolin-1 protein reduced the Dex-induced activation of Akt, but had no effect on 
GRE transactivation (Matthews et al., 2008). Taken together, since the existence of a novel mGR 
remains inconclusive, this suggests that the rapid non-genomic effects of GCs are most likely to 
be mediated via the classical GR localizing at the plasma membrane. The membrane-associated 
appears to crosstalk with several intracellular signaling pathways via a mechanism involving its 






1.2 Gonadotropin-releasing hormone receptor 
 
The hypothalamic neurohormone, gonadotropin-releasing hormone (GnRH), is released in a 
pulsatile manner and acts through a specific GPCR, the GnRHR, to activate a variety of 
intracellular signaling cascades regulating the synthesis and secretion of luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH) from gonadotrope cells in the anterior pituitary 
(Fink, 1988). The FSH and LH multi-subunit proteins form heterodimers and their synthesis 
requires the expression of three genes, Cga, Lhb and Fshb. Cga encodes an α-subunit common to 
both hormones, while Lhb and Fshb encode β-subunits unique to each hormone (Gharib et al., 
1990; Jorgensen et al., 2004). Once LH and FSH are secreted from the gonadotropes, they bind to 
distinct GPCRs in both male and female gonads stimulating gametogenesis and steroidogenesis 
(Segaloff and Ascoli, 1993; Simoni et al., 1997).  
 
The pituitary responsiveness to GnRH is dependent on the GnRHR numbers expressed on the cell 
surface of the gonadotropes (Kaiser et al., 1993; Norwitz et al., 1999). GnRH has been identified 
as a positive regulator of GnRHR gene expression in vivo and in vitro (Kaiser et al., 1993; Young 
et al., 1984; Wu et al., 1994), thereby generating a feedback mechanism controlling reproduction. 
At least two forms of the decapeptide hormone (GnRH I and GnRH II), as well as the receptor 
(GnRHR I and GnRHR II), have been found in most vertebrates, including mammals (Millar, 
2003; Neill et al., 2004; Pawson et al., 2003). However, both GnRH peptides can bind to and 
activate both receptors, while GnRH I has a greater affinity for GnRHR I and vice versa (Millar 
et al., 2001).  The regulation of GnRHR expression has been shown to occur at the 
transcriptional, translational and post-translational level, but the underlying molecular 
mechanisms involved have not been fully investigated (Hapgood et al., 2005; Ciechanowska et 
al., 2010; Naor, 2009).  
 
The amplification of the genomic DNA from several different vertebrates with a highly 
conserved domain of the GnRHR identified novel GnRHR sequences. The type II receptor was 
found in many mammalian and non-mammalian species, while this approach also identified type 
III receptors in several amphibian species (Troskie et al., 1998; Millar et al., 2004). The existence 
of several other GnRHRs suggests an early evolution of the three GnRH and GnRHR subtypes in 
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vertebrates. However, a full-length functional transcript of type II receptor has not been found in 
human or mouse cells, although it is present in monkey cells (Ronacher et al., 2004; Millar et al., 
2001; Hapgood et al., 2005). The absence of the full-length GnRHR type II transcript results 
from the presence of a frame-shift and premature stop codon in the human and mouse type II 
receptor genes (van Biljon et al., 2002; Faurholm et al., 2001; Morgan et al., 2003; Gault et al., 
2004). It is now becoming apparent that the vast effects of GnRH I and II are both mediated by 
the human type I GnRHR via coupling to different signaling pathways (Hawes et al., 1993).  
 
1.2.1 Physiological function 
 
The physiological importance of the GnRHR in mammalian reproduction is evident from the 
findings that several naturally-occurring mutations in the human receptor result in the disease 
named hypogonadotropic hypogonadism, with symptoms of delayed sexual development and low 
gonadotropin and steroid hormone levels (Seminara et al., 1998; Millar et al., 2004). The 
majority of these mutated GnRHR are incorrectly folded proteins that are retained in the 
endoplasmic reticulum or display attenuated trafficking to plasma membrane, which together 
result in low levels of functional GnRHR (Knollmann et al., 2005; Brothers et al., 2004). GnRHR 
agonists and antagonists have been extensively used in clinical treatments for fertility-related 
disorders, various reproductive diseases and hormone-dependent cancers (Conn and Crowley, 
1994; Neill, 2002). 
 
In addition to its important function in regulating gonadotropin expression in the pituitary, there 
is convincing evidence in the literature showing the expression of GnRHR I in female 
reproductive tissues, including the breast, ovary, endometrium and the placenta (Hapgood et al., 
2005; Cheng and Leung, 2005). In these tissues, GnRH-activation of GnRHR I plays a role in the 
establishment and maintenance of pregnancy, regulation of the menstrual cycle, regulation of 
breast and ovary development and inhibition of steroidogenesis in the ovary (Kottler et al., 1997; 
Kogo et al., 1999; Raga et al., 1998; Guerrero et al., 1993). Several studies have shown the 
expression of GnRH and GnRHR I in the human testis and prostate, where they play a role in 
regulating testicular development, sperm motility and sperm-oocyte interactions (van Biljon et 
al., 2002; Kakar et al., 1992; Cheung and Hearn, 2003; Morales, 1998).  
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Besides the wide distribution of the GnRHR in the pituitary and reproductive systems, the 
receptor has been found in other cell types. Hypothalamic GnRH neurons have been found to 
express GnRHR I, while both GnRHR I and II has been detected in many mammalian brain 
tissues, supporting a role for GnRH as a neurotransmitter (Hapgood et al., 2005; Martinez-
Fuentes et al., 2004). In addition, a few studies have indicated a role for GnRH in regulating 
immune responses. From this point onwards, the type I GnRHR will be referred to as the 
GnRHR. The expression of GnRH and GnRHR has been detected in T-cells, where GnRH was 
shown to stimulate the adhesion, migration and homing of T-cells into specific organs (Chen et 
al., 2002; Jacobson et al., 1998). The expression of functional GnRHR has been detected in a 
wide range of carcinomas originating from the endometrium, ovary and breast tissues (Imai et al., 
1994; Imai and Tamaya, 2000; Limonta et al., 2003). It is well known that continuous 
administration of GnRH analogues can inhibit proliferation of human malignant tumors (Cheng 
and Leung, 2005; Grundker et al., 2002). Another study found GnRH analogs to have anti-
proliferative effects in human melanoma cells, suggesting that the GnRHR-mediated inhibition of 
growth effects are not unique to reproductive tissue carcinomas (Limonta et al., 2003). The anti-
tumor effects appear to be mediated via inhibition of gonadal steroids and modulation of growth 
factor expression (Cheng and Leung, 2005). However, the signaling pathways and mechanisms 
mediating the anti-proliferative effects of GnRH are unknown and further work is required 
(Pawson et al., 2003). Taken together, the above findings indicate that the GnRHR is expressed 
in a wide variety of mammalian tissues and appears to be involved in a wide range of functions, 
including proliferation of several types of carcinomas by modulating growth factor expression 
and steroid synthesis in the gonads. 
 
1.2.2 Protein structure 
 
The GnRHR was first identified in the mouse by cloning the receptor from the pituitary αT3-1 
gonadotrope cell line (Tsutsumi et al., 1992), which was confirmed by another study (Reinhart et 
al., 1992). Subsequently, the GnRHR sequence was cloned from pituitary tissues of various 
mammalian species including human (Chi et al., 1993; Kakar et al., 1992), rat (Kaiser et al., 
1992; Eidne et al., 1992), sheep (Illing et al., 1993; Brooks et al., 1993) and pig (Weesner et al., 
1994). In contrast to the genes of many other members of the GPCR family, which are without 
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introns, the human and mouse GnRHR genes span more than 15 kb of DNA and contain two 
introns (Fan et al., 1994; Zhou and Sealfon, 1994). The introns are located at similar regions in 
the human and mouse GnRHR genes, although they appear to vary in size. Both the human and 
the mouse genome only have a single copy of the GnRHR gene, as determined by Southern blot 
analysis (Zhou and Sealfon, 1994).  
 
The mammalian GnRHRs share a conserved amino acid sequence with over 80% homology 
across species (Stojilkovic et al., 1994). Homologs of the mammalian GnRHR have also been 
found in various other non-mammalian species, sharing 42 – 47% amino acid sequence identity 
with mammalian receptors and 58 – 67 % homology among each other (Millar et al., 1994; 
Troskie et al., 1998). The GnRHR belongs to the rhodopsin-like GPCR superfamily and consists 
of a single polypeptide chain of 327 or 328 amino acids for the mouse and the human GnRHR, 
respectively (Sealfon et al., 1997). The mammalian GnRHR consist of a N-terminal domain and 
seven transmembrane helix (TM) domains, which are connected by three extracellular loop 
domains and three intracellular loop domains. A unique feature of the mammalian type I GnRHR 
is the absence of a carboxyl-terminal tail, which is present in all other GPCRs and in type II 
GnRHR (Millar et al., 2004; Sealfon et al., 1997). The extracellular domains are involved in the 
binding of ligands and the TM domains are believed to be involved in conformational changes 
associated with signal propagation of the activated receptor. These conformational changes are 
thought to be crucial for the receptor to interact with G-proteins and other proteins involved in 
signal transduction (Millar et al., 2004).  
 
1.2.3 Signaling pathways 
 
When GnRH binds to its receptor in the plasma membrane of gonadotrope cells, it induces a 
conformational change in the receptor that stimulates the activation of heterotrimeric G-proteins. 
GnRHR may couple to multiple G-proteins to achieve the various biological effects of GnRH 
(Stanislaus et al., 1998; Liu et al., 2003). The members of the Gαq/11 protein family are the main 
group of G-proteins that are activated by GnRH in a GnRHR-dependent manner, while the 
activation of Gαi/o and Gαs has also been reported (Naor, 2009). However, the activation of Gαi/o 
and Gαs proteins by the GnRHR was not found in all experimental systems, suggesting that the 
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nature of G-protein coupling to the GnRHR depends largely on the cellular context (Ruf et al., 
2003). Two immortalized mouse pituitary gonadotrope cell lines have mainly been used to 
investigate GnRHR signaling. These are αT3-1 cells, that represent precursor gonadotrope cells 
and do not express the β-subunit of gonadotropins, and LβT2 cells that represent more mature 
gonadotrope cells expressing fully functional gonadotropin mRNA and proteins (Mellon et al., 
1990; Turgeon et al., 1996). The GnRHR has been shown to couple to Gαq/11 in αT3-1 cells, 
while both Gαq/11 and Gαs can couple to the receptor in LβT2 cells (Grosse et al., 2000; Liu et al., 
2002a). In primary pituitary cultures, GnRHR can couple to several different G-proteins, 
including Gi, Gq11 and Gs (Hawes et al., 1992; Stanislaus et al., 1998; Stanislaus et al., 1997). In 
addition, the GnRHR can couple to different G-proteins, as would potentially be required from 
the significant variation in the expression levels of G-proteins in the pituitary during the different 
phases of the reproduction cycle (Bouvier et al., 1991). 
 
The GnRHR activates many intracellular signaling pathways, including phospholipase A2, Cβ 
and D, which result in the release of various secondary signaling molecules such as IP3, 
diacylglycerol and arachidonic acid (Ando et al., 2001; Kraus et al., 2001). The release of IP3 
mobilizes intracellular Ca
+2
 stores and induces Ca
+2
-influx by voltage-gated ion channels, which 
activates PKC isoforms expressed in gonadotrope cells (Liu et al., 2002b; Kraus et al., 2001). In 
addition, GnRH-stimulation was shown to increase intracellular cAMP levels via a Ca
+2
-
independent mechanism involving the activation of adenylyl cyclase 5 and 7 by PKC in LβT2 
cells (Lariviere et al., 2007). Furthermore, GnRH has been reported to activate all four of the 
known mammalian MAPK cascades, namely JNK, p38, ERK-1/2 and the big MAPK 
(BMK1/ERK-5) in pituitary gonadotrope cell lines (Naor et al., 2000; Kraus et al., 2001). 
Additionally, GnRH activates all of the MAPKs in both αT3-1 and LβT2 cells in a PKC-
dependent manner (Bonfil et al., 2004; Roberson et al., 1999, Liu et al., 2002b; Liu et al., 2003; 
Mulvaney et al., 1999; Sundaresan et al., 1996). PI3K and c-src have also been reported to be 
activated in a GnRHR-dependent manner and to be involved in the regulation of the FSHβ gene 
in LβT2 cells (Bonfil et al., 2004; Kanasaki et al., 2006). Taken together, the above results 
suggest that the GnRHR can couple to and activate various G-proteins leading to the activation of 
many different intracellular signaling pathways, such as MAPKs and other protein kinases, to 
regulate mammalian reproduction.   
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1.2.4 Crosstalk with other receptor signaling pathways 
 
The GnRHR can crosstalk with several other receptor signaling pathways as a mechanism for 
generating signaling diversity. Crosstalk of GnRH with the EGF receptor (EGFR) has been 
reported in the literature, with studies reporting the GnRH-induced transactivation or inhibition 
of the EGFR (Cheung and Wong, 2008). The negative crosstalk of GnRH with the EGFR appears 
to be accountable for the anti-proliferative effects of GnRH on various reproductive tumor cells 
(Gunthert et al., 2005; Yates et al., 2005; Eicke et al., 2006; Moretti et al., 1996; Grundker et al., 
2001). The mechanism appears to be mediated by the GnRHR via activation of a tyrosine-
phosphatase, which reduces the EGF-induced autophosphorylation of the EGFR (Moretti et al., 
1996; Grundker et al., 2001; Lamharzi et al., 1998a). Similarly, GnRH inhibits expression of the 
insulin-like growth factor receptor, tyrosine phosphorylation of the receptor and the subsequent 
downstream activation of the PI3K/Akt pathway (Marelli et al., 1999; Lamharzi et al., 1998b; 
Montagnami Marelli et al., 2007). In addition to its inhibitory role in mitogenic signaling, the 
GnRHR has also been shown to crosstalk with several non-receptor tyrosine kinases such as focal 
adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2), suggesting a role for the 
GnRHR in regulating integrin signaling and cytoskeletal reorganization (Choi et al., 2006).  
 
The GnRHR has also been shown to modulate NF-κB signaling. A study by Sakamoto et al. 
showed that GnRH reduced the expression of IL-8 through attenuating the tumor necrosis factor 
α (TNFα)-induced signaling of NF-κB in endometriotic stromal cells (Sakamoto et al., 2003). A 
more recent study showed GnRH stimulates the phosphorylation of p65 to induce expression of 
the cyclooxygenase-2 gene by binding to composite NF-κB elements in the promoter in LβT2 
cells (Naidich et al., 2010). These findings suggest cell-specific differences in the modulation of 
NF-κB signaling by the GnRHR. In a recent study, Naor et al. demonstrated a reciprocal genomic 
crosstalk mechanism between the GnRHR and prostaglandin (PG) receptors in LβT2 cells (Naor 
et al., 2007). The authors showed that GnRH stimulates PG synthesis through induction of the 
cyclooxygenase-2 gene, which in turn inhibited the GnRH-induced expression of the GnRHR and 
LH genes (Naor et al., 2007).  
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The GnRHR has also been reported to crosstalk with several steroid hormone receptors. GnRH 
was shown to induce nuclear translocation of the AR by a mechanism involving c-src, however 
the receptor was not transcriptionally active (Maudsley et al., 2006). In addition, GnRH was 
shown to activate the PR through PKC-dependent phosphorylation  in a ligand-independent 
manner, resulting in induction of PR-responsive genes, such as glycoprotein hormone α-subunit 
and FSHβ in αT3-1 and LβT2 cells, respectively (An et al., 2006; An et al., 2009). A recent study 
by Chen et al. demonstrated that GnRH stimulates the ligand-independent activation of the 
estrogen receptor by phosphorylation in a GnRHR-dependent manner to induce transactivation of 
ER-responsive genes, such as FosB, in LβT2 cells (Chen et al., 2009). Kotitschke et al. 
demonstrated a reciprocal crosstalk mechanism between the GnRHR and the GR (Kotitschke et 
al., 2009). The authors showed that GnRH induced the rapid phosphorylation and activation of 
the GR resulting in transactivation of a transient GRE reporter gene or the induction of the 
endogenous GnRHR gene in a GR- and GnRHR-dependent manner. In addition, co-stimulation 
with Dex and GnRH resulted in a synergistic transcriptional response on both the transient GRE 
reporter and the endogenous GnRHR gene (Kotitschke et al., 2009). It is important to note that 
the underlying mechanisms involved for GnRHR crosstalk with other signalling pathways are not 
fully understood. There is no report in literature indicating a direct reciprocal modulation of 
GnRHR activity with any other receptors, while most of the above-mentioned effects of GnRH 
appear to be mediated via downstream signalling molecules, such as kinases or transcription 
factors. An important question that remains to be determined is if the mechanism of GnRHR 
crosstalk with other receptor signalling pathways could be mediated by co-localization and 
perhaps even an interaction of these receptors. In summary, the above results suggest that the 
GnRHR can crosstalk with several signalling pathways, including tyrosine kinases, MAPKs, 








1.3 Lipid rafts 
 
1.3.1 Properties and structure 
 
The plasma membrane of eukaryotic cells defines the cell boundary and is involved in transport, 
cell signaling, cellular contact and many other cellular events to maintain their physiological 
state. For a long time, the fluid mosaic model, postulated by Singer and Nicholson in 1972, has 
provided the foundation for the understanding of the structure of cellular membranes (Singer and 
Nicholson, 1972). In this model, membranes are described as a sea of lipids that exists in a liquid-
disordered state with membrane proteins randomly associated within the membrane. However, 
numerous studies over the past 15 years have indicated that it is possible for liquid-ordered 
domains to exist that allow the organization of proteins within membranes (Brown and London, 
1998; Pike, 2006). These ordered domains in membranes are called lipid rafts, which are 
localized regions of elevated cellular cholesterol and glycosphingolipid content. The fatty acid 
side-chains of the phospholipids in lipid rafts tend to be more saturated than those in the 
surrounding membrane, allowing the close packing of the lipids leading to phase separation 
(Lingwood et al., 2009). Furthermore, the high cholesterol content decreases the membrane 
fluidity, which further promotes the phase separation and results in the formation of lipid rafts 
(Pike, 2006). Simons and Ikonen have formulated a hypothesis regarding lipid rafts postulating 
the existence of lateral assemblies of glycosphingolipids and cholesterol, which associate with 
specific proteins while excluding others. The differential separation and co-localization of 
membrane proteins to a distinct phase of the cell membrane is the fundamental principle by 
which lipid rafts are thought to exert their physiological function (Simons and Ikonen, 1997).  
 
The first definition of lipid rafts was suggested by Brown and Rose, who reported that domains 
enriched in glycosylphosphatidylinositol (GPI)-anchored proteins and spingholipids from cellular 
membranes were insoluble in Triton X-100 and floated to a characteristic density with 
equilibrium density gradient centrifugation (Brown and Rose, 1992). Together with the 
observation that this detergent-resistance was dependent on cholesterol and mainly enriched for 
constituents of the liquid-ordered phase, these preparations, known as detergent-resistant 
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membranes (DRM), became the method for assigning the affinity of various proteins for lipid 
rafts (Schroeder et al., 1994a). The presence of lipid rafts in intact cell membranes is supported 
by several lines of evidence, including studies involving fluorescence resonance energy transfer 
(FRET), single-particle tracking, photonic force microscopy and the biochemical cross-linking of 
lipid raft proteins (Simons and Toomre, 2000; Pike, 2006; Brown and London, 1997; Mayor and 
Rao, 2004; Pike, 2004). A few recent studies have suggested that lipid rafts are small structures 
(10 – 200 nm), while rafts have also been reported to coalesce into larger platforms through 





Caveolae are characterized by flask-shaped invaginations of the plasma membrane that comprise 
a special subpopulation of lipid rafts and can be distinguished by the presence of caveolin-1 
(Figure 1.3.1) (Harder and Simons, 1997). They were first identified based on their morphology 
in mouse gall bladder epithelial cells by electron microscopy over 50 years ago (Yamada, 1955). 
Caveolae are found in many different types of cells, but they are most numerous in well-
differentiated cells, such as smooth-muscle cells, fibroblasts, endothelial cells and adipocytes 
(Volonte et al., 1999; Lisanti et al., 1995; Parton, 1996). Caveolin proteins (21 – 24 kDa) are the 
fundamental components of caveolae and there are three known proteins, caveolin-1 (Cav-1) with 
splice variants α and β, Cav-2 and Cav-3 (Tang et al., 1996; Scherer et al., 1996; Glenney, 1992). 
Human Cav-1 and Cav-2 have overlapping expression patterns in a variety of cell types, 
including endothelial, epithelial, glia and neurons (Galbiati et al., 1998a; Ikezu et al., 1998; 
Lisanti et al., 1994; Vogel et al., 1998), whereas Cav-3 is found in skeletal and smooth muscle 
cells (Tang et al., 1996; Way and Parton, 1995). Cav-1 has been shown to bind cholesterol, 
which is required for attaining a proper morphology and cellular function (Murata et al., 1995). 
This sequestration of cholesterol by Cav-1, together with the polymerization of caveolin proteins, 
which are hairpin-like palmitoylated integral membrane proteins, drives the invagination of 
caveolae into the cell membrane (Cohen et al., 2004). The discovery that caveolin proteins are 
highly enriched in DRMs led to the interpretation that caveolae and lipid rafts are equivalent 
membrane structures. However, lipid rafts could also be isolated from cells that do not have 
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caveolae (Fra et al., 1994; Gorodinsky et al., 1995). In addition, caveolae from isolated 
membrane fractions can be separated from the bulk lipid raft-associated GPI-anchored proteins 
(Schnitzer et al., 1995). These findings indicated that lipid rafts are distinct from caveolae and 
could exist inside or outside caveolae (Parton and Simons, 1995).  
 
It was previously shown that the over-expression of Cav-1 in cells lacking caveolae, such as 
lymphocytes, was sufficient to induce the formation of caveolae (Fra et al., 1995). Furthermore, 
the knockdown of Cav-1 and Cav-3 proteins results in the loss of caveolae formation in the 
specific cell type in which they are expressed (Galbiati et al., 2001; Razani et al., 2001; Cohen et 
al., 2004). In contrast, the knockdown of Cav-2 has no affect on caveolae formation in vivo 
(Razani et al., 2002), but it might contribute to stabilization of caveolae through oligomerization 
with Cav-1 in certain cell types (Lahtinen et al., 2003; Sowa et al., 2003). In summary, caveolae 
are a sub-population of lipid rafts that form omega-shape invaginations in the plasma membrane 
and are stabilized by caveolin proteins. The structure of caveolae provides a functional domain 














Figure 1.3.1: Plasma membrane organization of caveolae and lipid rafts. Several commonly 
associated molecules and proteins are shown, as well as the regions considered lipid raft 
microdomains, which are present in a more liquid-ordered state as compared to the bulk plasma 
membrane. Taken from (Allen et al., 2007). 
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1.3.2 Physiological function 
  
1.3.2.1 Cell signaling 
 
A great variety of proteins, especially those involved in cell signaling, have been shown to 
associate with lipid rafts via different mechanisms (Simons and Toomre, 2000; Pike, 2004; 
Zajchowski and Robbins, 2002). The mechanisms that dictate the lipid raft association of proteins 
are variable and not well understood. For some membrane proteins, lipid raft association is 
mediated via the transmembrane domain (Scheiffele et al., 1997), while other proteins can 
associate with lipid rafts through direct binding of cholesterol (Murata et al., 1995). However, the 
majority of proteins, including GPI-anchored proteins, members of the src kinase family and 
eNOS, associate with lipid rafts through the modification of reversible lipid modifications 
(Shenoy-Scaria et al., 1994; Shaul et al., 1996). Some membrane receptors have a weak affinity 
for lipid rafts in the unliganded state. After binding to a ligand, some membrane receptors 
changes conformation and oligomerize, which increases the affinity of association with lipid rafts 
(Harder et al., 1998). Taken together, the above findings suggest that a variety of mechanisms is 
employed to regulate the localization of proteins to lipid rafts. 
 
Many RTKs, including the EGFR, insulin receptor and the platelet-derived growth factor (PDGF) 
receptor, have been shown to localize to lipid rafts (Mineo et al., 1996, Gustavsson et al., 1999; 
Liu et al., 1996; Wu et al., 1997). The effect of ligand binding on this association of RTKs with 
lipid rafts is highly variable (summarized in Table 1.3.1). The unliganded EGFR exists in lipid 
rafts and partially moves out of lipid rafts upon agonist-binding and activation (Mineo et al., 
1999), a feature that is unique among RTKs. Consistent with its movement out of lipid rafts, the 
autophosphorylated EGFR localizes to intra-cellular compartments (Wang et al., 2009; Balbis et 
al., 2007). Interestingly, Puri et al. showed that several endocytic proteins are recruited to lipid 
rafts containing the activated EGFR (Puri et al., 2005). Therefore, lipid rafts have the ability to 
assemble both a signaling complex for the EGFR and proteins required for receptor 
internalization (Balbis et al., 2007). The insulin receptor is constitutively localized to caveolae, 
while ligand-binding is required for the receptor to localize to lipid rafts in cells that lack 
caveolae (Vainio et al., 2002). Furthermore, the constitutive localization of the PDGF and nerve 
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growth factor (NGF) receptors to lipid rafts appears to be unaffected by ligands (Huang et al., 
1999; Liu et al., 1996). Interestingly, PDGF and NGF receptors were shown to be 
autophosphorylated within lipid rafts after hormone treatment, which is required for these 
receptors to associate with their downstream signaling cascades (Liu et al., 1996; Huang et al., 
1999; Liu et al., 1997).  
 








rafts Unaffected Reference 
Receptor tyrosine kinase    
       
EGF  X  Mineo et al., 1999 
Insulin   X Gustavsson et al., 1999 
  X   Vainio et al., 2002 
NGF   X Liu et al., 1996 
       
G-protein-coupled receptor    
       
GnRH   X Navratil et al., 2003 
β2-adrenergic  X  Rybin et al., 2000 
Endothelin   X Chun et al., 1994 
Rhodopsin   X Seno et al., 2001 
Angiotensin II type I X   Ishizaka et al., 1998 
          
 
A large number of GPCRs have been shown to be enriched in lipid rafts, including the type I 
GnRHR, β1 and β2-adrenergic receptors, acetylcholine receptor, muscarinic cholinergic receptor, 
rhodopsin receptor, angiotensin II type I receptor and endothelin receptor (Navratil et al., 2003; 
Rybin et al., 2000; Xiang et al., 2002; Chun et al., 1994; Feron et al., 1997; Seno et al., 2001; 
Ishizaka et al., 1998; Dessy et al., 2000). Like the RTKs, the localization of GPCRs to lipid rafts 
appears to be modulated by ligand (summary in Table 1.3.1). The unliganded β-adrenergic 
receptor is present in lipid rafts and moves out upon ligand treatment, while the acetylcholine, 
muscarinic cholinergic and angiotensin II type I receptors are targeted to lipid rafts upon 
activation with ligand (Ishizaka et al., 1998; Feron et al., 1997; Dessy et al., 2000). In contrast, 
the GnRHR, endothelin receptor and rhodopsin receptor are constitutively localized to lipid rafts, 
and this localization is unaffected by ligand (Navratil et al., 2003; Chun et al., 1994). In addition, 
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various G-proteins have been reported to localize to lipid rafts through a mechanism involving 
lipid modifications (Seno et al., 2001; Pike and Miller, 1998; Huang et al., 1997; Li et al., 1995; 
Lisanti et al., 1994; Moffett et al., 2000).  
 
In addition to receptor localization with lipid rafts in the presence of ligand, many downstream 
signaling molecules can be recruited to the activated receptor in lipid rafts. For instance, 
stimulation of Rat1 cells with EGF resulted in the recruitment of raf-1 to lipid rafts within 30 
seconds (Mineo et al., 1996). Raf-1 recruited to lipid rafts is activated through phosphorylation of 
the lipid raft-associated protein Ras, which results in activation of MEK1/2 and the subsequent 
MAPK pathways (Zhong et al., 2001; Simons and Toomre, 2000). Furthermore, several different 
types of adenylate cyclase, including type III, IV, V and VI, have been found to localize to lipid 
rafts (Rybin et al., 2000; Ostrom et al., 2001; Ostrom et al., 2000; Ostrom et al., 2002). Several 
other types of signaling molecules have also been found in lipid rafts, including src family 
kinases, the phosphotyrosine phosphatase syp, growth factor receptor-bound protein 2 (Grb2), the 
p85 subunit of PI3K and CD44. (Sargiacoma et al., 1993; Lisanti et al., 1994; Gorodinsky and 
Harris, 1995; Bickel et al., 1997; Gomez-Mouton et al., 2001). 
 
In order to study the function of lipid rafts in signaling, several researchers have employed an 
approach that involves the cholesterol depletion of cells to disrupt the integrity of lipid raft 
structures (Table 1.3.2). The integrity of lipid rafts can be disrupted by treating cells with agent 
such as methyl-β-cyclodextrin (MβCD) and filipin-III, which extract and sequester cellular 
cholesterol (Ohtani et al., 1989; Kilsdonk et al., 1995; Pike and Miller, 1998). Treatment of cells 
with MβCD attenuated the insulin-induced autophosphorylation of its receptor and the insulin 
receptor substrate 1, while reducing glucose uptake and oxidation in adipocytes, suggesting a role 
for lipid rafts in insulin signaling and metabolism (Parpal et al., 2001; Gustavsson et al., 1999; 
Vainio et al., 2002; Le Lay et al., 2001). Furthermore, cholesterol depletion also decreased the 
insulin-induced activation of Akt, while having no effect on the activation of ERK-1/2 in 
adipocytes, suggesting that Akt rather than MAPK signaling is involved (Parpal et al., 2001). 
Similarly, disruption of lipid rafts inhibited the PDGF-induced activation of PI3K and decreased 
the tyrosine kinase activity of the PDGF receptor in endothelial cells (Liu et al., 1997; McGuire 
et al., 1993). In contrast, lipid rafts seem to play an inhibitory role in EGFR signaling, since 
 33 
disruption of lipid rafts resulted in an increased affinity for ligand binding of the EGFR and 
enhanced receptor dimerization, autophosphorylation and activation of the ERK-1/2 signaling 
pathway (Furuchi and Anderson, 1998; Pike and Casey, 2002; Ringerike et al., 2002; Roepstorff 
et al., 2002). Therefore, the unique feature of the EGFR to move out of lipid rafts seems to be 
coupled to activation of the receptor. 
 
Table 1.3.2: Summary of the effects of cholesterol depletion on the signaling of 





Receptor tyrosine kinase    
      
Ligand-binding EGF + Pike and Casey, 2002 
Dimerization EGF + Chen and Resh, 2002 
Autophosphorylation EGF + Ringerike et al., 2002 
MAPK activation EGF + Furuchi and Anderson, 1998 
Ligand-binding Insulin 0 Parpal et al., 2001 
Autophosphorylation Insulin 0 or - Vainio et al., 2002; Parpal et al., 2001 
IRS-1 phosphorylation Insulin - Parpal et al., 2001 
Glucose uptake Insulin - Gustavsson et al., 1999 
MAPK activation Insulin 0 Parpal et al., 2001 
Akt activation Insulin - Parpal et al., 2001 
      
G-protein-coupled receptor    
      
MAPK activation GnRH - Navratil et al., 2003 
Adenylate cyclase 
activation β2-Adrenergic + Rybin et al., 2000 
MAPK activation Endothelin - Teixeira et al., 1999 
FAK activation Endothelin - Teixeira et al., 1999 
EGFR transactivation Angiotensin II - Ushio-Fukai et al., 2001 
Activation Rhodopsin + Niu et al., 2002 
        
 
Cholesterol extraction with MβCD prevented the GnRHR from activating the ERK-1/2 pathway 
resulting in decreased gene expression of FosB in αT3-1 cells (Navratil et al., 2003; Bliss et al., 
2007). Similarly, the thrombin-stimulated phosphatidic acid generation and IP3 production was 
inhibited when lipid rafts were disrupted by cholesterol extraction, resulting in decreased 
activation of human platelets (Bodin et al., 2001). Likewise, the endothelin-stimulated tyrosine 
phosphorylation of ERK-1/2 and FAK was inhibited when primary astrocytes were treated with 
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filipin-III (Teixeira et al., 1999). In contrast, cholesterol extraction increased both adenylate 
cyclase activation and myocyte contraction mediated by the β-adrenergic receptor in cardiac 
myocytes (Rybin et al., 2000; Xiang et al., 2002). A very interesting observation is that both the 
β-adrenergic receptor and EGFR move out of lipid rafts upon ligand-binding and the signaling 
pathways of both receptors are activated with depletion of cholesterol. It is possible that the 
activation of the EGF and β-adrenergic receptors are inhibited by associating with specific 
inhibitory proteins in lipid rafts, while ligand-binding changes the conformation of the receptor 
with release of these inhibitory proteins. Thus, cholesterol depletion assays showed that lipid 
rafts are important for GPCR, RTK and MAPK signaling pathways as summarized in Table 
1.3.2.  
 
 1.3.2.2 Role in health and disease 
 
Lipid rafts regulate a wide variety of signaling pathways that are responsible for controlling 
crucial cellular functions. Therefore, lipid rafts have been implicated in a great variety of 
diseases, including atherosclerosis, diabetes, cancer, muscular dystrophy and neurodegenerative 
disorders (Frank et al., 2004; Inokuchi, 2006; Patra, 2008; Cohen et al., 2004; Simons and 
Ehehalt, 2002; Wolozin, 2001). Furthermore, there is increasing data in the literature showing 
that lipid rafts function as the entry and budding sites in host cells for various bacteria, viruses 
and pathogens (summarized in Table 1.3.3).  
 
Alzheimer’s disease is characterized by the formation of senile plaques containing the amyloid-β-
peptide (Aβ). The sequential enzymatic cleavage of the large type I transmembrane protein, 
amyloid precursor protein (APP), by β-secretase (BACE) and γ-secretase results in the formation 
of the peptide Aβ. Alternative enzymatic cleavage of APP in the middle of the Aβ domain by α-
secretase results in the release of the non-amyloidogenic α-domain (Mattson, 2004; Selkoe, 
2001). Importantly, the α- and β-secretase enzymes directly compete for their common substrate 
APP, suggesting that Aβ production could be regulated by controlling availability of APP to 
these enzymes. Interestingly, it has been reported that the β-, γ-secretases and Aβ partially 
localize to lipid rafts (Lee et al., 1998; Riddell et al., 2001; Wada et al., 2003), while APP 
appears to be largely excluded from lipid rafts in CHO cells (Kaether and Haass, 2004). 
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Furthermore, it was shown that cholesterol depletion inhibited the formation of Aβ by decreasing 
the activity of β-secretase, while enhancing α-cleavage (Simons et al., 1998; Kojro et al., 2001). 
Taken together, the above results suggest that the association of BACE with lipid rafts, which 
restricts access to APP, could be a potential mechanism regulating the formation of Aβ. 
 
Table 1.3.3: Diseases in which lipid rafts are involved 
Disease Reference 
Alzheimer's disease   Cecchi et al., 2009 
Atherosclerosis    Yu et al., 2010 
Pulmonary hypertension   Mathew et al., 2004 
Systemic lupus    Deng and Tsokos, 2008 
Asthma     Karman et al., 2010 
Niemann-Pick disease   Vainio et al., 2005 
Muscular dystrophy   Moral-Naranjo et al., 2010 
Viral infections      
  Enveloped viruses     
   Influenza virus Parpal et al., 2001 
   HIV-1   Kilsdonk et al., 1995 
   Herpes simplex virus Koshizuka et al., 2007 
   Ebola virus Freitas et al., 2007 
  Non-enveloped viruses   
   SV-40   Pike and Miller, 1998 
   Rotavirus   Cuadras and Greenberg, 2003 
Bacterial infections      
Escherichia coli    Clark et al., 2005 
Vibrio cholerae    Deng and Tsokos, 2008 
Mycobacterium tuberculosis   Shin et al., 2008 
Other pathogens      
Shiga toxin    Huang et al., 2010 
Lipopolysaccharide    Dhungana et al., 2009 
Prion (Creutzfeldt-Jakob disease) Taylor et al., 2009 
Plasmodium falciparum   Garcia et al., 2009 
          
 
Several bacteria and viruses utilize lipid raft-associated proteins to infect host cells (Table 1.3.3). 
The influenza virus was the first to be characterized and contains two integral membrane spike 
proteins, namely neuraminidase and hemagglutinin, which have been shown to localize to lipid 
rafts, based on studies of cholesterol depletion in MDCK cells (Scheiffele et al., 1999; Barman 
and Nayak, 2000). Influenza viruses preferentially include lipid raft-containing lipids in its 
envelope during budding from the apical membrane of MDCK cells (Zhang et al., 2000). 
Similarly, the envelope of the human immunodeficiency virus 1 (HIV-1) was shown to be 
derived from lipid rafts, and to include the host ganglioside GM1, as well as proteins such as 
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Thy-1 and CD59 (Brugger et al., 2006; Tritel and Resh, 2001; Chazal and Gerlier, 2003; Nguyen 
and Hildreth, 2000), suggesting that budding from lipid rafts may be a general mechanism 
amongst envelope viruses. HIV-1 mediates entry into host cells by binding to the CD4 receptor 
through the viral envelope glycoprotein gp120. The binding to CD4 receptors induces a 
conformational change in gp120, allowing the virus to interact with the cell-surface chemokine 
receptors, namely CXCR4 and CCR5, resulting in fusion of the virus with the plasma membrane 
and intracellular release of the genetic material (Manes et al., 2000). Interestingly, the CD4, 
CXCR4 and CCR5 receptors have been localized to lipid rafts and cholesterol depletion 
decreased the efficiency of infection of HIV-1 in T-lymphocytes (Manes et al., 2000). Similarly, 
a recent study by Carter et al. showed that the CD4 and CCR5 receptors partitioned into DRMs 
with the lipid raft-associated protein flotillin-1 and early virus particles co-localized with GM1 in 
macrophages (Carter et al., 2009). Taken together, the above results suggest that lipid rafts play 
an important role in the infection and budding of envelope viruses.  
 
1.3.3 The reggie/flotillin family of proteins 
 
A family of proteins, which is found in lipid rafts in cells that lack caveolae, is the reggie/flotillin 
family of proteins (Figure 1.3.1). To identify key proteins that are upregulated in retinal ganglion 
cells during axon regeneration after optic nerve lesion in the goldfish, two 47-kDa proteins called 
reggie-1 and -2 were discovered (Schulte et al., 1997). In the same year, another group identified 
two proteins associated with the low-density floating lipid raft fraction from mouse lung tissue, 
which were called flotillin-1 and -2 (Bickel et al., 1997). A study by Lang et al. reported that the 
molecular cloning of reggie-1 and -2 revealed 80% homology to the goldfish reggie proteins, 
while reggie-2 is practically identical to the mouse flotillin-1 (Flot-1) (Lang et al., 1998). Flotillin 
proteins or their homologs have been found in almost all species, with orthologs demonstrated in 
plants, bacteria and fungi (Rivera-Milla et al., 2006; Edgar and Polak, 2001; Borner et al., 2005). 
Flotillin proteins are highly conserved amongst species, with amino acid identity of 99% between 
human and mouse, whereas the mouse Flot-1 shares 61% homology with Drosophila (Galbiati et 
al., 1998b). In vertebrates, flotillin proteins show a similarity of about 90%, while invertebrates 
have 64% homology (Rivera-Milla et al., 2006). The high evolutionary conservation of flotillin 
proteins within vertebrates, especially within mammals, suggests that these proteins are likely to 
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be involved in fundamental cellular processes, which could be characteristic of their structural 
conformation.  
 
1.3.3.1 Structural features 
 
There are two closely related flotillin proteins that differ only in structure by a second 
hydrophobic region of the Flot-1 protein and the precise function of these two proteins remains to 
be determined (Babuke and Tikkanen, 2007; Langhorst et al., 2005). The human gene encoding 
for Flot-1 is located on chromosome 6 and contains 13 exons extending over 15 kb (Edgar and 
Polak, 2001), while the human Flot-2 gene is located on chromosome 17 and consists of 11 exons 
(Cho et al., 1995). Both genes are single copy genes that encode for proteins with 428 amino 
acids. Flotillin proteins belong to the Stomatin/Prohibitin/Flotillin/HflK/C (SPFH) protein family 
that shares a common SPFH domain in the N-termini (Tavernarakis et al., 1999). This domain 
was discovered by another group that called it the prohibitin homology domain (PHB) (Schultz et 
al., 1998). The three-dimensional structure of the SPFH domain of mouse Flot-2 has been solved, 
which indicated that the domain is a compact ellipsoidal-globular structure of four to five α-
helices and six β-strands (Miyamoto et al., 2004). Flotillin proteins contain a unique flotillin 
domain in the C-terminal region that is not present in other members of the SPFH family. This 
flotillin domain is characterized by several repeats of glutamic acid and alanine (EA repeats), 
which have been predicted to form coiled-coil structures (Schroeder et al., 1994b; Bickel et al., 
1997).  
 
The C-terminal end of human Flot-2 has been shown to be important for the formation of homo-
oligomers in HeLa cells (Neumann-Giesen et al., 2004). In addition, chemical cross-linking 
experiments showed that the smallest oligomer of flotillin proteins that could be detected was a 
tetramer (Langhorst et al., 2005). Furthermore, a recent study by Babuke et al. showed that Flot-1 
and -2 could form hetero-oligomers, which require the tyrosine residue 163 of Flot-2 in HeLa 





 1.3.3.2 Tissue distribution and expression 
 
Flot-2 is ubiquitously expressed in almost all mammalian tissues, while Flot-1 has a more 
restrictive expression pattern than Flot-2 (Schroeder et al., 1994b; Volonte et al., 1999). The 
stability of Flot-1 proteins is strongly dependent on the presence of Flot-2, as knockdown of Flot-
2 protein expression reduces Flot-1 protein levels in mammalian cells and Drosophila (Langhorst 
et al., 2005; Chintagari et al., 2008; Hoehne et al., 2005). In contrast, the knockdown of Flot-1 
has a much weaker effect on the protein stability of Flot-2 (Langhorst et al., 2005, Chintagari et 
al., 2008), suggesting that the stability of Flot-1 proteins is dependent on the presence of Flot-2. 
 
The expression patterns of flotillin proteins during differentiation have been investigated in 
several types of cells. The expression of Flot-2 is enhanced during the in vitro differentiation of 
C2C12 skeletal myoblasts (Volonte et al., 1999). Similarly, differentiation of osteoclasts strongly 
induces the expression of Flot-1 (Ha et al., 2003). During differentiation of 3T3 fibroblasts to 
adipocytes, the expression of Flot-1 is increased and Flot-1 translocates from intracellular 
compartments to the plasma membrane (Liu et al., 2005). In addition, the expression of Flot-1 
appears to be increased during the formation of cell-cell interactions in 3T3 fibroblasts (Lopez-
Casas and del Mazo, 2003). In contrast, the expression of flotillin proteins is unaffected during 
differentiation of PC12 cells (Volonte et al., 1999). In summary, the expression and sub-cellular 
localization of Flot-1 and -2 is regulated during differentiation of cells in a cell-specific manner. 
 
 1.3.3.3 Subcellular localization 
 
The plasma membrane association of flotillin proteins has been shown in many cell types, 
including neurons and lymphocytes (Lang et al., 1998; Stuermer et al., 2001). Interestingly, 
flotillin proteins do not contain a transmembrane domain, but seem to interact with membranes 
through their hydrophobic region that results in both the N- and C-termini facing the cytoplasm 
(Gkantiragas et al., 2001; Morrow et al., 2002). Anchoring of flotillin proteins to the inner leaflet 
of the plasma membrane is mediated by lipid modifications (Neumann-Giesen et al., 2004).  
Although Flot-1 and -2 shares a high degree of homology between them, they have been shown 
to associate with the membrane via different mechanisms. Mouse Flot-1 has been shown to be 
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palmitoylated at Cys34, which was required for the plasma membrane localization in baby 
hamster kidney (BHK) cells (Morrow et al., 2002). In contrast, Liu et al. reported that mutation 
of Cys34 had no effect on the localization of mouse Flot-1 in mouse 3T3-L1 adipocytes, 
suggesting cell-specific differences (Liu et al., 2005). It has also been reported that a hydrophobic 
region within the SPFH domain of Flot-1 might be imbedded in the membrane without traversing 
it (Morrow et al., 2002), similar to other proteins of the SPFH family (Roselli et al., 2002; Snyers 
et al., 1998). In addition, Flot-1 contains two hydrophobic regions (amino acids 10 - 36 and 134 - 
151), both of which are important for membrane association. The first hydrophobic region of 
Flot-1 was shown to be important for the association with lipid rafts, while the second 
hydrophobic domain was required for plasma membrane localization (Liu et al., 2005). The Flot-
2 protein has been shown to be myristoylated at Gly2 and palmitoylated at multiple residues, 
including Cys4, 19 and 20. Both post-translational modifications were shown to be required for 
plasma membrane localization in mouse 3T3-L1 adipocytes (Neumann-Giesen et al., 2004). 
Interestingly, myristoylation of Flot-2 has been shown to be a requirement for palmitoylation in 
HeLa cells. The authors also reported that a mutant Gly2Ala protein, which is neither 
myristoylated nor palmitoylated, shows increased solubility with decreased lipid raft association, 
supporting a role for lipid modifications in targeting Flot-2 to lipid rafts. In addition, the homo-
oligomerization of Flot-2 has been reported to play a role in targeting Flot-2 to lipid rafts 
(Neumann-Giesen et al., 2004, 2007). In contrast to Flot-1, there is only one short hydrophobic 
region present in Flot-2, which is not continuous and therefore unlikely to act as a membrane 
insertion (Babuke et al., 2007). Taken together, lipid modifications regulate the association of 
flotillin proteins with lipid rafts and the plasma membrane. 
 
Unlike other lipid raft-associated proteins, flotillins form stable cluster-size hetero-oligomers at 
the plasma membrane that are readily detectable by electron microscopy and immunogold 
staining of rat neurons and brain tissue (Lang et al., 1998; Stuermer et al., 2001; Kokubo et al., 
2003). The flotillin clusters were found to be uniform in size with an estimated diameter of 100 
nm (Stuermer et al., 2001; Kokubo et al., 2003). Flotillin clusters appear to be quite widely 
spaced along the plasma membrane with increased clustering at cell-cell contact points and after 
crosslinking of lipid raft-associated proteins, such as the GPI-anchored Thy-1 and the cellular 
prion protein (PrP
c
) (Stuermer et al., 2001, 2004).  
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Flotillin proteins have also been localized to various intracellular vesicular compartments, 
including endosomal compartments in rat neurons and astrocytes, phagosomes in mouse J774 
macrophages and Golgi compartments in CHO cells (Dermine et al., 2001; Stuermer et al., 2001; 
Gkantiragas et al., 2001). In addition, Flot-1 has been shown to associate with the phosphatase 
prostate tumor overexpressed gene 1 protein (PTOV-1), followed by translocation to the nucleus 
in a cell cycle-dependent manner in PC-3 cells (Santamaria et al., 2005). Taken together, these 
findings indicate a wide subcellular distribution of flotillin proteins that appears to be a highly 
dynamic process, which is regulated by lipid modifications in a cell-specific manner (Glebov et 
al., 2006; Neumann-Giesen et al., 2007).  
 
 1.3.3.4 Cellular function 
 
Although, they are ubiquitously expressed and evolutionary well conserved, the exact molecular 
function of flotillin proteins is still unclear. Nonetheless, several studies have indicated a role for 
flotillin in signaling processes through membrane receptors, endocytosis and regulation of 
cytoskeleton signaling (Baumann et al., 2000; Dermine et al., 2001; Glebov et al., 2006; 
Hazarika et al., 2004; Lang et al., 1998; Neumann-Giesen et al., 2004, 2007; Schulte et al., 
1997). In addition, a variety of proteins has been shown to co-localize and interact with flotillin 
proteins as described below (Langhorst et al., 2005; Babuke et al., 2007; Morrow and Parton, 
2005).  
 
The GPI-anchored protein Thy-1 was shown to co-localize and interact with flotillin proteins in 
PC12 cells and lymphocytes (Stuermer et al., 2001). Interestingly, flotillins also co-localize and 
can be co-immunoprecipitated with other GPI-anchored proteins, including F3/contactin and PrP
c
 
(Stuermer et al., 2001, 2004). In addition, flotillin proteins interact with the src kinases LCK and 
FYN in T-cells and adipocytes, as shown by co-immunoprecipitation, suggesting a role for 
flotillins in GPI-anchored proteins and tyrosine-kinase signaling (Liu et al., 2005; Slaughter et 
al., 2003). Flot-2 has been shown to be co-immunoprecipitated with the thrombin GPCR receptor 
PAR-1 in melanoma cells (Hazarika et al., 2004), while Flot-1 was identified to interact with 
neuroglobin in a yeast two-hybrid assay (Wakasugi et al., 2004), suggesting a role for flotillins in 
GPCR and neuronal signaling, respectively. Taken together, these findings suggest that flotillins 
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are involved in the signal transduction by GPI-anchored proteins, RTKs and GPCRs across the 
plasma membrane. 
 
The most well described examples of a functional role for flotillin proteins are in glucose uptake 
and cytoskeletal remodeling. An early study by Baumann et al. described a novel insulin-
signaling pathway mediated via lipid rafts (Baumann et al., 2000). In this study it was shown that 
in the absence of insulin, a complex between a proto-oncogene, called c-Cbl, which is recruited 
by an adaptor protein with multiple functions called Cbl-associated protein (CAP, also known as 
ponsin), associates with the insulin receptor in adipocytes. Stimulation of these cells with insulin 
induced the phosphorylation of c-Cbl and resulted in dissociation of the CAP-Cbl complex from 
the insulin receptor. Subsequently, the complex translocates to lipid rafts where it forms a ternary 
structure with Flot-1, resulting in glucose uptake by the glucose transporter GLUT4 (Baumann et 
al., 2000). Therefore, localization of the CAP-Cbl complex to lipid rafts enriched with Flot-1 
appears to generate a pathway that is important in the regulation of glucose uptake. The 
interaction between Flot-1 and CAP is mediated by a sorbin homology (SoHo) domain in the N-
terminus of CAP and the first hydrophobic region of Flot-1 (Baumann et al., 2000; Liu et al., 
2005). Several isoforms of CAP have been found with some containing more than one SoHo 
domain (Mandai et al., 1999; Ribon et al., 1998). However, Flot-1 seems to interact specifically 
with an isoform called CAP4 in adipocytes, which contains only one SoHo domain (Liu et al., 
2005). CAP has been shown to recruit c-Cbl and the tyrosine kinase Pyk-2 to lipid rafts via three 
src homology 3 (SH3) domains  in the carboxy terminus, a process that is crucial for 
neuritogenesis, a process involved in development of the adult nervous system and spinal cord, in 
differentiating PC12 cells (Haglund et al., 2004). In addition, both flotillin proteins have been 
shown to be involved in the process of differentiation in primary rat hippocampal neurons. Flot-2 
was shown to be crucial for differentiation by mediating the recruitment of CAP and c-Cbl to 
lipid rafts in primary rat hippocampal neurons (Langhorst et al., 2008), while Flot-1 was shown 
to be a molecular mediator of neurite outgrowth by the synaptic adhesion-like molecule 4 
(SALM4) (Swanwick et al., 2010). Interestingly, the SoHo domain is also present in two other 
proteins, namely ArgBP2 and vinexin-α (Kimura et al., 2001). Vinexin-α has been shown to 
interact with Flot-1 directly, indicating a role for actin remodeling (Kioka et al., 2002; Kimura et 
al., 2001). Taken together, the above findings support a role for flotillins in regulating 
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metabolism by enhancing glucose uptake by GLUT4 and a role in cytoskeletal remodeling. The 
latter would explain the increased expression of flotillins during differentiation of various cell 
types.  
 
A previous study by Neumann-Giesen et al. indicated that Flot-2 plays a role in growth factor 
signaling by showing EGF-induced tyrosine 163 phosphorylation of Flot-2 by src kinases in 
HeLa cells (Neumann-Giesen et al., 2007). It was also shown that stimulation of cells with EGF 
promoted tyrosine phosphorylation at Y163 and endocytosis of Flot-2 from the plasma membrane 
to late endosomes, where it partially co-localizes with the EGFR. Similarly, a recent study by 
Riento et al. showed with phospho-specific antibodies that EGF-induced the tyrosine 
phosphorylation of both Flot-1 and -2 at Y160 and Y163, respectively, which was required for 
their internalization from the plasma membrane (Riento et al., 2009). The same study showed 
that the EGF-induced internalization of flotillins was inhibited in SYF cells that lack expression 
of LYN kinase, which was restored by overexpression of LYN kinase (Riento et al., 2009). 
Taken together, the above findings suggest a novel function of flotillin lipid rafts as a tyrosine-
kinase-regulated endocytic pathway.  
 
The flotillin proteins have also been implicated to have a role G-protein signaling. Sugawara et 
al. showed that Gαq proteins interact with both Flot-1 and -2 and knockdown of Flot-2 attenuated 
the UTP-induced activation of p38 by src-kinases, but not the activation of ERK-1/2 in HeLa 
cells (Sugawara et al., 2007). A more recent study reported that knockdown of Flot-2 reduced the 
insulin-like growth factor 1-induced activation of ERK-1/2, p38 and FAK, while having no effect 
on the activation of Akt, PKC or JNK in mouse N2a neuroblastoma cells (Munderloh et al., 
2009), suggesting cell- or species-specific differences. Taken together, these above findings 
support a role for flotillins in the signal transduction of GPCRs, RTKs, MAPKs and other 







1.4 Hypothesis, aims and strategies 
 
The project was based on the following hypothesis: 
 
Crosstalk between the glucocorticoid receptor (GR) and the gonadotropin-releasing 
hormone receptor (GnRHR) involves the co-localization of these receptors to lipid rafts in 
LβT2 cells. 
 
This project consists of three parts. The aim of the first part (sections 1 – 4) was to confirm the 
GnRH and synergistic response with Dex and GnRH on a GRE-reporter gene in LβT2 cells. 
Additional evidence for the crosstalk mechanism between the GR and GnRHR signaling 
pathways on other cis-elements and the effect of GnRH on the stability of GR protein was also 
investigated.  
 
The second part (sections 5 – 7) of this study focused on the sub-cellular localization of the GR 
and GnRHR in LβT2 cells. Firstly, the lipid raft marker proteins that are expressed in LβT2 cells 
had to be identified and several techniques were set up and optimized. These included 
optimization of LβT2 cell growth conditions on different coating substrates for 
immunoflorescence experiments, sucrose-density gradient fractionation and co-
immunoprecipitation assays. Specific aims of the second part were to investigate whether the GR 
localized to lipid rafts containing flotillin-1 (Flot-1) in LβT2 cells, under various hormonal 
conditions, by immunoflorescence analysis. In addition, it was investigated whether the GnRHR 
localized to lipid rafts containing Flot-1 in LβT2 cells, by immunoflorescence analysis. To 
provide additional evidence for the localization of the GR and GnRHR to lipid rafts and the 
effects of ligands thereon, the aims included to set up and optimize isolation of lipid rafts by 
density-gradient fractionation. Thereafter, the aim was to investigate whether the GR and the 
GnRHR were present in the lipid raft fraction, under various hormonal conditions. Whether the 
GR occurs in a complex with Flot-1 under the various hormonal conditions was also investigated, 
after optimization of the method, by co-immunoprecipitation assays using extracts from LβT2 
cells.  
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The third part (sections 8 and 9) of this study was to investigate if lipid rafts or Flot-1 have a 
functional role in GR and GnRHR signaling in LβT2 cells. Specifically, the aim was to 
investigate whether lipid raft disruption, with cholesterol depletion agents, affects the ability of 
the GR to transactivate a GRE-reporter gene in response to the various hormonal conditions. In 
addition, whether lipid raft disruption affects GnRH-induced phosphorylation of the GR was also 
investigated. Finally, a requirement for Flot-1 in the transactivation of a GRE-reporter gene by 
Dex, GnRH or by co-stimulation with both was investigated by siRNA-mediated knockdown of 

























Chapter 2: Materials and methods 
 
2.1 Compounds and antibodies 
 
Dex, GnRH, TNFα (T7539), Hoechst (86140-5), methyl-β-cyclodextrin (MβCD) (C4555), 
Filipin-III (F4767), phenylmethanesulfonyl fluoride (PMSF), poly-L-ornithine (P3655) and all 
other general reagents and chemicals were purchased from Sigma-Aldrich, South Africa. 
Dithiothreitol (DTT) was obtained from Promega Corp., USA. Bovine-serum albumin (BSA), 
leupeptin, aprotinin and FuGENE 6 were purchased from Roche Diagnostics, South Africa. 
 
Laminin (354239) and antibodies to caveolin-1 (610406) and GM130 (610822) were purchased 
from BD Transduction Laboratories, USA. The non-specific rabbit IgG antibody (R1131),was 
obtained from Sigma-Aldrich, South Africa, while the anti-mouse HRP (sc-2005) and anti-rabbit 
HRP (sc-2313) secondary antibodies were purchased from Santa Cruz Biotechnology, USA. 
Antibodies to GAPDH (14C10), p44/42 MAPK (9102) and phospho-p44/42 MAPK 
(Thr202/Tyr204) (9101) were obtained from Cell Signaling Technology, USA. The anti-histone-
H3 antibody (ab1791) was obtained from Abcam, UK. The rabbit anti-GnRHR antibody, raised 
against amino acids 193 – 212 in the extracellular loop of the ovine receptor, was a generous gift 
from D.C. Skinner (University of Wyoming, Department of Zoology and Physiology & 
Neurobiology Program, USA) and has been described before (Bliss et al., 2007). The rabbit 
polyclonal anti-GR H300 (sc-8992) antibody, raised against amino acids 121 – 420 of the human 
receptor, was purchased from Santa Cruz Biotechnology, USA, while the anti-phospho-serine 
226 GR antibody (corresponding to pSer234 in the mouse) was a generous gift from M.J. 
Garabedian (New York University, School of Medicine, USA). The rabbit polyclonal anti-
flotillin-1 antibody, raised against the full-length goldfish flotillin-1 protein, was a generous gift 
from D.M. Lang (University of Cape Town, Medical School, South Africa), while the 
monoclonal anti-flotillin-1 antibody (610820), raised against amino acids 312 – 428 of mouse 
flotillin-1, was purchased from BD Transduction Laboratories, USA. The anti-rabbit 
AlexaFluor488 (A21206) and Cholera Toxin subunit B AlexaFluor647 (C-34778) were 
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purchased from Invitrogen, USA, while the donkey anti-mouse Cy3 antibody (715-166-150) was 




The pTAT-GRE-E1b-luc plasmid was a kind gift from G. Jenster (University of Rotterdam, 
Netherlands) and has been described before (Sui et al., 1999). The minimal luciferase reporter 
construct (IL-6κB)3-50hu.IL6P that contains three repeats of the NF-κB responsive element from 
the human IL-6 promoter, was kindly provided by G. Haegeman (University of Ghent, Belgium) 
and has been described before (Plaisance et al., 1997). The pRK7-Flotillin-1 plasmid that 
encodes a FLAG-tagged mouse Flot-1 protein was a generous gift from A.R. Saltiel (University 
of Michigan Medical School, USA). The pAP-1 luciferase plasmid containing seven copies of a 
consensus AP-1 site was purchased from Stratagene, USA. The pSV-β-galactosidase expression 
vector was obtained from Promega Corp., USA. 
 
2.3 Plasmid transformation and preparation 
 
Plasmids were transformed into competent Escherichia coli DH5α cells by the heat-shock 
procedure described by Sambrook et al. (Sambrook et al., 1989). Briefly, 50 μL of competent 
cells were incubated on ice with 10 ng of plasmid DNA for 30 min. The cells were heat-shocked 
for 2 min at 42°C, followed by 2 min incubation on ice. Thereafter, outgrowth was stimulated by 
the addition of 500 μL Luria Broth (LB, 1% (w/v) tryptone, 0.5% (w/v) yeast extract and 0.5% 
(w/v) NaCl) and incubation for 1 h at 37°C shaking. Cells were plated onto LB-agar (LB with 
1.5% agar) plates-containing 100 μg/mL ampicillin and incubated over-night at 37°C. For 
plasmid purification, a single colony was picked to inoculate LB cultures containing 100 μg/mL 
ampicillin and incubated over-night at 37°C shaking. The following day, plasmid DNA was 
purified with the Promega Pureyield Plasmid Midi-prep kit (Promega Corp., USA), according to 
the manufacturer’s instructions. The integrity and purity of the plasmids were analyzed by 




2.4 Cell culture 
 
P.L. Mellon at the University of California, USA, kindly provided the immortalized mouse LβT2 
pituitary gonadotrope cells (Turgeon et al., 1996). The COS-7 monkey kidney fibroblast cells 
were a generous gift from S. Prince at the University of Cape Town, South Africa. Both cell lines 
were grown in high glucose (1 g/mL) Dulbecco’s Modified Eagles Medium (DMEM) 
supplemented with 10% fetal calf serum (FCS) (Sigma-Aldrich, South Africa), 100 IU/mL 
penicillin and 100 μg/mL streptomycin (Gibco, Invitrogen, UK). The cells were maintained in 
75-cm
2
 culture flasks (Greiner Bio-one International, Austria) at 37°C in an environment of 5% 
CO2 and 90% humidity up to a confluency of 85% before sub-culturing. Cells were sub-cultured 
with 0.25% trypsin/0.1% EDTA in calcium- and magnesium-free PBS. The LβT2 cells proved 
very sensitive to the trypsinization procedure and were therefore never incubated with the trypsin 
solution for longer than three min. LβT2 cells were cultured up to a maximum of 25 passages. 
Cells were routinely tested for mycoplasma infection by Hoechst staining and suspicious cell 
cultures were further analyzed by a luminescent-based assay (Glo-Max, Promega Corp., USA). 
Only mycoplasma-negative cells were used in experiments. 
 
2.5 Transient transfection of cells 
 
To generate a positive control of the Flot-1 protein for the experiment in Figure 3.5.1, COS-7 
cells were seeded into 12-well plates at a density of 1 X 10
5
 cells per well in DMEM with 10% 
FCS and antibiotics as described above. Twenty-four hours after plating the medium was 
replaced and the cells were transfected with 250 ng pRK7-Flotillin-1 using 0.5 μL FuGENE 6 in 
100 μL serum free DMEM, according to the manufacturer’s instructions. Forty-eight hours after 
transfection, cells were washed twice with ice-cold PBS and harvested in 50 μL 2 X SDS sample 
buffer (5 X SDS sample buffer: 100 mM Tris-Cl pH 6.8, 5% (w/v) SDS, 20% (v/v) glycerol, 2% 
ß-mercaptoethanol and 0.1% (w/v) bromophenol-blue). The samples were boiled for 10 min at 
100°C before storage at -20°C or equal amounts of cell lysates were analyzed by Western 
blotting as described below, probing with specific anti-GR and anti-Flot-1 antibodies (see section 
2.6 for dilutions of antibodies used). 
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For the reporter gene assays in Figures 3.1, 3.2, 3.3 and 3.8, LβT2 cells were seeded in 24-well 
plates at a density of 1 X 10
5
 cells per well in DMEM with 10% FCS and antibiotics as described 
elsewhere. Forty-eight hours after plating, medium was replaced with fresh medium and the cells 
were co-transfected with 250 ng of pTAT-GRE-E1b-luc plasmid (Figure 3.1, 3.8) or 250 ng of 
pAP-1-luc plasmid (Figure 3.2) or 400 ng of (IL-6κB)3-50hu.IL6P-luc plasmid (Figure 3.3) and 
25 ng pSV-β-galactosidase plasmid to correct for transfection efficiency. Twenty-four hours after 
transfection, cells were washed once with PBS before being stimulated in serum-free medium as 
indicated in the figure legends. The cells were harvested in 50 μl reporter lysis buffer (Promega 
Corp., USA) per well. Both the luciferase assays (Luciferase Assay System, Promega Corp., 
USA) and the β-galactosidase assays (Galacto-Star, Tropix Inc, USA) were performed with 10 
μL of cell extracts in white 96-well plates in a Modulus microplate reader (Turner Biosystems, 
USA). The luciferase values were normalized for transfection efficiency with β-galactosidase 
values and the fold induction expressed relative to vehicle (control). 
 
2.6 SDS-PAGE and Western blotting 
 
LβT2 cell lysates were prepared and adjusted to a final concentration of 1 X SDS sample buffer 
before separating on an 8% SDS-polyacrylamide gel at 120 V in 1 X SDS running buffer (25 mM 
Tris-Cl (pH 8.4), 250 mM glycine and 0.1% SDS) (Sambrook et al., 1989), using a BioRad Mini 
Protean II electrophoresis cell chamber. Proteins were transferred onto a HyBond ECL 
nitrocellulose membrane (AEC-Amersham, South Africa) for 1 h at 180 mA in a Tris/glycine 
buffer (25 mM Tris, 250 mM glycine and 20% (v/v) methanol), using a Mini Protean II blotting 
system (BioRad, South Africa). The membranes were blocked for 1 h at room temperature in 4% 
ECL blocking solution (4% (w/v)) ECL advance blocking powder, (AEC-Amersham, South 
Africa) and Tris-buffered saline (TBS: 50 mM Tris-Cl (pH 7.5) and 150 mM NaCl) containing 
0.1% Tween-20 (TBST). After blocking, membranes were incubated with primary antibodies 
(dilutions in Table 2.1) in 4% ECL blocking solution (all except pERK-1/2 and ERK-1/2, which 
were diluted in TBST) at 4°C over-night. The following day, the membranes were washed with 
TBST for 15 min, followed by 2 X 5 min washes at room temperature before incubation with 
secondary HRP-conjugated antibodies for 1 h at room temperature in 5% non-fat milk powder 
(w/v) in TBST. Membranes were washed for 1 X 15 min and 2 X 5 min with TBST, followed by 
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1 X 5 min wash at room temperature with TBS and visualized by autoradiography. The 
membranes were stripped for 30 min at 60°C in stripping buffer (100 mM β-mercaptoethanol, 2% 
(w/v) SDS and 62.5 mM Tris-Cl (pH 6.8)), washed twice for 10 min with TBST, blocked for 1 h 
at room temperature in 4% ECL blocking solution before incubating with antibody again as 
described above. The proteins were visualized with ECL Western blotting detection reagents 
(AEC-Amersham, South Africa) and Hyperfilm MP high performance autoradiography film 
(AEC-Amersham, South Africa), according to the manufacturer’s instructions. Bands on the 
autoradiography film were scanned and quantification was performed with AlphaEaseFC 
FluorChem 5500 (Alpha Innotech). 
 





















2.7 Confocal immunoflorescence 
 
2.7.1 Live cell GnRHR staining 
Glass cover slips were washed twice for 30 min in 3.2% HCL and rinsed with distilled water and 
absolute ethanol. Cover slips were sterilized by flaming and placed in 6-well plates followed by 
seeding LβT2 cells at a density of 3 X 10
5
 cells per well in DMEM with 10% FCS and antibiotics 
as described elsewhere. After 48 h, cells were washed twice with ice-cold PBS, followed by live-
cell staining for 1 h with rabbit anti-GnRHR (1:400) in ice-cold PBS, on ice water. Thereafter, 
cells were washed with ice-cold PBS for 3 X 5 min, fixed and permeabilized with methanol at -
20°C for 10 min and washed with PBS for 3 X 5 min. Cells were blocked with 5% BSA in PBS 
for 1 h at room temperature, followed by staining with mouse anti-Flot-1 (1:50) antibody in PBS 
with 5% BSA for 1 h at room temperature. Subsequently, the cells were washed with 1% BSA in 
PBS for 3 X 5 min before incubating with anti-rabbit labeled Alexa488 (1:500) and anti-mouse 
labeled Cy3 (1:1000) antibodies in PBS with 5% BSA for 1 h at room temperature in the dark. 
The cells were washed with 1% BSA in PBS for 3 X 5 min, followed by incubation with Hoechst 
(100 μg/mL) in PBS for 5 min. Slides were mounted in Mowiol (475904, Calbiochem, USA) 
containing n-propyl gallate (Sigma-Aldrich, South Africa) as anti-fading agent and allowed to set 
over-night at room temperature in the dark, followed by storage at 4°C in the dark until 
visualization. 
 
2.7.2 Live cell cholera toxin staining 
Glass cover slips were washed twice for 30 min in 3.2% HCL and rinsed with distilled water and 
absolute ethanol. Cover slips were sterilized by flaming and placed in 6-well plates followed by 
seeding LβT2 cells at a density of 3 X 10
5
 cells per well in DMEM with 10% FCS and antibiotics 
as described previously. The following day cells were washed once with PBS before replacing 
the media with DMEM containing 10% charcoal stripped serum and antibiotics as described 
above. The following day the cells were stimulated with 100 nM Dex, 100 nM GnRH or a 
combination of both for 30 min followed by two washes with ice-cold PBS. To minimize 
internalization of the cholera toxin during the live-cell staining procedure, until after the fixation 
process, the cells were maintained on ice water. The live cells were stained with 10 μg/mL 
cholera toxin subunit B conjugated to Alexa647 in PBS with 1% BSA for 30 min at 4°C in a 
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humidified environment. Following the live-cell stain, the cells were washed for 3 X 5 min with 
ice-cold PBS followed by fixation with freshly prepared 2% para-formaldehyde in PBS (pH 7.0) 
for 10 min at room temperature. Optimal fixation conditions for the lipid raft stain were 
investigated and it was found that 2% para-formaldehyde was appropriate, while methanol 
fixation reduced the amount of lipid raft staining significantly. The cells were washed for 2 X 5 
min with ice-cold PBS, followed by permeabilization with 1% Triton X-100 in ice-cold PBS for 
10 min on ice water.  Cells were washed with PBS for 5 min, blocked with 5% BSA in PBS for 1 
h at room temperature, before staining with rabbit anti-GR (1:250) and mouse anti-Flot-1 (1:50) 
antibodies in PBS with 5% BSA for 1 h at room temperature in a humidified environment. 
Thereafter, cells were washed for 3 X 5 min with 1% BSA in PBS, followed by incubation with 
anti-rabbit labeled Alexa488 (1:500) and anti-mouse labeled Cy3 (1:1000) antibodies in PBS 
with 5% BSA for 1 h at room temperature in a lightproof humidified environment. Slides were 
washed for 3 X 5 min with 1% BSA in PBS and incubated with Hoechst (100 μg/mL) in PBS for 
5 min, followed by mounting in Mowiol at room temperature over-night in the dark. Slides were 
stored at 4°C in the dark until visualization.  
 
2.7.3 Confocal imaging 
Confocal microscopy was performed with a Zeiss Axiovert 200M LSM 510 Meta NLO Confocal 
Microscope using the 40X water immersion objective. A multi-track scanning configuration 
using the 488nm (HeNe gas laser), 561nm (solid state laser), 633nm (argon laser) and 800nm 
(Ti:Sa femtosecond infrared laser) excitation lines was employed to minimize bleed through 
between the fluorophores. The photomultiplier gain and offset were adjusted to exclude any 
background fluorescence emitted by the cells and fluorophores. At least three different fields of 
view from three independent experiments were collected. The GnRHR images were analyzed 
with ImageJ software with the Pearson correlation co-efficient (Manders et al., 1993) between the 
two fluorophores. The cholera toxin images were analyzed with the LSM 510 Meta software by 
demarcating the region of interest, setting the channel intensities to zero, adjusting the amount of 
co-localization with the appropriate thresholds intensities of each channel, followed by 
determination of the Pearson correlation co-efficient (Manders et al., 1993) between the two 
relevant fluorophores. The Pearson correlation co-efficient values range from -1 to 1 and a value 
near 1 suggests true co-localization. Similarly, the Mander’s overlap co-efficient values range 
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from 0 to 1 and a value near 1 suggests true co-localization, whereas the intensity correlation 
analysis values range from -0.5 to 0.5 and a value near 0.5 suggests true co-localization (Manders 
et al., 1993). 
 
2.8 Lipid raft isolation 
 
The non-detergent based method for lipid raft isolation as shown in Addendum Bi has been 
described before (Gagescu et al., 2000) and was performed as follows. LβT2 cells were seeded in 
150-mm
2
 dishes at a density of 8 X 10
6
 cells per dish in DMEM with 10% FCS with antibiotics 
as described elsewhere. After three days of growth, LβT2 cells were washed with PBS and 
scraped on ice in 1 mL PBS. Thereafter, the cells were collected by centrifugation for 5 min at 
500 X g, washed once with 4 mL of homogenization buffer (HB, 250 mM sucrose, 3 mM 
imidazole (pH 7.4), 2 mM EDTA and 1 mM PMSF) and resuspended in 2.2 mL HB. Thereafter, 
the cells were lysed with 8 strokes in a Dounce homogenizer. Unbroken cells and nuclei were 
removed by centrifugation at 4°C for 10 min at 3000 X g, followed by adjusting the sample to 
40.6% sucrose with the addition of 2.4 mL HB containing 60% sucrose. Subsequently, the 
sample was laid at the bottom of a SW40 centrifuge tube (13 mL) and overlaid with a 
discontinuous density-gradient of 4 mL of 35% sucrose in HB, 3 mL of 25% sucrose in HB and 
0.6 mL HB. Thereafter, the sample was subjected to equilibrium flotation at 4°C for 16 h at 30 
000 rpm in a SW40Ti rotor. Twelve 1 mL fractions were collected from the top of the gradient 
and equal amounts of fractions were loaded on an 8% SDS-PAGE gel, transferred onto 
nitrocellulose membrane and probed with a specific antibody against Flot-1. 
 
The detergent based method for lipid raft isolation as shown in Addendum Bii and Biii has been 
described before (Lafont and Simons, 2001) and was performed with a few modifications as 
follows. LβT2 cells were seeded in 150-mm
2
 dishes at a density of 8 X 10
6
 cells per dish in 
DMEM with 10% FCS with antibiotics as described elsewhere. After three days of growth, LβT2 
cells were washed with PBS and scraped on ice in 1 mL PBS. Thereafter, the cells collected by 
centrifugation for 5 min at 500 X g, washed once with 1 mL of extraction lysis buffer (ELB, 10 
mM Hepes (pH 7.9), 10 mM NaCl, 3 mM MgCl2, 1 mM DTT, 1 mM PMSF, 5 μg/mL leupeptin 
and 2 μg/mL aprotinin) and resuspended in 1 mL ELB. Thereafter, cells were lysed with 12 
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strokes in a Dounce homogenizer and unbroken cells and nuclei were removed by centrifugation 
at 4°C for 3 min at 350 X g. The crude membrane fraction was obtained by centrifugation at 4°C 
for 15 min at 15 000 X g, washed once with 1 mL ELB and resuspended in  0.4 mL solubilization 
buffer (SB) (25 mM Tris-Cl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1 mM DTT, 1 mM PMSF, 5 
μg/mL leupeptin and 2 μg/mL aprotinin) containing 1% or 0.05% Triton X-100. After incubation 
for 45 min on ice, the crude membrane fraction was adjusted to 60% sucrose with the addition of 
0.8 mL SB containing 90% sucrose. Subsequently, the sample was laid at the bottom of a SW65 
(5 mL) centrifuge tube and overlaid with a discontinuous density-gradient with 2 mL of 43% 
sucrose in ELB, 1 mL of 13% sucrose in ELB and 0.8 mL ELB. Thereafter, the sample was 
subjected to equilibrium flotation at 4°C for 18 h at 40 000 rpm in a SW65Ti rotor. Ten fractions 
(0.5 mL) were collected from the top of the gradient and equal amounts of fractions were loaded 
on an 8% SDS-PAGE gel, transferred onto nitrocellulose membrane and probed with a specific 
antibody against Flot-1 (ii) or Flot-1 and GR (iii). 
 
Plasma membrane lipid rafts as shown in Figure 3.6 were prepared using the Triton X-100 
procedure as described by Lafont and Simons with some modifications (Lafont and Simons, 
2001). This method was optimized as described in Addendum B. LβT2 cells were seeded in 150-
mm
2
 dishes at a density of 8 X 10
6
 cells per dish in DMEM with 10% FCS containing antibiotics 
as described elsewhere. The cells were washed twice with PBS and serum starved over-night in 
serum-free DMEM. The following day the cells were stimulated with 100 nM Dex, 100 nM 
GnRH or a combination of both for 30 min before being washed twice with ice-cold PBS. The 
cells were scraped on ice in 1 mL PBS containing 1 mM PMSF, 5 μg/mL leupeptin and 2 μg/mL 
aprotinin per dish. Thereafter, the cells were centrifuged at 500 X g for 5 min and each cell pellet 
(10 dishes) was resuspended in 1 mL SB containing 0.05% Triton X-100 and incubated on ice 
water for 45 min. The lysates was adjusted to 60% sucrose in SB and layered at the bottom of 
SW40 Ultraclear centrifuge tubes (Beckman, South Africa). A discontinuous sucrose gradient 
was prepared consisting of 2 mL extraction lysis buffer (ELB), 10 mM Hepes (pH 7.9), 10 mM 
NaCl, 3 mM MgCl2, 1 mM DTT, 1 mM PMSF, 5 μg/mL leupeptin and 2 μg/mL aprotinin), 4 mL 
of 13% sucrose in ELB, 4 mL of 43% sucrose in ELB and 4 mL of 60% sucrose containing the 
sample. Thereafter, the samples were subjected to equilibrium flotation in a SW40Ti rotor (38 
000 rpm for 18 h at 4°C). Flocculent material could be seen at the interfaces and fractions (1 mL) 
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were collected as follows: 1) Top of the gradient, 2) ELB/13% interface, 3) 13%/43% interface 
(lipid raft fraction), 4) middle of 43% sucrose, 5) 43%/60% interface, 6) middle of 60% sucrose 
(loading fraction) and fraction 7) the pellet. All fractions were sonicated for 30 sec pulses in a 
water bath at room temperature until a homogenous solution was obtained. Fractions were 
aliquoted and stored at -80°C. For analysis, sample preparation was optimized and performed as 
follows. Fractions were adjusted to a final concentration of 1 X SDS sample buffer without β-
mercaptoethanol, sonicated again for 2 X 30 sec and incubated at 100°C for 10 min. The samples 
were prepared without β-mercaptoethanol as previous studies have reported that when membrane 
proteins are boiled in the presence of reducing reagents, it can potentially result in aggregate 
formation, which could make Western blot analysis difficult. After boiling, the samples were 
briefly incubated on ice before analyzing equal amounts of fractions by Western blotting as 
described elsewhere. The membranes were probed with specific antibodies against the GR, 
GnRHR, Flot-1 and histone H3. 
 
2.9 Co-immunoprecipitation assays 
 
LβT2 cells were seeded in 100-mm
2
 dishes at a density of 3 X 10
6
 cells per dish in DMEM with 
10% FCS and antibiotics as described elsewhere. Seventy-two hours after plating, cells were 
washed twice with PBS and incubated for 2 h in serum-free DMEM, before being stimulating 
with 100 nM Dex, 100 nM GnRH or a combination of both for 30 min as indicated in the figure 
legends. The cells were washed twice with ice-cold PBS and scraped on ice in 1 mL RIPA lysis 
buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% (v/v) NP-40, 0.1% (w/v) SDS, 0.5% (w/v) 
sodium deoxycholate, 1 mM EDTA, 1 mM PMSF, 2 μg/mL aprotinin, 5 μg/mL leupeptin and 
2.5% (w/v) casein). The lysates were briefly vortexed before incubating on ice for 10 min and 
centrifugation at 5000 X g for 10 min at 4°C, after removing 50 μL aliquot to represent inputs. 
The supernatants were collected and incubated with 1 μg rabbit anti-GR, 4 μL rabbit anti-Flot-1 
or non-specific rabbit IgG antibodies by rotating at 4°C over-night. The following day the Protein 
A/G-Agarose beads (Santa Cruz, USA) were prepared by blocking them for 30 min with 
saturated casein in PBS, while rotating at 4°C, followed by 30 min incubation with 5% BSA in 
PBS, while rotating at 4°C. The beads were washed once with PBS after which a 25% slurry was 
prepared with PBS. The antibodies and bound protein complexes were incubated with 20 μL of 
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the Protein A/G-Agarose bead slurry and rotated for 1 h at 4°C. The protein-immune complexes 
were collected by centrifugation at 1 000 X g for 5 min at 4°C, followed by two washes with 1 
mL PBS. The proteins were eluted from the beads by addition of 24 μL of 2 X SDS sample 
buffer and incubated at 100°C for 5 min. The samples were centrifuged at 20 000 X g at room 
temperature and the supernatants collected and resolved on an 8% SDS-PAGE followed by 
Western Blotting as described elsewhere, probing with antibodies as indicated in the figure 
legends. 
 
2.10 Incubation with cholesterol depletion agents 
 
2.10.1 Luciferase gene reporter assays 
LβT2 cells were seeded in 24-well plates at a density of 1 X 10
5
 cells per well in DMEM with 
10% FCS and antibiotics as described elsewhere. Forty-eight hours after plating, medium was 
replaced with fresh medium and the cells were transfected with 250 ng of pTAT-GRE-E1b-luc 
plasmid and 25 ng pSV-β-galactosidase plasmid to correct for transfection efficiency. Twenty-
four hours after transfection, the cells were treated with cholesterol depletion agents. For Figure 
3.8A, the cells were incubated for 45 min with 10 mM MβCD in serum-free medium, followed 
by a P BS wash before being stimulated for 8 h in serum-free medium as indicated in the figure 
legend. For Figure 3.8D, cells were pre-treated for 30 min with 5 ng/mL Filipin-III in serum-free 
medium, followed by stimulation for 8 h in the presence Filipin-III as indicated in the figure 
legend. The cells were harvested in 50 μl reporter lysis buffer (Promega Corp., USA) per well. 
Both the luciferase assays (Luciferase Assay System, Promega Corp., USA) and the β-
galactosidase assays (Galacto-Star, Tropix Inc, USA) were performed with 10 μL of cell extracts 
in white 96-well plates in a Modulus microplate reader (Turner Biosystems, USA). The luciferase 
values were normalized for transfection efficiency with β-galactosidase values and the fold 
induction expressed relative to vehicle (control). 
 
2.10.2 Phosphorylation assays 
LβT2 cells were seeded in 24-well plates at a density of 1 X 10
5
 cells per well in DMEM with 
10% FCS and antibiotics as described elsewhere. Forty-eight hours after plating, medium was 
replaced with fresh medium and cells pre-treated for 30 min with 5 ng/mL Filipin-III in serum-
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free medium, followed by stimulation for 1 h with 100 nM GnRH in the presence Filipin-III. 
Cells were washed twice with ice-cold PBS and harvested in 25 μL 2 X SDS sample buffer. The 
samples were incubated for 10 min at 100°C before analyzing equal amounts of cell lysates by 
Western blotting as described elsewhere. The membranes were probed with specific antibodies 
against pSer234 GR, total GR and GM130 (Figure 3.8B) or pERK-1/2 and total ERK-1/2 (Figure 
3.8C).  
 
2.11 RNA interference 
 
Optimization of Flot-1 siRNA-mediated knockdown experiments as shown in Addendum D1 was 
performed as follows. LβT2 cells were seeded in 24-well plates at a density of 1.5 X 10
5
 cells per 
well in 500 μL DMEM with 10% FCS and antibiotics as described elsewhere. Twenty-four hours 
after plating, medium was replaced with fresh medium and the cells were transfected with siRNA 
using HiPerfect transfection reagent (Qiagen, USA), according to the manufacturer’s instructions. 
Briefly, either mouse Flot-1 siRNA (Mm_FLot1_1 (SI01003583), Mm_FLot1_2 (SI01003590), 
Mm_FLot1_3 (SI01003597), or Mm_FLot1_4 (SI01003604), (FlexiTube siRNA (1027415), 
Qiagen, USA)) or non-silencing scrambled (NSC) siRNA (Negative control siRNA (1027310), 
Qiagen, USA) was diluted in 25 μL Opti-MEM+GlutaMAX-I (Gibco-BRL Life Technologies, 
UK) with 1.75 μL HiPerfect. The mixture was incubated for 10 min at room temperature and 
added drop-wise to the cells to obtain a final concentration of 20 nM siRNA per well. Either 48 h 
or 72 h after transfection, the cells were washed twice with ice-cold PBS and harvested in 25 μL 
2 X SDS sample buffer, followed by boiling at 100°C for 10 min. Equal amounts of cell lysates 
were analyzed by Western blotting as described elsewhere, probing with specific anti-Flot-1 and 
anti-GM130 antibodies. The optimization of siRNA concentration experiment shown in 
Addendum D2 was performed as in D1 with a few modifications. Briefly, an equimolar 
combination of all four Flot-1 siRNA oligonucleotides was diluted in either 25 μL Opti-
MEM+GlutaMAX-I with 1.75 μL HiPerfect or diluted in 50 μL Opti-MEM+GlutaMAX-I with 
3.5 μL HiPerfect and added dropwise to the cells to achieve a final concentration per well of 20 
nM or 40 nM, respectively. After incubation with siRNA for 72 h, the cells were washed twice 
with ice-cold PBS and harvested in 25 μL 2 X SDS sample buffer, followed by boiling at 100°C 
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for 10 min. Equal amounts of cell lysates were analyzed by Western blotting as described 
elsewhere, probing with specific anti-Flot-1 and anti-GM130 antibodies. 
 
For the optimized method as reported in Figure 3.9, LβT2 cells were seeded in 24-well plates at a 
density of 1.5 X 10
5
 cells per well in 500 μL DMEM with 10% FCS and antibiotics as described 
elsewhere. Twenty-four hours after plating, medium was replaced with fresh medium and the 
cells were transfected with siRNA using HiPerfect transfection reagent (Qiagen, USA), according 
to the manufacturer’s instructions. Briefly, mouse Flot-1 siRNA (Mm_FLot1_1, Mm_FLot1_2, 
Mm_FLot1_3, Mm_FLot1_4, (FlexiTube siRNA, Qiagen, USA)) or non-silencing scrambled 
(NSC) siRNA (Negative control siRNA (1027310), Qiagen, USA) were diluted in 50 μL Opti-
MEM+GlutaMAX-I (Gibco-BRL Life Technologies, UK) with 3.5 μL HiPerfect. The mixture 
was incubated for 10 min at room temperature and added drop-wise to the cells to obtain a final 
concentration of 40 nM siRNA per well. After incubation with siRNA for 48 h, the medium was 
replaced with fresh medium, followed by transfection of the cells with 250 ng of pTAT-GRE-
E1b-luc plasmid. After 24 h, the cells were stimulated for 8 h in serum-free medium as indicated 
in the figure legends. The cells were harvested in 50 μl reporter lysis buffer (Promega Corp., 
USA) per well. The luciferase assay (Luciferase Assay System, Promega Corp., USA) was 
performed with 10 μL of cell extracts in white 96-well plates in a Modulus microplate reader 
(Turner Biosystems, USA). Luciferase values were normalized to total protein content per well as 
determined by standard Bradford assay (Bradford, 1976). Equal amounts of cell lysates were 
analyzed by Western blotting as described elsewhere, probing with specific anti-Flot-1, anti-GR 
and anti-GAPDH antibodies. 
 
2.12 Statistical analysis 
 
Statistical analysis were performed with GraphPad Prism software (version 5) using the one-way 
ANOVA analysis of variance with either a Dunnett (when comparing all values to a single 
control) or Tukey (when comparing all values to each other) post-test. Statistical significance is 
denoted as *, ** or *** to indicate P < 0.05, P < 0.01 or P < 0.001, respectively. The statistical 
tests performed for each experiment are indicated in the respective figure legends.  
 
 58 
Chapter 3: Results 
 
3.1 Confirmation of the GnRH and the synergistic transcriptional responses 
on a GRE in LβT2 cells 
 
The present study was to further investigate the mechanisms of ligand-independent activation of 
the endogenous GR by GnRH and explore the synergistic transcriptional responses observed with 
co-stimulation of GnRH and Dex. Firstly, it was necessary to establish that GnRH induces 
transactivation and that co-stimulation with Dex and GnRH induces a synergistic transcriptional 
response of a transient GRE reporter gene in LβT2 cells in the hands of the present author. 
 
3.1.1 GnRH activates the endogenous unliganded GR to induce a transcriptional 
response on a GRE in LβT2 cells 
It has previously been shown that GnRH activates the unliganded GR inducing a transcriptional 
response on a GRE-luciferase reporter construct in LβT2 cells (Kotitschke et al 2009). To 
confirm this result, LβT2 cells were transfected with a GRE-luciferase plasmid, followed by 
stimulation for 8 h with 100 nM GnRH or 100 nM Dex in serum-free medium. As shown in 
Figure 3.1A, Dex treatment significantly increased the transcriptional activity of the luciferase 
reporter gene by about 4-fold (Figure 3.1A, bar 2). This result is a positive control required for 
the GRE assay and indicates LβT2 cells express functional endogenous GR. Treatment of the 
cells with GnRH significantly increased the transcriptional activity of the luciferase reporter gene 
by about 4-fold (Figure 3.1A, bar 3). The GnRH response was similar to the response induced 
with Dex treatment (Figure 3.1A), confirming the result from Kotitschke et al. (Kotitschke et al., 
2009). 
 
3.1.2 Co-stimulation with Dex and GnRH induces a synergistic transcriptional 
response on a GRE in LβT2 cells 
Kotitschke et al. also reported that co-treatment with Dex and GnRH results in a synergistic 
transcriptional response on a GRE-reporter in LβT2 cells. To confirm this result, LβT2 cells were 
transfected with a GRE-luciferase plasmid, followed by co-stimulation for 8 h with 100 nM 
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GnRH and 100 nM Dex in serum-free medium. From the results presented in Figure 3.1A, it is 
clear that Dex and GnRH have an equivalent ability to increase transcription of the GRE-reporter 
gene by about 4-fold (Figure 3.1A, compare bar 2 and 3). The results presented in Figure 3.1B 
show that the presence of both Dex and GnRH results in a significant 12-fold increase in the 
transcriptional activity of a GRE-reporter gene in LβT2 cells (Figure 3.1B), indicating that the 
hormones act synergistically. The above data indicate that crosstalk occurs between the GR and 
GnRHR signaling pathways, resulting in the ligand-independent activation of the GR by GnRH 




Figure 3.1: Ligand-independent activation of the GR by GnRH occurs in LβT2 cells and 
Dex and GnRH have a synergistic effect on the transcriptional activity of a GRE-reporter 
gene 
LβT2 cells were transfected with 250 ng of TAT-GRE-luciferase construct and 25 ng pSV β-
galactosidase. After 24 h cells were incubated for 8 h in serum-free medium with 100 nM Dex 
and 100 nM GnRH (A) or a combination of both (B). Results were normalized for transfection 
efficiency and expressed relative to vehicle (control). The graphs show combined results from 


















































post-test was used for statistical analysis and denoted as *, ** or *** to indicate P < 0.05, P < 
0.01 or P < 0.001, respectively. 
 
3.2 Dex increases the GnRH induced transcriptional response on an AP-1 cis-
element in LβT2 cells 
 
To investigate whether crosstalk between the GR and GnRHR signaling pathways occurs on a 
minimal AP-1 reporter construct in LβT2 cells, the cells were transfected with an AP-1-luciferase 
plasmid. The ability of GnRH to activate the AP-1 reporter gene was compared to that of TNFα, 
a cytokine previously shown to upregulate AP-1-containing genes in other cell lines (Kassel et 
al., 2004; Park et al., 2004; De Bosscher and Haegeman, 2009; Van Bogaert et al., 2010). TNFα 
was unable to induce a transcriptional response after 24 h stimulation (Figure 3.2A, bars 2 and 4), 
while GnRH induced a significant increase in AP-1 reporter activity in a dose-dependent manner 
(Figure 3.2A, bars 5 and 6). Interestingly, co-stimulation of LβT2 cells with 10 nM GnRH and 
100 nM or 1 μM Dex appeared to further enhance transcription, as compared to 10 nM GnRH 
alone (Figure 3.2B). The results show that Dex significantly increased the GnRH-induced 
transcriptional response by about 1.6-fold (Figure 3.2B). The above results provide evidence for 
crosstalk between Dex and GnRH signaling pathways on a minimal synthetic AP-1 cis-element 


















































































































Figure 3.2: Dex increases the GnRH-induced transcriptional response on an AP-1 cis-
element in LβT2 cells 
LβT2 cells were transfected with 250 ng of a pAP-1-luciferase construct and 25 ng pSV β-
galactosidase. After 24 h, cells were incubated for 24 h in serum-free medium with hormones, as 
indicated. Results were normalized for transfection efficiency and expressed relative to vehicle 
(control). The graphs show combined results from three independent experiments, each 
performed in triplicate. A one-way ANOVA with Dunnett’s and Tukey’s (Figure 3.2A, bars 5 
and 6) post-tests were used for statistical analysis and denoted as *, ** or *** to indicate P < 
0.05, P < 0.01 or P < 0.001, respectively. 
 
3.3 Crosstalk does not occur between the Dex and GnRH signaling pathways 
on an NF-κB cis-element in LβT2 cells 
 
To investigate if crosstalk between the GR and GnRHR signaling pathways occurs on a minimal 
NF-κB reporter construct in LβT2 cells, the cells were transfected with an NF-κB luciferase 
plasmid. The results presented in Figure 3.3 show a significant increase of approximately 3-fold 
in the transcriptional activity after stimulating the cells for 24 h with 20 ng/mL TNFα (Figure 3.3, 
bar 5), as compared to vehicle (control). Interestingly, treatment with 100 nM GnRH resulted in a 
similar and statistically significant transcriptional response of about 3-fold relative to vehicle 
(control) (Figure 3.3, compare bars 3 and 5). Thus, TNFα selectively increased the transcriptional 
activity of an NF-κB (Figure 3.3, bar 5) but not an AP-1 (Figure 3.2A, bar 2) reporter gene, while 
both were induced by GnRH. In contrast, addition of 100 nM Dex repressed basal reporter 
activity (Figure 3.3, compare bars 1 and 2) as well as TNFα-induced transcriptional activity 
(Figure 3.3, compare bars 5 and 6), while having no effect on the GnRH response (Figure 3.3, 
compare bars 3 and 4). Co-stimulation with GnRH and TNFα resulted in an additive 
transcriptional response of the NF-κB reporter gene (Figure 3.3, compare bars 3 and 5 with 7). 
Furthermore, the additive response of GnRH and TNFα on NF-κB transcription remained 































































































Figure 3.3: Crosstalk does not occur between the Dex and GnRH signaling pathways acting 
on an NF-κB cis-element in LβT2 cells 
LβT2 cells were transfected with 400 ng of (IL-6κB)3-50hu.IL6P-luciferase construct and 25 ng 
pSV β-galactosidase. After 24 h, cells were incubated for 24 h in serum-free medium with 
hormones, as indicated. Results were normalized for transfection efficiency and expressed 
relative to vehicle (control) in the absence of TNFα. The graph shows combined results from 
three independent experiments, each performed in triplicate. A one-way ANOVA with Dunnett’s 
post-test was used for statistical analysis and denoted as *, ** or *** to indicate P < 0.05, P < 
0.01 or P < 0.001, respectively. 
 
3.4 Similar to Dex, GnRH appears to induce GR protein degradation 
 
The GR protein levels are down regulated after ligand binding and transcriptional activation of 
target genes (Dong et al., 1988; Webster et al., 1997). To assess if GnRH results in protein 
degradation of the GR and whether the transcriptional responses observed in Figure 3.2 could 
result in changes of GR protein expression levels, the cell lysates of the AP-1 gene reporter assay 
were analyzed by Western blotting. The results shown in Figure 3.4 are from cell lysates 
analyzed in Figure 3.2A and B, after stimulation for 24 h with 1 μM Dex, 10 or 100 nM GnRH, a 
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combination of 10 nM GnRH with 100 nM or 1 μM Dex. Stimulation of LβT2 cells with 1 μM 
Dex for 24 h, appeared to result in a 40% decrease in GR protein expression (Figure 3.4, compare 
bars 1 and 2). Interestingly, treatment of LβT2 cells with increasing concentrations of GnRH 
resulted in a decrease of GR protein levels (Figure 3.4, compare bars 1, 3 and 4). Co-stimulation 
with 10 nM GnRH and varying amounts of Dex appeared to increase the GR protein turnover 
(Figure 3.4, compare bars 3 with 5 and 6). No statistical significance could be established from 
two independent experiments. The decrease in GR protein levels with GnRH co-treatment 



























































































































































































Figure 3.4: Similar to Dex, GnRH appears to induce GR protein degradation 
LβT2 cells were incubated with hormone for 24 h in serum-free medium as indicated in the 
figure. Equal amounts of cell lysates were loaded on an 8% SDS-PAGE gel, transferred onto 
nitrocellulose membrane and probed with antibodies to GR and Flot-1 (loading control). The 
results on the left panel shows a representative Western blot and the graph shows combined 
results of two independent experiments. A one-way ANOVA with Dunnett’s post-test was used 
for statistical analysis and denoted as *, ** or *** to indicate P < 0.05, P < 0.01 or P < 0.001, 
respectively. 
 
3.5 Subcellular localization of the GnRHR and GR with lipid raft markers by 
immunoflorescence analysis in LβT2 cells 
 
3.5.1 LβT2 cells express the lipid raft marker protein Flot-1 and not Cav-1 
Recently, lipid rafts have been implicated in rapid GC signaling and the GR was shown to 
localize to caveolae in A549 cells (Matthews et al., 2008). The GnRHR has been shown to 
localize exclusively to lipid rafts and to be necessary for activation of the ERK signaling pathway 
by GnRH in αT3-1 cells (Navratil et al., 2003; Bliss et al., 2007). It was hypothesized in the 
present study that the crosstalk between the GR and GnRHR signaling pathways could involve a 
co-localization of the receptors to lipid rafts in LβT2 cells. To investigate whether LβT2 cells 
express the lipid raft proteins Flot-1 and Cav-1, Western blot analysis was performed with whole 
cell LβT2 lysates using specific Flot-1 and Cav-1 antibodies. As shown in Figure 3.5.1, Flot-1 
protein expression was detected in LβT2 cells. To confirm the identity of the band, COS-7 cells 
were transfected with a Flot-1 expression plasmid as a positive control (Figure 3.5.1). In contrast, 
Cav-1 protein expression was not detected in LβT2 cells while a band of the right size was 
detected in COS-7 cells (Figure 3.5.1). This result shows that LβT2 cells express a detectable 

















Figure 3.5.1: LβT2 cells express a detectable level of the lipid raft marker protein Flot-1, 
but not Cav-1 
Whole LβT2, untransfected COS-7 and Flot-1 transfected COS-7 cell lysates were loaded on a 
10% SDS-PAGE gel, followed by transfer onto nitrocellulose membrane and probing with 
specific antibodies to Flot-1 and Cav-1. 
 
3.5.2 Immunoflorescence analysis shows that the endogenous GnRHR co-localizes 
with endogenous Flot-1 at the plasma membrane of LβT2 cells, independent of 
ligand 
In order to investigate protein co-localization of endogenous GnRHR and Flot-1 in LβT2 cells by 
immunoflorescence using specific primary antibodies and fluorescently labeled secondary 
antibodies, optimum growth conditions for slide preparation needed to be established. In order to 
detect expression of proteins in the plasma membrane by immunoflorescence, cells needed to 
grow as a monolayer. LβT2 cells have a strong tendency to grow in clusters tightly together that 
makes membrane co-localization difficult to detect. It has previously been shown that many cell 
lines and primary cells have an increased rate of proliferation and grow in a monolayer when 
certain coating substrates have been applied to the growth surface (Beck et al., 1990; Calof and 
Lander, 1991). Therefore, the effect on morphology of LβT2 cells growing on uncoated, laminin- 
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or poly-L-ornithine-coated glass cover slips for two days was investigated. The results from 
Addendum A show that there was no difference in proliferation or cell morphology between 
uncoated or laminin coated slides. It also appears that the cells growing on poly-L-ornithine have 
significant changes in cell morphology with a decreased rate of proliferation, as compared to cells 
in normal culture conditions. Therefore, LβT2 cells were grown on uncoated glass cover slips for 
two days for immunoflorescence experiments. 
 
The GnRHR has been shown to localize exclusively to lipid rafts in αT3-1 cells (Bliss et al., 
2007) and Flot-1 has been shown to interact with the G-protein Gαq in HeLa cells (Sugawara et 
al., 2007). The αT3-1 cell line represents precursor gonadotrope cells, whereas the LβT2 cell line 
represents more mature and differentiated gonadotrope cells (Fernandez-Vazquez et al., 1996; 
Turgeon et al., 1996). To investigate whether the endogenous GnRHR co-localizes with 
endogenous Flot-1 in LβT2 cells, live-cell staining for the receptor was performed followed by 
fixation and staining for Flot-1. The cells were visualized with a confocal microscope and it was 
found that Flot-1 was mainly localized to the plasma membrane (large arrow) with some 
distribution in vesicle-like intracellular compartments (Figure 3.5.2, small arrow). The GnRHR 
was found to mainly localize to the plasma membrane (large arrow), but a small percentage was 
also detected in the cytoplasm (Figure 3.5.2, small arrow). This could be due to internalization of 
the receptor upon antibody binding that could not be avoided. The data was analyzed by over-
laying the GnRHR (green) and Flot-1 (red) channels and a significant amount of GnRHR was 
found to co-localize with Flot-1 at the plasma membrane of LβT2 cells (Figure 3.5.2). 
Furthermore, the Pearson’s and Mander’s co-localization coefficient values were close to 1 and 
the intensity correlation value was near to 0.5, suggesting true co-localization (Figure 3.5.2i). The 
fluorogram showing the intensity correlation analysis of the co-localization between the GnRHR 
and Flot-1 displays a diagonal relationship (Figure 3.5.2ii), also suggesting true co-localization. 
This novel result demonstrating the endogenous GnRHR co-localizing with endogenous Flot-1 in 















Figure 3.5.2: Immunoflorescence analysis shows that the endogenous GnRHR co-localizes 
with endogenous Flot-1 at the plasma membrane of LβT2 cells, independent of ligand  
LβT2 cells were grown on glass cover slips and were stained live with rabbit anti-GnRHR 
(Green) for 1 h, followed by fixation. Slides were stained with mouse anti-Flot-1 (Red) antibody, 
followed by incubation with anti-rabbit Alexa488 and anti-mouse Cy3 antibody. Nuclei were 
stained with Hoechst before mounting in Mowiol. Staining was visualized with a Zeiss LSM510 
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group of cells, as indicated by the multiple nuclei visible in the Hoechst stain. Co-localization 
analysis was performed as described in Materials and Methods. A representative analysis of co-
localization co-efficients (i) and a fluorogram (ii) is shown. The results shown are representative 
of three independent experiments. Large and small arrows indicate a localization to the plasma 
membrane and intra-cellular vesicles, respectively. 
 
3.5.3 Immunoflorescence analysis shows that a small population of endogenous GR 
appears to co-localize with endogenous Flot-1 to lipid rafts independent of ligand 
in LβT2 cells 
The previous result showed the GnRHR localizes to Flot-1-containing lipid rafts. There is no 
report in the literature indicating GR localization to lipid rafts in the pituitary, while two studies 
have indicated its association with caveolae in Hep3B and A549 cells (Jain et al., 2005; 
Matthews et al., 2008). This could be a potential mechanism enabling crosstalk between the GR 
and GnRHR signaling pathways in LβT2 cells shown in Figures 3.1, 3.2 and 3.4. To explore this 
possibility, LβT2 cells were grown on glass cover slips, stimulated for 30 min with 100 nM Dex, 
100 nM GnRH or a combination of both, followed by live-cell staining with cholera toxin B 
subunit conjugated to Alexa647. The toxin binds specifically to GM1, a ganglioside that is highly 
enriched in lipid rafts (Janes et al., 1999; Harder, 1998). GnRH has previously been reported to 
induce maximal GR phosphorylation after 30 min in LβT2 cells (Kotitschke et al., 2009). 
Therefore, a time point of 30 min was chosen for all ligand stimulations of LβT2 cells to 
investigate if lipid rafts are involved in this non-genomic crosstalk mechanism between the GR 
and the GnRHR. Subsequently, cells were fixed and permeabilized, followed by staining with 
anti-GR- and anti-Flot-1-specific antibodies. The results presented in Figure 3.5.3 panels A to D 
show that the GM1 stain is exclusively localized to the plasma membrane (small arrow) and 
displays a clustering pattern, characteristic of lipid rafts. The stain for Flot-1 displays a partial 
membrane localization (large arrow) together with intra-cellular compartments (small arrow) 
(Figure 3.5.3, panels A to D). In untreated cells, the GR appears evenly distributed throughout the 
cell, with a small percentage co-localizing with GM1 and Flot-1 (Figure 3.5.3A). Treatment with 
Dex resulted in distinct nuclear translocation of the GR, but a significant amount of GR remained 
in the cytoplasm with a small percentage co-localizing with GM1 and Flot-1 (Figure 3.5.3, 
compare panel A with B). When cells were treated with GnRH, there was no clear difference in 
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localization of the GR compared to untreated cells after 30 min (Figure 3.5.3, compare panels A 
and C). Co-stimulation with GnRH had no detectable effect on the amount of Dex-induced 
nuclear import of the GR (Figure 3.5.3, compare panel A with B and D). However, regardless of 
the large percentage of nuclear import of the GR, a small population co-localizes with GM1 and 
Flot-1 (Figure 3.5.3D). Interestingly, co-stimulation with Dex and GnRH resulted in the most GR 
co-localizing with Flot-1 under all stimulated conditions (Figure 3.5.3, panels A to D). The 
amount of GR that co-localizes with Flot-1 relative to the remaining GR proved insufficient to 
perform statistical analysis from three independent experiments, although it is clear that the GR 
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Figure 3.5.3: Immunoflorescence analysis shows that the endogenous GR co-localizes with 
endogenous Flot-1 at the plasma membrane of LβT2 cells, independent of ligand  
LβT2 cells were grown on glass cover slips and incubated for 30 min in medium containing 
charcoal-stripped serum (A), or including 100 nM Dex (B), 100 nM GnRH (C) or a combination 
of both (D). Cells were stained live for GM1 (Yellow) with Cholera Toxin B subunit conjugated 
to Alexa647 for 30 min before being fixed and permeabilized. Slides were stained with rabbit 
anti-GR (Green) and mouse anti-Flot-1 (Red) antibodies followed by incubation with anti-rabbit 
Alexa488 and anti-mouse Cy3 antibodies. Nuclei were stained with Hoechst before mounting in 
Mowiol. Staining was visualized with a Zeiss LSM510 Meta Confocal microscope using the 40X 
objective and a representative image is shown for a group of cells, as indicated by the multiple 
nuclei visible in the Hoechst stain. Co-localization analysis was performed with the LSM510 
Meta software as described in Materials and Methods with the area of interest demarcated in 
green if needed to exclude artifacts resulting from cellular debris. The images in blue show the 
regions of co-localization between the GR and GM1, or Flot-1, respectively. The results shown 
are representative of three independent experiments. 
 
3.6 Density-gradient analysis shows that the endogenous GR localizes with the 
endogenous GnRHR to Flot-1 containing lipid rafts independent of ligand in 
LβT2 cells 
 
Having shown by immunoflorescence that the GnRHR co-localizes with Flot-1 and the GR 
appears to localize to lipid rafts at the plasma membrane, a different strategy was persued to 
provide additional evidence that these receptors localize to lipid rafts in LβT2 cells.  Initial 
experiments were performed to set up a method for the biochemical isolation of lipid rafts in 
LβT2 cells. The following parameters were investigated to optimize the fractionation of lipid 
rafts. The use of a non-detergent method (Gagescu et al., 2000) and a detergent-resistant method 
(Lafont and Simons, 2001), different concentrations of Triton X-100 and the use of a crude 
membrane fraction or whole cell lysates as starting material, were compared. The search criteria 
were based on the detectable isolation of lipid rafts into minimal fractions with a low-density, as 
analyzed by Western blotting for the lipid raft marker protein, Flot-1. The results from 
Addendum B show that the use of a non-detergent-based method did not result in adequate 
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fractionation of Flot-1,  while the detergent-resistant method showed a better degree of 
fractionation at 0.05% and not 1% Triton X-100. Using whole cell lysates as compared to a crude 
membrane fraction as starting material in the 0.05% Triton X-100 method dramatically decreased 
the amount of degraded GR in the lipid raft fraction (compare Addendum B with Figure 3.6). 
Therefore, it was decided to use whole cell lysates as starting material with the 0.05% Triton X-
100 method for the isolation of lipid rafts from LβT2 cells.  
  
To investigate if the GR localizes to lipid rafts in LβT2 cells, whole cells were incubated with 
0.05% Triton X-100 before fractionation on a discontinuous sucrose gradient. First, it was 
important to establish that adequate fractionation was achieved by analyzing the lipid raft fraction 
for nuclear material. Therefore, the nuclear fraction was identified with the nuclear marker, 
histone H3. The results from Figure 3.6A show that histone H3 localized only to fractions 5, 6 
and 7, which are the most-dense fractions where the starting material was applied. Importantly, 
no histone H3 could be detected in the lipid raft fraction (Figure 3.6A), indicating the absence of 





The results from Figure 3.6B show that the majority of Flot-1 is located in fraction 3 (lipid rafts) 
under basal and all stimulated conditions. A small amount of Flot-1 was detected in fraction 5 
under all treated conditions (Figure 3.6B, panels i to iv), which represents the interface of the 
60%/43% interface. No Flot-1 could be detected in fraction 6 under all tested conditions 
(representing a sampling of the region where the cell lysate was made up to 60% and loaded), 
while a small amount of Flot-1 were detected in fraction 7 under all tested conditions 




Interestingly, the results suggest that the GnRHR localizes exclusively to Fraction 3 in untreated 
and under all stimulated conditions (Figure 3.6B, panels i to iv). The results indicate that all of 
the detectable endogenous GnRHR is located in the lipid raft fraction in LβT2 cells. This is 
supported by the result from Figure 3.5.2 showing significant co-localization of the GnRHR with 
Flot-1 in the plasma membrane of LβT2 cells.  
 
A small percentage of GR was detected in the lipid raft fraction in untreated cells (Figure 3.6B, 
panel i). Despite the resulting nuclear import of the GR with Dex, a small amount of GR was 
detected in the lipid raft fraction after 30 min treatment with Dex (Figure 3.6B, panel ii). 
Similarly, a small amount of GR was detected in lipid rafts after 30 min stimulation with either 
GnRH or co-stimulation with Dex and GnRH (Figure 3.6B, panels iii and iv). No GR was 
detected in Fraction 4, indicating specific localization of the GR to lipid rafts rather than 
incomplete separation of the density-gradients (Figure 3.6B, panels i to iv). The remaining 
percentage of GR fractionated into fractions 5, 6 and 7 in unstimulated cells and under all 
stimulated conditions (Figure 3.6B, panels i to iv), which is the 60% sucrose fraction of the 
gradient where the cell lysate was applied and contains all cellular material excluding the low-
density membrane fractions. To quantify the relative extent of GR recruitment to lipid rafts under 
hormonal stimulation, the lipid raft GR protein levels were expressed relative to lipid raft Flot-1 
protein levels (Figure 3.6B, panel v). The results show the level of GR localized to lipid rafts is 
independent of short exposures to Dex, GnRH or a combination of both (Figure 3.6B). This is in 
agreement with the result from Figure 3.5.3 showing a small percentage of GR co-localizing with 
Flot-1 and GM1 at the plasma membrane of LβT2 cells independent of hormone treatment 






























































Figure 3.6 B 
















Figure 3.6: Density-gradient analysis shows the endogenous GR localizes with the 
endogenous GnRHR to Flot-1 containing lipid rafts independent of ligand in LβT2 cells 
A. Lipid rafts were isolated by ultracentrifugation employing the detergent resistant flotation 
strategy in a discontinuous sucrose density gradient consisting of 2 mL ELB, 4 mL of 13% 
sucrose in ELB, 4 mL of 43% sucrose in ELB and 4 mL of 60% (the sample). Seven 1 mL 
fractions were collected: 1) Top of the gradient, 2) ELB/13% interface, 3) 13%/43% interface 
(lipid raft fraction), 4) middle of 43% sucrose, 5) 43%/60% interface, 6) middle of 60% sucrose 
(middle of loading fraction containing unbroken nuclei and unsuspended cells) and fraction 7) the 
pellet. Samples were prepared as described in Materials and Methods. Equal amounts of fraction 
samples were loaded on an 8% SDS-PAGE gel, transferred onto nitrocellulose membrane and 
probed with an antibody against histone H3. The Western blot shown is representative of three 
independent experiments. Fraction 3 is considered the lipid raft fraction as indicated with an 
arrow. B. i - iv. LβT2 cells were serum-starved over night and incubated for 30 min in serum-free 
medium (panel i), including 100 nM Dex (panel ii), 100 nM GnRH (panel iii) or a combination of 
both (panel iv). Lipid rafts were isolated as described in A. Equal amounts of fraction samples 
were loaded on an 8% SDS-PAGE gel, transferred onto nitrocellulose membrane and probed 
successively with antibodies against GR, Flot-1 and GnRHR. Results shown in panels (i) to (iv) 
are single Western blots that are representative of three independent experiments. The lower band 
detected in panel (ii) from the GR Western blot resulted from partial degradation of the receptor. 
The detectable band in fraction 2 of panel (iv) in the GR Western blot has a larger size than the 
GR and is most likely a non-specific band. The GR protein levels were normalized against Flot-1 
protein levels for each stimulated condition from a single gel and expressed relative to vehicle 
(control) (iv). The graph shows combined results of three independent experiments as performed 








3.7 Co-immunoprecipitation assays show the in vitro interaction between the 
endogenous GR and endogenous Flot-1 in a ligand-independent manner in 
LβT2 cells 
 
The results from Figure 3.6B show that endogenous GR localizes with endogenous GnRHR in 
Flot-1 containing lipid rafts. Furthermore, the localization appears to be independent of short 
exposures to 100 nM Dex, 100 nM GnRH or a combination thereof. The GR has been shown to 
localize to caveolae through a physical interaction with Cav-1 in A549 cells (Matthews et al., 
2008). To investigate if a similar mechanism underlies the GR localization to lipid rafts in LβT2 
cells, co-immunoprecipitation assays were performed with whole LβT2 cell lysates and an anti-
GR antibody. Remarkably, the results show that Flot-1 was co-immunoprecipitated with the 
unliganded GR (Figure 3.7A). Furthermore, treating the cells with 100 nM Dex for 30 min had 
no effect on the interaction of Flot-1 with the endogenous GR (Figure 3.7A). Importantly, there 
was no GR or Flot-1 that co-immunoprecipitated with the non-specific IgG under basal or Dex-
treated cells (Figure 3.7A), suggesting that the interaction of Flot-1 with the GR is specific. 
 
It was important to confirm this association of the GR with Flot-1 in LβT2 cells by reciprocal 
immunoprecipitation with a Flot-1 antibody. When Flot-1 was precipitated from whole-cell 
lysates with anti rabbit polyclonal antibody, co-immunoprecipitation of the GR occurred 
independent of Dex treatment (Figure 3.7B). There was no statistically significant differential 
interaction of Flot-1 with the GR in the presence of Dex for 30 min as compared to unstimulated 
cells from pooled results of two independent experiments (Figure 3.7B). It is important to note 
that no precipitated GR proteins were detected when a mouse monoclonal Flot-1 antibody was 
used in the co-immunoprecipitation assay (data not shown). A possible explanation could be that 
the immunogen used to raise the monoclonal anti-Flot-1 antibody contains the domain of Flot-1 
required for an interaction with the GR. The monoclonal antibody was raised to the last 116 C-
terminal residues of the 428 amino acid Flot-1 protein. Therefore, the antibody recognizes a 
significant region of the protein, which could be masked by a GR-Flot-1 complex allowing no 
access for that specific antibody. The result suggests that the GR possibly interacts with the C-
terminal domain of Flot-1. 
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In order to investigate if treatment with GnRH alone or with Dex plus GnRH could result in a 
differential interaction of Flot-1 with the GR in LβT2 cells, the GR was immunoprecipitated from 
whole cell lysates with an anti-GR antibody. In agreement with the results from Figure 3.7A, a 
similar amount of Flot-1 co-immunoprecipitated with the GR under basal and Dex-treated 
conditions (Figure 3.7C). Stimulation with GnRH or co-stimulation with Dex and GnRH did not 
result in a differential interaction of Flot-1 with the GR from three independent experiments 
(Figure 3.7C). The results from Figure 3.7 together with results shown in Figure 3.5 and 3.6 
strongly suggest that the co-localization of the endogenous GR with Flot-1 in lipid rafts at the 
plasma membrane of LβT2 cells could be mediated by a mechanism involving a physical 






















































Figure 3.7: Co-immunoprecipitation assays show the in vitro interaction between the 
endogenous GR and endogenous Flot-1 in a ligand-independent manner in LβT2 cells 
A. LβT2 cells were incubated in serum-free medium for 2 h before addition of 100 nM Dex for 
30 min. Equal amounts of cell lysates were incubated with GR or non-specific IgG antibody 
followed by precipitation with Protein A/G beads. The samples were loaded on an 8% SDS-
PAGE gel, transferred onto nitrocellulose membrane and probed separately with anti-GR- and 
anti-Flot-1-specific antibodies. B. LβT2 cells were incubated in serum-free medium for 2 h 
before addition of 100 nM Dex for 30 min. Equal amounts of cell lysates were incubated with a 
rabbit anti-Flot-1 or non-specific IgG antibody followed by precipitation with Protein A/G beads. 
The samples were loaded on an 8% SDS-PAGE gel, transferred onto nitrocellulose membrane 
and probed with anti-GR- and anti-Flot-1-specific antibodies. The panel on the left shows a 
single representative Western blot and the graph shows combined results of two independent 
experiments where vehicle (control) was set to 100%. C. LβT2 cells were incubated in serum-
free medium for 2 h before addition of 100 nM Dex, 100 nM GnRH or both together for 30 min. 
Co-immunoprecipitation was performed as in A. The panel on the left shows a single 
representative Western blot and the graph shows combined results of three independent 
experiments where vehicle (control) was set to 100%. 
IP: GR

















3.8 Results using cholesterol depletion agents suggest that lipid rafts are not 
required for the hormone-induced transcriptional response on a GRE or the 
GC-independent phosphorylation of the GR in LβT2 cells 
 
Having established that a small amount of GR localizes at the plasma membrane in a complex 
with Flot-1, it was next investigated wheteher lipid rafts play a functional role in GR signaling. 
LβT2 cells were transfected with a GRE-luciferase plasmid and incubated continuously for 8 h 
with MβCD in the presence of 100 nM Dex or 100 nM GnRH. The results indicate that the 
continuous treatment with 2% MβCD (approximately 15 mM) for 8 h dramatically decreased the 
basal, Dex- and GnRH-induced transcriptional activity of the GRE-reporter gene in LβT2 cells, 
while also dramatically decreasing the expression of the constitutive β-galactosidase gene 
(Addendum C). In addition, the 8 h incubation with MβCD resulted in significant changes in the 
morphology of LβT2 cells (data not shown). Taken together, these findings suggests that 
continuous treatment with MβCD results in cell death, which prevents the use of this method for 
the investigation of a role for lipid rafts in GR transactivation in LβT2 cells. Therefore, a 
different strategy involving incubation of cells for 45 min with MβCD, followed by washing of 
the cells with PBS before incubation with ligand, was investigated (Navratil et al., 2003). LβT2 
cells were pretreated with 10 mM MβCD for 45 min and the cholesterol extraction drug was 
washed out, followed by stimulation for 8 h with 100 nM Dex, 100 nM GnRH or a combination 
of both. Importantly, the constitutive expression of the β-galactosidase gene was unaffected in 
cells that were incubated with MβCD, as compared to cells not incubated with MβCD (data not 
shown).  The results from Figure 3.8A show that Dex increased the transcriptional activity of the 
reporter gene by about 2-fold and the increased GRE reporter activity was unaffected by MβCD 
(Figure 3.8A). Similarly, GnRH increased the transcriptional activity of the reporter gene by 
about 2-fold, which remained unchanged by MβCD treatment (Figure 3.8A). Co-stimulation of 
the cells with Dex and GnRH resulted in a synergistic increase of the GRE reporter gene of about 
8-fold (Figure 3.8A). However, the synergistic transcriptional response with Dex and GnRH also 
remained unaffected in the presence of MβCD (Figure 3.8A). The results suggest that lipid rafts 














Having established that the disruption of lipid rafts with MβCD appeared to have no effect on the 
GnRH-induced transcriptional response on a GRE, a possible role for lipid rafts in site-specific 
phosphorylation of the GR by GnRH was investigated. Therefore, LβT2 cells were treated with 
10 mM MßCD for 45 min, after which the cholesterol extraction drug was washed out, followed 
by incubation with 100 nM GnRH for 1 h. Equal amounts of cell lysates were separated on SDS-
PAGE, followed by Western blotting with an antibody specific for phospho-Ser234 GR. The 
results from Figure 3.8B show that GnRH significantly increased the phosphorylation status of 
the endogenous GR at Ser234 by about 1.5-fold (Figure 3.8B). Furthermore, no difference was 
detected in the basal phosphorylation status of the GR in the presence of MßCD (Figure 3.8B). 
Importantly, treatment with MßCD had no effect on the phosphorylation status of the GR in the 
presence of GnRH at Ser234 (Figure 3.8B). Therefore, the results from Figure 3.8B suggest that 
disruption of lipid rafts with MßCD has no effect on the ligand-independent phosphorylation of 













































It must be noted that there is no evidence to prove that the lipid rafts were disrupted in the above 
experiments. It has previously been shown that the GnRH-induced activation of ERK-1/2 was 
abolished when αT3-1 cells were treated with MβCD (Navratil et al., 2003; Bliss et al., 2007). In 
the same study it was shown that GnRH-induced activation of ERK-1/2 requires intact lipid rafts, 
since it was established that MβCD extracted cellular cholesterol and the GnRH-induced 
activation of ERK-1/2 was restored by cholesterol repletion (Navratil et al., 2003). Therefore, the 
LβT2 cell lysates from Figure 3.8B were analyzed by Western blotting for ERK-1/2 activation. 
However, the results in Figure 3.8C show MβCD had no effect on the GnRH-induced 
phosphorylation of ERK-1/2 (Figure 3.8C). Thus, this result suggests that lipid rafts were not 



































There is one report in the literature suggesting inhibition of Dex-induced transactivation of a 
GRE-reporter mediated via the GR with continuous treatment of Hep3B cells with Filipin-III 
(Jain et al., 2005). Filipin-III is a potentially less toxic cholesterol-binding drug that can be 
continuously included during stimulation and is a lipid raft disrupting agent. Thus, to investigate 
a role for lipid rafts in Dex-induced transactivation of a GRE via the GR, LβT2 cells were 
transfected with a GRE-luciferase plasmid and pre-treated for 30 min with 5 ng/mL Filipin-III, 
followed by stimulation for 8 h with 100 nM Dex in the presence or absence of Filipin-III. 
Similar to results obtained previously, stimulation with Dex resulted in a significant 6-fold 
increase in the transcriptional activity of the reporter gene compared to vehicle treated cells 
(Figure 3.8D). However, treatment with Filipin-III had no effect on the basal or Dex-induced 
transcriptional response (Figure 3.8D). Taken together the results from Figure 3.8 suggest that the 
disruption of lipid rafts has no effect on the Dex- or GnRH-induced transcriptional responses on a 
GRE-reporter gene in LβT2 cells. However, no direct evidence exists for the disruption of lipid 
rafts with the cholesterol depletion agents used in the present study. In addition, the finding that 
MβCD treatment did not inhibit GnRH-induced phosphorylation of ERK-1/2 in LβT2 cells, 
suggests that the integrity of lipid rafts was not disrupted with MβCD in LβT2 cells. Thus, the 









Figure 3.8: Cholesterol depletion of cells suggest that lipid rafts are not required for the 
hormone-induced transcriptional response on a GRE or the GC-independent 
phosphorylation of the GR in LβT2 cells. 
A. LβT2 cells were transfected with 250 ng of TAT-GRE-luciferase construct and 25 ng pSV β-
galactosidase. After 24 h cells were incubated for 45 min with 10 mM MβCD in serum-free 
medium, followed by one PBS wash and incubation in serum-free medium for 8 h with 100 nM 
D) 
GRE-luc



























Dex or 100 nM GnRH or a combination of both. Results were normalized for transfection 
efficiency and expressed relative to vehicle (control) without MβCD. The graph shows combined 
results from three independent experiments, each performed in triplicate. B. LβT2 cells were 
incubated for 45 min with 10 mM MβCD in serum-free medium, followed by one wash with PBS 
and incubated in serum-free medium for 1 h with 100 nM GnRH. Equal amounts of cell lysates 
were loaded on an 8% SDS-PAGE gel and transferred to nitrocellulose membrane and probed 
with specific antibodies against pSer234 GR, total GR and GM130 (loading control). The 
pSer234 GR levels were normalized to total GR and expressed relative to vehicle (control). The 
panel on the left shows a single representative Western blot and the graph shows combined 
results of three independent experiments expressed relative to vehicle (control). C. As in B, 
except the membrane was probed with specific antibodies against pERK-1/2 and total ERK. The 
Western blot shown is representative of two independent experiments. D. LβT2 cells were 
transfected with 250 ng of TAT-GRE-luciferase construct and 25 ng pSV β-galactosidase. After 
24 h, cells were pre-treated with 5 ng/mL Filipin-III for 30 min in serum-free medium, followed 
by incubation for 8 h with addition of 100 nM Dex. Results were normalized for transfection 
efficiency and expressed relative to vehicle control without Filipin-III. The graph shows 
combined results from three independent experiments, each performed in triplicate. A one-way 
ANOVA with Dunnett’s post-test was used for statistical analysis and denoted as *, ** or *** to 
indicate P < 0.05, P < 0.01 or P < 0.001, respectively. 
 
3.9 Flot-1 is required for Dex-induced transcriptional response and the 
synergistic transcriptional response with Dex and GnRH on a GRE in LβT2 
cells 
 
The results from the cholesterol depletion assays in Figure 3.8 were inconclusive, hence another 
approach was needed to investigate a potential role for lipid rafts in the transcriptional response 
of the GR on a GRE-reporter gene in LβT2 cells. Therefore, a role for Flot-1 in transcriptional 
activity of the GR on a GRE-reporter was investigated by specific knockdown of Flot-1 protein 
expression. To decrease Flot-1 protein expression in LβT2 cells, cells were transfected with 
siRNA specific for mouse Flot-1 or non-silencing scrambled siRNA (NSC) as control. To obtain 
an approximate 50% decrease in Flot-1 protein levels, the siRNA transfection conditions was 
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optimized for LβT2 cells, including different siRNA oligonucleotides sequences, time of 
incubation with siRNA and concentration of siRNA required. The results showed that there was 
no distinct difference between the four different oligonucleotides investigated with respect to the 
amount of Flot-1 knockdown (Addendum, Figure D1). However, a greater level of Flot-1 
knockdown was achieved after 72 h incubation compared to 48 h incubation with a combination 
of all four siRNA oligonucleotides (Addendum, Figure D1). In addition, incubating the cells for 
72 h with a combination of all four siRNA oligonucleotides at final concentration of 40 nM 
appeared to result in more Flot-1 knockdown as compared to using a final concentration of 20 
nM siRNA (Addendum, Figure D2). Thus, for knockdown experiments of Flot-1 in LβT2 cells, 
an equimolar combination of all four siRNA oligonucleotides was used for 72 h at a final 
concentration of 40 nM. 
 
To investigate if Flot-1 is required for the transactivation of a GRE-reporter gene in LβT2 cells, 
cells were transfected with Flot-1 siRNA as described above, followed by transfection with a 
GRE-luciferase plasmid and stimulation for 8 h with 100 nM Dex, 100 nM GnRH or both 
together. To validate the efficiency of Flot-1 knockdown in the siRNA-transfected cells, an 
aliquot of the GRE-reporter cell lysates was analyzed by Western blotting. The results from 
Figure 3.9A show that Flot-1 protein expression was decreased by approximately 50% for all 
stimulated conditions in the siRNA-transfected cells as compared to NSC in several repeat 
experiments (Figure 3.9A). In addition, the effect of decreased Flot-1 protein levels on the 
stability of the GR protein was investigated for all stimulated conditions. The results from Figure 
3.9B show that knockdown of Flot-1 protein expression appears to have no effect on the 
degradation of the GR under basal and all stimulated conditions, suggesting that Flot-1 is not 
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Having confirmed that the Flot-1 siRNA-transfected cells have statistically significant decreased 
levels of Flot-1 protein expression (Figure 3.9A), the effect of decreased Flot-1 protein levels on 
GRE transactivation was analyzed. It was found that Dex increased the transcriptional activity of 
the reporter gene by about 5.5-fold, while knockdown of Flot-1 protein levels with siRNA 
reduced the activity slightly relative to NSC (Figure 3.9Ci). The decrease in the Dex-induced 
transcriptional response of the reporter gene with Flot-1 siRNA was not statistically significant. 
However, GnRH-induced GRE-reporter activity as shown previously could not be established in 
the NSC or siRNA-transfected cells (Figure 3.9Ci). Therefore, the requirement for Flot-1 in the 
GnRH-induced transcriptional response on a GRE in LβT2 cells could not be investigated. 
However, it was found that the synergistic transcriptional response mediated by co-stimulation 












To illustrate that decreased Flot-1 protein levels result in decreased GR-mediated transactivation, 
the transcriptional responses in the presence of Flot-1 siRNA were expressed as a percentage 
relative to each NSC (Figure 3.9Cii). Interestingly, the transformed results from Figure 3.9C 
show that knockdown of Flot-1 significantly repressed the Dex-induced transcriptional response 
of the GRE-reporter gene by about 30% in LβT2 cells (Figure 3.9Cii). Similarly, the synergistic 
transcriptional response with both Dex plus GnRH was significantly repressed when Flot-1 
protein expression was decreased in LβT2 cells (Figure 3.9Cii). These results from Figure 3.9 
strongly suggest a requirement for Flot-1 in the Dex-mediated response as well as the synergistic 






































Figure 3.9: Flot-1 is required for the synergistic transcriptional response with Dex and 
GnRH on a GRE promoter in LβT2 cells 
A. LβT2 cells were transfected with non-silencing control (NSC) or specific mouse Flot-1 siRNA 
at a final concentration of 40 nM and incubated for 72 h. The medium was replaced with fresh 
medium and cells were transfected with 250 ng TAT-GRE-luciferase construct. After 24 h, cells 
were incubated for 8 h in serum-free medium with 100 nM Dex or 100 nM GnRH or a 
combination of both. Equal amounts of samples were loaded on an 8% SDS-PAGE gel, 
transferred onto nitrocellulose membrane and probed with specific antibodies against GR, Flot-1 
and GAPDH. The Flot-1 protein levels were normalized to GAPDH protein levels and expressed 
relative to NSC vehicle (control). The panel on left shows a Western blot that is representative of 
two independent experiments and the graph shows combined results from the two independent 
experiments. One-way ANOVA with Tukey’s post-tests was used for statistical analysis between 
NSC and Flot-1 siRNA for each condition respectively. B. As in A. The graph shown is 
representative of three independent experiments. A one-way ANOVA with Dunnett’s post-tests 
was used for statistical analysis. C. As in A. Results were normalized to total protein and 
expressed relative to NSC vehicle (control) (i) or the percentage of repression expressed relative 
to NSC for each condition (ii). The graph shows combined results from three independent 
experiments, each performed in triplicate. One-way ANOVA with Dunnett’s (Figure 3.9Ci) and 
Tukey’s (Figure 3.9Cii) post-tests were used for statistical analysis and denoted as *, ** or *** to 




































Chapter 4: Discussion and Conclusions 
 
4.1 Evidence for the crosstalk mechanism between GR and GnRHR signaling 
pathways in LβT2 cells 
 
Some of the effects of stress on reproduction are mediated via glucocorticoids (GCs) from the 
adrenal gland as part of a cross talk mechanism between the hypothalamic-pituitary-adrenal axis 
(HPA) and hypothalamic-pituitary-gonadal (HPG) axis (Rivier and Rivest, 1991). A recent study 
from the Hapgood laboratory demonstrated a novel crosstalk mechanism between the GR and 
GnRHR (Kotitschke et al., 2009), indicating an additional direct mechanism for the effects of 
stress on reproduction. The study showed that GnRH activates the unliganded GR through site-
specific phosphorylation, resulting in nuclear translocation and transactivation of a transient 
GRE-reporter gene and the endogenous mouse GnRHR gene in LβT2 cells in a GR- and 
GnRHR-dependent manner (Kotitschke et al., 2009). In addition, Kotitschke et al. reported a 
synergistic transcriptional response on both the GRE-reporter gene and the endogenous GnRHR 
gene upon co-stimulation for 8 h with Dex and GnRH in LβT2 cells (Kotitschke et al., 2009). 
However, the exact mechanisms underlying the crosstalk between the GR and GnRHR are 
unknown. The findings are intriguing considering the difference in sub-cellular localization of the 
receptors involved. For instance, the GR is cytoplasmic in the absence and nuclear in the 
presence of GCs, while the GnRHR is a 7-transmembrane receptor found on the cell surface that 
has previously been shown to localize exclusively to lipid rafts in another gonadotrope cell line, 
αT3-1 (Navratil et al., 2003; Bliss et al., 2007). Interestingly, a recent study showed that the GR 
could also associate with caveolae, which is required for the rapid Dex-induced phosphorylation 
of the GR in A549 cells (Matthews et al., 2008). Thus, it is possible that the crosstalk mechanism 
between the GR and GnRHR could involve their co-localization to lipid rafts, whereby activation 
of the one receptor modulates the activity of the other. These findings lead to the formulation of 
the following hypothesis in the current thesis i.e. that the crosstalk mechanism between the GR 
and GnRHR involves the co-localization and interaction of these receptors in lipid rafts in LβT2 
cells. Several strategies were pursued in the present study to investigate this hypothesis. Co-
localization of both receptors with markers for lipid rafts was investigated by confocal 
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immunflorescence. Isolation of lipid rafts with density-gradients followed by Western blotting for 
both receptors and the lipid raft marker protein Flot-1 was performed. In addition, the interaction 
between the GR and Flot-1 was investigated by co-immunoprecipitation assays. In the last part of 
the study a functional role for the co-localization of both the GnRHR and the GR to lipid rafts 
were investigated by disruption with cholesterol depletion agents and by Flot-1 siRNA-mediated 
knockdown.  
 
First, it needed to be established in the hands of the present author that GnRH induces 
transactivation and that co-stimulation with Dex and GnRH induces a synergistic transcriptional 
response on a transfected GRE-reporter gene in LβT2 cells. In Figure 3.1A it is clear that 
stimulation of LβT2 cells for 8 h with GnRH increased the transcriptional activity of the GRE-
reporter gene by about 4-fold, while co-stimulation with Dex and GnRH synergistically increased 
the transcriptional activity by about 12-fold (Figure 3.1B). These results confirmed the study of 
Kotitschke et al. and enabled the present investigation into the mechanism of ligand-independent 
activation of the GR by GnRH in these cells. Interestingly, GnRH and Dex treatment exhibited a 
similar fold response in inducing transactivation of the GRE-reporter gene (Figure 3.1A), 
indicating that GnRH activates the GR to an equal extent as compared to Dex.  
 
GnRH has recently been shown to induce the phosphorylation and activation of other steroid 
receptors in mouse gonadotrope cells, including the PR and ER. A study by An et al. reported 
that GnRH treatment induced the nuclear translocation of the PR within 1 h in αT3-1 cells (An et 
al., 2006). A more recent study showed that GnRH induced the phosphorylation of the PR at 
S249, resulting in nuclear translocation and transactivation of a progesterone-response-element 
(PRE)-reporter gene and the endogenous FSHβ gene in LβT2 cells (An et al., 2009). Similarly, 
Chen et al. reported that treatment with GnRH induced phosphorylation of the ER in the 
cytoplasm and the nucleus, resulting in transactivation of an estrogen-response-element (ERE)-
reporter gene and the endogenous FosB gene in LβT2 cells (Chen et al., 2009). Therefore, the 
ligand-independent activation of steroid receptors by GnRH through phosphorylation appears to 
be a common mechanism for regulating target gene expression in murine gonadotrope cell lines. 
 
 93 
The study by Kotitschke et al. was the first to demonstrate the ligand-independent activation of 
the GR by GnRH as well as the synergistic transcriptional effect with Dex and GnRH on a GRE-
containing promoter in the pituitary (Kotitschke et al., 2009). The only other report of the 
synergistic behavior between Dex and GnRH was by Sasson et al. on a glycoprotein hormone α-
subunit-reporter gene in LβT2 cells (Sasson et al., 2008). However, there have been several 
reports of the synergistic transcriptional effect of GnRH with other sex hormones in gonadotrope 
cell lines. An et al. reported that the GnRH-induced PRE-reporter activity was synergistically 
enhanced with progesterone in αT3-1 cells (An et al., 2006). Furthermore, the LHβ and 
glycoprotein α-subunit gene expression is synergistically increased in the presence of estrogen 
and GnRH in LβT2 cells (Kowase et al., 2007), while estrogen has no effect on the GnRH-
induced ERE-reporter activity in LβT2 cells (Chen et al., 2009). Taken together, these findings 
indicate that GnRHR can act synergistically with several steroid receptors to increase expression 
of target genes in gonadotrope cell lines. However, there is no study in the literature investigating 
the synergistic behavior of GnRHR with GCs on AP-1 or NF-κB minimal promoters in 
gonadotrope cell lines. 
 
To investigate if the GR and GnRHR can crosstalk on other cis-elements, LβT2 cells were 
transfected with a minimal AP-1-reporter gene in the present study. The continuous treatment of 
cells with 10 nM or 100 nM GnRH for 24 h resulted in a dose-dependent increase in the 
transcriptional activity of the AP-1-reporter gene (Figure 3.2A). The finding that GnRH increased 
the transcriptional activity of the AP-1-reporter gene in a dose-dependent manner is consistent 
with a recent study showing the importance of the AP-1 site in mediating the GnRH-induction of 
the pituitary adenylate cyclase-activating polypeptide (PACAP) gene in LβT2 cells (Grafer et al., 
2009). In addition, a recent study by Tsutsumi et al. reported that both continuous and pulsatile 
stimulation with GnRH increased transcription via an AP-1-reporter gene in LβT2 cells 
(Tsutsumi et al., 2010). The further increase in the GnRH-induced transcriptional activity of the 
AP-1-reporter gene in the presence of Dex is interesting (Figure 3.2B), as other reports have 
shown a decrease via transrepression by the GR on AP-1 regulated genes (Heck et al., 1994; 
Kassel et al., 2004). However, the ligand-activated GR has also been shown to enhance 
transcription of AP-1 regulated genes, depending on the nature of the dimeric AP-1 complex 
(Teurich and Angel, 1995). GnRH stimulation most likely results in differential phosphorylation 
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of the GR that favors interactions with co-activators, rather than co-repressors. This is supported 
by a recent study by Avenant et al. demonstrating the requirement of GR phosphorylation for the 
recruitment of co-activators in COS-1 cells (Avenant et al., 2010a). The increase of the GnRH-
induced response of the AP-1-reporter gene in the presence of Dex suggests that the synergistic 
transcriptional response of the endogenous GnRHR with Dex and GnRH reported by Kotitschke 
et al. might be partly mediated via the AP-1 site in LβT2 cells (Kotitschke et al., 2009). 
However, Dex alone was unable to induce a transcriptional response of the minimal AP-1 
reporter gene, indicating that additional cis-elements are required for the Dex response of the 
GnRHR gene. The increase of the GnRH-induced AP-1 response with Dex also indicates that in 
addition to effects on a GRE containing promoter, the GR and GnRHR signaling pathways can 
positively crosstalk on an AP-1 cis-element in LβT2 cells.  
 
The above results provide strong support for the ligand-activated GR to modulate the GnRH-
induced transcriptional response on an AP-1-containing promoter in LβT2 cells. To investigate 
the effects of the crosstalk mechanism between these signaling pathways on a well-characterized 
transrepression model for the GR (De Bosscher and Haegeman, 2009), a minimal NF-κB-reporter 
gene was transfected into LβT2 cells. Interestingly, GnRH was found to activate pathways 
targeting both AP-1- and NF-κB-regulated genes (Figure 3.2A and Figure 3.3), while TNFα was 
only able to activate a pathway targeting NF-κB. This finding suggests that different signaling 
pathways regulate these cis-elements in LβT2 cells. In contrast, it has previously been shown that 
TNFα induces expression of both AP-1- and NF-κB-regulated genes in other cell types (Kassel et 
al., 2004; Park et al., 2004; De Bosscher and Haegeman, 2009; Van Bogaert et al., 2010). 
Although the AP-1 and NF-κB cis-elements appear to be regulated by different signaling 
pathways in LβT2 cells, the TNFα response was similar to the GnRH-induced response of the 
NF-κB-reporter gene. The TNFα-induction was repressed by addition of Dex, while the GnRH-
induction remained unaffected by the addition of Dex (Figure 3.3, bar 5 and vs 3 and 4). Co-
stimulation of LβT2 cells with GnRH and TNFα resulted in an additive transcriptional response 
of the NF-κB-reporter gene, which remained unaffected by addition of Dex (Figure 3.3, bar 7 vs 
8). Taken together, the above results show that the crosstalk mechanism between the GR and 
GnRHR signaling pathways has no effect on a minimal NF-κB regulated gene. 
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The GnRH-induced activation of the NF-κB-reporter gene is consistent with a recent study by 
Naidich et al. showing that this mechanism involves hyper-phosphorylation of p65 in LβT2 cells 
(Naidich et al., 2010). The finding that the additive effect of the NF-κB transcriptional activity 
with TNFα and GnRH co-stimulation was unaffected by Dex treatment is surprising as Dex 
stimulation repressed the TNFα-induced response (Figure 3.3, bar 5 vs 6). The inability of the 
ligand-activated GR to repress the GnRH-mediated increase of an NF-κB as well as the additive 
response of GnRH with TNFα on the NF-κB-reporter gene, suggests that the GnRH activation of 
the GR interferes with the Dex-induced transrepression ability of the GR. This finding is 
consistent with the result in the present study showing the partial increase of the GnRH-induced 
transcriptional activity with Dex of the AP-1-reporter gene. This abolishment of transrepression 
by Dex-activated GR on both AP-1- and NF-κB-reporter genes in the presence of GnRH is 
interesting, as this indicates a mechanism that selects for the transactivation and not the 
transrepression activity of the GR. Although the precise mechanisms regulating this finding are 
unknown, this could involve specific GnRH-induced post-translational modifications of the GR 
that could favor an interaction with co-activators rather than co-repressors. The study by 
Kotitschke et al. showed that co-stimulation with Dex and GnRH did not result in a different GR 
phosphorylation pattern at Ser220 and 234 as compared with Dex alone (Kotitschke et al., 2009). 
However, it is possible that co-stimulation with Dex and GnRH could induce different patterns of 
post-translational modifications of the GR as compared to Dex alone, at sites not yet investigated. 
 
It is well established that activation of steroid receptors by their respective steroid ligands induces 
receptor degradation (Berry et al., 2008; Lee and Chang, 2003). To investigate whether the 
observed increase with Dex of the GnRH-induced AP-1-reporter transcriptional activity was 
mediated by increased GR protein expression levels, cell lysates were analyzed by Western 
blotting. The results from Figure 3.4 show that 1 μM Dex appeared to decrease GR protein levels 
after 24 h by about 40% (Figure 3.4, bar 2). This finding is similar to a recent report showing the 
human GR having a half-life of about 12 h with 100 nM Dex stimulation (Wallace et al., 2010). 
Interestingly, stimulation of cells with 10 nM or 100 nM GnRH for 24 h appeared to increase GR 
protein degradation also resulting in about 40% degradation compared to vehicle control (Figure 
3.4, bars 3 and 4). The GnRH-induced degradation of the GR is a novel finding and the 
mechanism probably involves post-translational modifications of the GR that decreases its 
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stability.  Furthermore, the addition of 100 nM or 1 μM Dex appeared to partially enhance the 
GnRH-induced degradation of GR protein (Figure 3.4, bar 3 vs 5 and 6), with the addition of 1 
μM Dex showing approximately 50% receptor turnover (Figure 3.4, bar 6). Therefore, the 
increase in the GnRH-induced transcriptional activity of the AP-1 reporter gene by Dex appeared 
not to be mediated via increased GR protein expression levels. Taken together the above findings 
suggest that GnRH alone induces degradation of GR protein, which provides further evidence 
that GnRH can activate the GR in LβT2 cells. 
 
4.2 Co-localization of the GR and GnRHR to lipid rafts in LβT2 cells 
 
Having established functional evidence for the GnRHR to modulate the activity of the GR in the 
hands of the present author in LβT2 cells, the next aim of the present study was to demonstrate 
co-localization in lipid rafts, which would suggest a mechanism whereby the GR and GnRHR 
could interact. It first needed to be established which lipid raft marker proteins are expressed in 
LβT2 cells by Western blotting of whole-cell lysates. The results from Figure 3.5.1 show that 
LβT2 cells express the lipid raft protein Flot-1 but not Cav-1, which is consistent with reports 
from other studies in gonadotrope cells (Navratil et al., 2003, Bliss et al., 2007), but in contrast to 
a recent report in LβT2 cells (Dobkin-Bekman et al., 2009). In order to investigate the sub-
cellular localization and lipid raft association of the GnRHR, LβT2 cells were stained and 
visualized with a confocal microscope. The results from Figure 3.5.2 show the endogenous 
GnRHR (green) co-localizing with endogenous Flot-1 (red) in the absence of ligand at the plasma 
membrane (large arrow) and at intracellular vesicles (small arrow) in LβT2 cells (Figure 3.5.2). 
The finding that the GnRHR localizes to lipid rafts in LβT2 cells suggests that lipid rafts play a 
key role in regulating GnRHR function, most likely by the assembly of a pre-formed signaling 
complex that efficiently fine-tunes GnRHR signaling. In addition to the plasma membrane 
localization of the GnRHR, there seems to be a small percentage of GnRHR localized to the 
cytoplasm in LβT2 cells (Figure 3.5.2, small arrow).  
 
Previous studies in the literature have reported that the GnRHR localizes exclusively to lipid rafts 
containing Flot-1 in αT3-1 cells, as determined by density-gradient fractionation experiments 
(Navratil et al., 2003). Similarly, a more recent study by Bliss et al. showed that the transiently 
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transfected GnRHR-GFP fusion protein co-localized exclusively with GM1, a ganglioside that is 
highly enriched in lipid rafts, in αT3-1 cells (Bliss et al., 2007). However, the present study is the 
first to demonstrate the co-localization of the endogenous GnRHR with endogenous Flot-1 in any 
cell type of pituitary-origin by immunoflorescence analysis. In contrast to results in αT3-1 cells, a 
small amount of GnRHR localized to the cytoplasm in LβT2 cells. This could be due to the 
experimental design in the live-cell staining process, resulting in receptor internalization upon 
antibody-binding. However, some intra-cellular localization of the GnRHR is not unexpected 
since Finch et al. showed that exogenous human GnRHR displays intra-cellular and plasma 
membrane localization in HeLa cells (Finch et al., 2010).  In the present study, the small amount 
of intra-cellular GnRHR co-localized with intra-cellular Flot-1. Flot-1 has also previously been 
reported by others to reside within intra-cellular vesicles (Lang et al., 1998).  The intra-cellular 
co-localization of some of the GnRHR and Flot-1 suggests that Flot-1 could be involved in the 
internalization of the GnRHR to result in its degradation or recycling to the plasma membrane. 
The mechanisms that regulate the sub-cellular trafficking and localization of the GnRHR are not 
well understood and further investigations are necessary. 
 
Having established that the endogenous GnRHR co-localizes with the lipid raft marker protein 
Flot-1 at the plasma membrane, the sub-cellular localization of the endogenous GR upon 
stimulation with Dex, GnRH or both together for 30 min was investigated in LβT2 cells. The 
results show that the unliganded GR is almost evenly distributed throughout the cell (Figure 
3.5.3A), while Dex stimulated distinct nuclear translocation of the GR (Figure 3.5.3B). However, 
30 min GnRH treatment did not induce any observable difference in the localization of the GR 
(Figure 3.5.3C). Co-stimulation with GnRH and Dex increased the amount of Dex-induced 
nuclear import of the GR (Figure 3.5.3D). Furthermore, it is very interesting that a small amount 
of GR did not translocate to the nucleus with Dex or with Dex and GnRH co-stimulation, but 
remained in the cytoplasm with a small percentage appearing to localize at the plasma membrane 
in LβT2 cells (Figure 3.5.3, panel B and D). A possible explanation for the remaining GR that did 
not translocate to the nucleus could be that if associated with lipid rafts.  
 
Having established that a small amount of GR localizes to the plasma membrane under all 
stimulated conditions, whether this membrane-localized GR was associated with lipid rafts was 
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subsequently investigated. This involved staining for the general lipid raft marker GM1, a 
ganglioside that is highly enriched in lipid rafts (Janes et al., 1999; Harder, 1998). The results 
from Figure 3.5.3 show that GM1 is localized exclusively to the plasma membrane under all 
conditions investigated (Figure 3.5.3). In addition, a small percentage of GR co-localizes with 
GM1 for all stimulated conditions at the plasma membrane (Figure 3.5.3). The amount of GR that 
co-localizes with GM1 relative to the remaining GR proved insufficient to perform statistical 
analysis from three independent experiments. Taken together, the above results suggest that a 
small population of GR localizes at the plasma membrane, which appears to co-localize with 
GM1, under all stimulated conditions. The finding that both the GR and GnRHR localize to lipid 
rafts at the plasma membrane suggests that they could interact to modulate each other’s activity 
or signaling pathways. 
 
Whether the GR co-localizing with GM1-containing lipid rafts also localizes with a more specific 
class of lipid rafts containing Flot-1 was next investigated. Similar to that of GM1, the sub-
cellular localization of Flot-1 appeared to be largely localized to the plasma membrane under all 
stimulated conditions (Figure 3.5.3). A small amount of Flot-1 displayed a clustering pattern with 
a cytoplasmic localization under all stimulated conditions (Figure 3.5.3). Similar to GM1, there 
appears to be a small population of GR co-localizing with Flot-1 at the plasma membrane under 
all stimulated conditions (Figure 3.5.3). However, the amount of GR co-localizing with Flot-1 at 
the plasma membrane was little and was found not to be statistically significant with four 
independent experiments. Taken together, the above findings suggest that endogenous GR and 
Flot-1 appears to co-localize to lipid rafts at the plasma membrane of LβT2 cells. This finding 
provides a possible mechanism for GnRHR-mediated modulation of GR activity within lipid rafts 
in LβT2 cells and supports the hypothesis of this study. 
 
The nuclear translocation of the GR with Dex is consistent with other reports (Nishi, 2010; 
Sarabdjitsingh et al., 2010). However, the finding that 30 min treatment with GnRH did not 
induce nuclear translocation of the GR was surprising as Kotitschke et al. demonstrated that 1 h 
treatment with 100 nM GnRH resulted in approximately 50% nuclear translocation of the GR, as 
compared with Dex (Kotitschke et al., 2009). A possible explanation for not detecting any 
significant change in the localization of the GR with 30 min GnRH treatment could be that the 
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GR displays a lag-phase in its nuclear import within the first 30 min, after which the rate is 
increased making nuclear localization detectable after 1 h stimulation with GnRH.  
 
The present study investigated the effects of Dex, GnRH or both together on the localization of 
the GR to lipid rafts containing Flot-1. A small population of GR co-localizes with Flot-1 at the 
plasma membrane under all stimulated conditions. Similar to the co-localization with GM1, no 
statistical significance could be established, most like resulting from the small percentage of GR. 
Another interesting finding is that the localization of Flot-1 with co-stimulation of Dex and 
GnRH appears to be largely intra-cellular (Figure 3.5.3D), potentially indicating a role for the GR 
and GnRHR in regulating Flot-1 internalization. There appears to be more GR that co-localizes 
with Flot-1 after co-stimulation with Dex and GnRH compared to the other stimulated conditions 
(Figure 3.5.3, compare panels A, B and C with D).  It is surprising that there was no statistically 
significant differential recruitment to the plasma membrane with the ligands investigated. 
However, this is supported by a recent study of Grossmann et al. showing that the MR localizes 
to the plasma membrane independent of short exposures to ligand, while 24 h stimulation with 
aldosterone resulted in the disappearance of MR at the plasma membrane in HEK-293 cells 
(Grossmann et al., 2010). Therefore, the plasma membrane localization of steroid receptors 
independent of ligand could potentially be a mechanism to ensure the sensitivity for the rapid 
signaling of steroid hormones. This could be achieved by the constitutive localization of the 
receptor at the membrane leading to the modulation of non-genomic signaling pathways upon 
hormone exposure. This is the first study investigating the localization of GR to lipid rafts by 
immunoflorescence.  
 
Having shown GnRHR and GR co-localization with Flot-1, it was important to determine co-
localization of the GR with GnRHR in LβT2 cells. However, the experiment investigating direct 
co-localization of these receptors could not be performed due to the lack of suitable commercially 
available GnRHR antibodies. The present author obtained two different GnRHR antibodies (sc-
8681 and sc-13944, Santa Cruz, USA), which proved to be unsuccessful in this experiment after 
several attempts. Therefore, a non-commercial antibody obtained from D.C. Skinner that was 
raised in a rabbit against the ovine GnRHR, was used to perform the co-localization experiments 
of the GnRHR with Flot-1 (Figure 3.5.2). This antibody has been shown to recognize the murine 
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GnRHR in LβT2 cells (Albertson et al., 2008) and in whole mouse pituitaries (Bliss et al., 2007). 
In order to investigate the possible co-localization of the endogenous GR with the endogenous 
GnRHR, a GR antibody raised in a species other than rabbit was required. The mouse anti-GR 
antibody did not detect the GR on a Western blot and failed to show any specific staining, that 
was above the background level, in immunoflorescence analysis. Therefore, due to time 
constraints of the present study, the experiment could not be performed. However, it is likely that 
the GR and GnRHR co-localize in LβT2 cells, as the present study showed the co-localization of 
the GnRHR with Flot-1 and the co-localization of the GR with Flot-1. 
 
Having shown by immunoflorescence analysis that both the endogenous GR and GnRHR localize 
to lipid rafts at the plasma membrane of LβT2 cells, a different strategy was employed to provide 
further support. This strategy involved the isolation of lipid rafts by biochemical fractionation 
with a discontinuous density-gradient to obtain adequate separation of lipid rafts in LβT2 cells. 
First, a method for the isolation of lipid rafts from LβT2 cells needed to be established. A few 
previously described methods were investigated, including a non-detergent method (Gagescu et 
al., 2000) and a detergent-resistant method (Lafont and Simons, 2001), as shown in Addendum 
B. The criteria dictating selection of a particular method were based on the sufficient isolation of 
lipid rafts into one or two fractions, as analyzed by Western blotting for the lipid raft marker 
protein Flot-1. The gradient in the method chosen consisted of five different phases and 
employed the use of 0.05% Triton X-100, which is a more stringent test compared to non-
detergent methods for association of proteins with lipid rafts. The initial investigation into 
localization of the GR to lipid rafts was performed with overexpressed GR and used a crude 
membrane fraction as the starting material for isolation of lipid rafts from LβT2 cells. Although 
the advantage of using a crude membrane fraction as the starting material is ensuring the isolation 
of only plasma membrane-derived lipid rafts, this proved to be problematic owing to GR 
degradation problems, despite including protease inhibitors (Addendum B). The degradation 
appeared to be specific for the GR, as the stability of Flot-1 was unaffected (Addendum B). In 
order to minimize this degradation problem, the use of whole-cell lysates as starting material was 
investigated. The results from Addendum B show that starting with whole-cell lysates decreased 
the amount of GR degradation compared to the use of a crude membrane fraction for starting 
material in the isolation of lipid rafts from LβT2 cells (compare Addendum B with Figure 3.6). 
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This decrease in the amount of degradation of the GR is most likely a result of increased substrate 
availability for the proteases when starting with whole-cell lysates, because this degradation 
probably occurs during the 45 min incubation with Triton X-100 before layering of the gradients 
in the isolation process. 
 
The results from Figure 3.6B show the novel finding that the unliganded GR appears to localize 
with GnRHR to lipid rafts containing Flot-1 in LβT2 cells. The localization of the endogenous 
unliganded GnRHR with Flot-1 to lipid rafts supports the immunoflorescent result from Figure 
3.5.2 showing co-localization of GnRHR with Flot-1 at the plasma membrane of LβT2 cells. In 
order to determine if the GR was differentially recruited to lipid rafts with Dex, GnRH or a 
combination of both for 30 min, the GR protein levels in the lipid raft fraction were normalized to 
Flot-1 protein levels. The results from Figure 3.6Bv show that there is no difference in the levels 
of GR localized to lipid rafts with treatment of Dex, GnRH or a combination of both (Figure 
3.6B, panel v). The present study is the first to report the localization of GR to lipid rafts under 
different hormonal stimulation conditions in the pituitary and the first report localizing the GR 
with Flot-1 in any cell type. Furthermore, the ligand-independent localization of endogenous GR 
to lipid rafts further supports the immunoflorescence data of Figure 3.5.3 showing a small 
percentage of GR localizing with Flot-1 at the plasma membrane of LβT2 cells under all 
stimulated conditions. The above results and the small percentage of GR co-localizing with Flot-
1 at the plasma membrane in Figure 3.5.3 together with the significant co-localization of GnRHR 
with Flot-1 at the plasma membranes, suggests that it is likely that the GR and GnRHR are both 
present in lipid rafts at the plasma membrane of LβT2 cells. 
 
The density-gradient results from Figure 3.6A show that the nuclear marker histone H3 localized 
only to fractions 6 and 7, which is the high-density fractions where the starting material was 
applied (Figure 3.6A). Importantly, Flot-1 localizes to a single fraction under all tested 
conditions, indicating specific fractionation of lipid rafts. The GnRHR is still present in lipid rafts 
after 30 min of treatment with GnRH, consistent with the study by Navratil et al. showing that 
localization of the GnRHR to lipid rafts is independent of ligand in αT3-1 cells (Navratil et al., 
2003). The finding that there is no differential recruitment of the GR to lipid rafts with these 
hormones is similar to a recent study indicating that the MR localizes to lipid rafts in a ligand-
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independent manner in HEK-293 cells (Grossmann et al., 2010). It is possible that the GR is 
differentially recruited to lipid rafts in response to hormone, at times other than the 30 min time-
point investigated in this study. In support, a study by Jain et al. reported that Dex treatment 
(time not stated) increased the association of GR with caveolae in Hep3B cells (Jain et al., 2005). 
However, the levels of GR in lipid rafts were not normalized to Cav-1 levels and were judged by 
analyzing equal amounts of the lipid raft fraction with only one experiment shown (Jain et al., 
2005). 
 
The GR and GnRHR co-localize with Flot-1-containing lipid rafts at the plasma membrane of 
LβT2 cells in a ligand-independent manner as shown in Figure 3.5 and 3.6. This finding suggests 
that the GR and GnRHR exist in a pre-formed signaling complex at the plasma membrane. 
However, the co-localization of these receptors to lipid rafts provides no proof of a multi-protein 
complex. To investigate if the GR exists in a complex with Flot-1 in a ligand-dependent manner 
in LβT2 cells, co-immunoprecipitation with an anti-GR and non-specific IgG antibody were 
performed on whole LβT2 cell lysates with or without 30 min Dex treatment. The results from 
Figure 3.7A show that Flot-1 co-immunoprecipitated with the unliganded GR, while the addition 
of Dex had no effect on this interaction (Figure 3.7A). Furthermore, no detectable Flot-1 protein 
co-immunoprecipitated with the IgG antibody in the absence or presence of Dex (Figure 3.7A), 
suggesting that the GR interaction with Flot-1 is specific. In addition, the reciprocal co-
immunoprecipitation assay with a rabbit Flot-1 antibody confirms the interaction of Flot-1 with 
GR (Figure 3.7B). Therefore, the above results suggest that the GR is found in a complex with 
Flot-1 in LβT2 cells. Since multi-protein signaling complexes including the GR and Cav-1 have 
been shown to occur in caveolae in Hep3B and A549 cells (Jain et al., 2005; Matthews et al., 
2008), the association of GR with Flot-1 suggest that the GR may be part of such a complex. This 
suggests that the GR could be activated by lipid raft-associated proteins, such as other receptors 
and kinases, providing a mechanism for the reciprocal modulation of receptor activity. Thus, the 
reciprocal modulation of GR and GnRHR signaling pathways could involve a physical 
interaction between these receptors. 
 
To further investigate if the GR interacts with Flot-1 in a ligand-dependent manner, co- 
immunoprecipitation assays with an anti-GR antibody were performed on whole LβT2 cell 
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lysates stimulated for 30 min with Dex, GnRH or a combination of both. The results from Figure 
3.7C show that there was no difference in the amount of Flot-1 that co-immunoprecipitated with 
the GR in the presence of Dex, GnRH or both together (Figure 3.7C). This finding that the 
interaction of Flot-1 with the GR was ligand-independent, is consistent with the 
immunofluorescence results showing ligand-independent co-localization of the GR with Flot-1 in 
lipid rafts, as shown in Figure 3.5.3 and 3.6B.  
 
Several attempts were made to identify the GnRHR in the immunoprecipitated complex. 
However, the co-immunoprecipitation assay significantly enriched several non-specific proteins 
that resulted in the detection of several non-specific bands at a similar size to the GnRHR in 
Western blots. In addition, the limitation of commercially available GnRHR antibodies resulted 
in the author being unable to provide evidence for the presence of the GnRHR in the novel GR-
Flot-1 complex precipitated from LβT2 cell extracts. A potentially important finding that could 
give insight on the nature of the complex formed between the GR and Flot-1 is the finding that no 
GR could be detected in the co-immunoprecipitation assay using the mouse monoclonal anti-
Flot-1 antibody. As suggested before, a possible reason for this could be that the GR interacts 
with the epitope recognized by the antibody, i.e. the C-terminal domain of mouse Flot-1. 
Therefore, the C-terminal domain of Flot-1, which excludes the SPFH and hydrophobic domains, 
but includes the EA repeats, could be important for the interaction with GR. Further work is 
required to characterize this novel interaction of Flot-1 with the GR in LβT2 cells. 
 
4.3 Functional role of lipid rafts and Flot-1 in GR and GnRHR signaling 
 
The results of the present study showed that a crosstalk mechanism exists between the GR and 
GnRHR, supported with immunoflorescence data and density-gradient analysis showing that the 
GR and GnRHR co-localize with Flot-1 to lipid rafts at the plasma membrane of LβT2 cells. 
Furthermore, co-immunoprecipitation assays showed that the GR exists in a complex with Flot-1, 
which provides a mechanism for the GR to associate with lipid rafts through a ligand-
independent interaction with Flot-1. A possible explanation for the crosstalk mechanism observed 
between the GR and GnRHR signaling pathways could result from the following theory, i.e. 
GnRH activates the GnRHR and since the GR is in close proximity and most likely in a complex 
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with kinases, these kinases get activated and results in the direct or indirect modulation of GR in 
the complex. This is supported by the GnRH-induced ligand-independent phosphorylation of the 
GR, which could then result in activation and nuclear translocation of the GR to regulate 
transcription of target genes.  
 
The last part of the present study was to investigate if lipid rafts have a functional role in GR and 
GnRHR signaling in LβT2 cells. A well-established method for investigating the role of lipid 
rafts in mediating the signaling of various receptors involves disrupting the integrity of lipid rafts 
by incubating cells with cholesterol depletion agents (Literature review, Table 1.3.2). In order to 
investigate if lipid rafts have a functional role in the transcriptional activity of the GR on GRE 
transactivation, LβT2 cells were incubated continuously for 8 h with MβCD in the presence of 
Dex, GnRH or both together. The results from Addendum C indicate that the continuous 
treatment with 2% MβCD (approximately 15 mM) for 8 h dramatically decreased the basal, Dex- 
and GnRH-induced transcriptional activity of the GRE-reporter gene in LβT2 cells, while also 
dramatically repressing the expression of the constitutive β-galactosidase gene (Addendum C). In 
addition, the 8 h incubation with MβCD resulted in significant changes in the morphology of 
LβT2 cells (data not shown). Taken together, these findings suggests that continuous treatment 
with MβCD results in cell death of LβT2 cells, which prevents the use of this method for the 
investigation of a role for lipid rafts in GR transactivation in LβT2 cells.  
 
A similar strategy to disrupt lipid rafts previously described by Navratil et al. in αT3-1 cells was 
employed to investigate the role of lipid rafts in GR and GnRHR signaling. This method involves 
incubating cells for 45 min with MβCD, followed by washing of the cells with PBS before 
incubation with ligand (Navratil et al., 2003). The results from Figure 3.8A show incubation of 
cells with MβCD for 8 h had no effect on the GRE-reporter gene activity mediated by Dex, 
GnRH or both together in LβT2 cells. Similarly, the results from Figure 3.8B show that there was 
no effect on the GnRH-induced phosphorylation at S226 of the GR when cells were treated with 
MβCD (Figure 3.8B). Taken together, the above results suggest that the disruption of lipid rafts 
had no effect on GR or GnRHR signaling in LβT2 cells. 
The finding that the transactivation of a GRE-containing promoter was unaffected in the presence 
of MβCD in LβT2 cells is surprising (Figure 3.8A). It is possible that this could have resulted 
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from the reformation of lipid rafts during the 8 h stimulation period. The incubation time with 
ligand could not be reduced due to the nature of the assay, which requires the synthesis of the 
luciferase protein. The finding that disruption of lipid rafts with MβCD had no effect on the 
GnRH-induced phosphorylation at Ser234 of the GR in LβT2 cells is inconsistent with a recent 
report of Matthews et al. showing that the knockdown of Cav-1 protein expression, which 
decreases caveolae formation, increased the basal and prevented the Dex-induced 
phosphorylation of the human GR at S211 in A549 cells (Matthews et al., 2008). Thus, the above 
results suggest that either cholesterol depletion has no effect on GR and GnRHR signaling or 
cholesterol depletion has no effect on the integrity of lipid rafts in LβT2 cells. 
 
Previous studies reported that cholesterol depletion with MβCD disrupted lipid rafts in another 
gonadotrope cell line, αT3-1, which prevented the GnRH-induced activation of ERK-1/2 
(Navratil et al., 2003; Bliss et al., 2007). Therefore, to investigate if MβCD treatment of LβT2 
cells had a similar effect on the activation of ERK-1/2, cells were treated with MβCD and the 
GnRH-induced activation of ERK-1/2 was investigated by Western blotting and probing with a 
phospho-specific ERK-1/2 antibody. In contrast to the previous reports in αT3-1 cells, the results 
from Figure 3.8C show that MβCD had no effect on the GnRH-induced ERK-1/2 
phosphorylation in LβT2 cells (Figure 3.8C). This finding suggests that cholesterol depletion 
with MβCD had no effect on the integrity of lipid rafts in LβT2 cells. Thus, the results of Figure 
3.8A and B are inconclusive and the role of lipid rafts in GR and GnRHR signaling could not be 
established using this strategy in LβT2 cells. 
 
There is one report in the literature showing that the Dex-induced transactivation of a GRE-
reporter gene by the GR is inhibited with continuous treatment of Hep3B cells with the 
cholesterol depletion agent, Filipin-III (Jain et al., 2005). Therefore, to investigate a role for lipid 
rafts in transactivation of a GRE-reporter by the GR, the effect of cholesterol depletion with 
Filipin-III was investigated in LβT2 cells. The results from Figure 3.8D show that Filipin-III had 
no effect on the Dex-induced transcriptional activity of a GRE-reporter gene in LβT2 cells. 
Therefore, neither MβCD nor Filipin-III treatment yielded evidence for a role of lipid rafts in GR 
and GnRHR signaling in LβT2 cells.  
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Since the results using cholesterol depletion agents to disrupt lipid rafts in LβT2 cells were 
inconclusive, a more specific approach was employed to investigate a functional role of Flot-1 in 
GR and GnRHR signaling. This was investigated by knockdown of Flot-1 protein expression 
with specific siRNA in LβT2 cells. To achieve sufficient knockdown of Flot-1 protein, initial 
optimization experiments of the knockdown conditions were performed. This involved testing 
four different Flot-1 siRNA oligonucleotides, varying the incubation time and the final 
concentration of siRNA in LβT2 cells. The results from Addendum D show that there was no 
significant difference with respect to knockdown efficiency between the four different siRNA 
sequences investigated for Flot-1 knockdown. However, the incubation of the cells with siRNA 
for 72 h compared to 48 h appeared to result in more Flot-1 protein knockdown in LβT2 cells 
(Addendum D). Therefore, all four siRNA oligonucleotides were combined in the attempt to 
increase the amount of Flot-1 knockdown. The results from Addendum D show that there appears 
to be more Flot-1 knockdown with 40 nM siRNA compared to 20 nM siRNA after 72 h 
incubation in LβT2 cells. Therefore, all four oligonucleotides were used at a combined 
concentration of 40 nM for 72 h in all further Flot-1 knockdown experiments in LβT2 cells. 
 
To investigate a functional role for Flot-1 in GR and GnRHR signaling, Flot-1 protein levels 
were decreased by siRNA-mediated knockdown and the transcriptional activity of the GR on a 
GRE-promoter in response to Dex, GnRH or both in combination was investigated in LβT2 cells. 
The results from Figure 3.9A show that Flot-1 protein levels were significantly reduced when 
cells were incubated with specific mouse Flot-1 siRNA, as compared to non-silencing scrambled 
control siRNA (NSC) for all tested conditions. Furthermore, the levels of GR protein appears 
unchanged in the presence of Flot-1 siRNA compared to NSC-transfected cells under all 
treatment conditions (Figure 3.9B). Knockdown of Flot-1 significantly repressed the Dex-
mediated transcriptional response on a GRE-reporter gene in LβT2 cells (Figure 3.9C). In 
addition, the synergistic response with Dex and GnRH was significantly repressed in cells with 
decreased Flot-1 protein levels (Figure 3.9C). The present study is the first report showing Flot-1 
to have a role in the GR-mediated transactivation of a simple GRE-reporter gene. Taken together, 
the results from Figure 3.9 indicate that Flot-1 is required for the Dex and synergistic 
transcriptional responses on a GRE-reporter gene, which supports a role for lipid rafts in GR and 
GnRHR signaling in LβT2 cells. 
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The decrease of the Dex-induced transcriptional activity of the GRE-promoter in Flot-1 siRNA-
transfected cells appears to be responsible for the decrease in the synergistic transcriptional 
response observed in the presence of Flot-1 siRNA. However, a previous study by Sugawara et 
al. reported that Flot-1 and -2 interact with Gαq, which is important for the UTP-induced 
activation of p38 and not ERK-1/2, as shown by knockdown of Flot-1 and -2 in HeLa cells 
(Sugawara et al., 2007). Thus, this finding suggests that attenuation of GnRHR signaling through 
Flot-1 knockdown could potentially play a part in the repression of the synergistic transcriptional 
response in LβT2 cells. 
 
The effect of decreased Flot-1 protein levels on the GnRH-induced transactivation of a GRE-
reporter gene could not be investigated, because GnRH failed to induce a significant 
transcriptional response in NSC- or siRNA-transfected cells (Figure 3.9C). However, co-
stimulation with Dex and GnRH still resulted in a synergistic transcriptional response on a GRE-
reporter gene, even though there was no response with GnRH alone (Figure 3.9C). This finding 
did come as a surprise and resulted in numerous attempts to investigate the source behind it. The 
first experiment towards solving the problem was to confirm that the cells still responded to 
GnRH. Therefore, the ability of GnRH to induce a transcriptional response on an AP-1 reporter 
gene was investigated. The results showed a significant increase in the transcriptional activity of 
the AP-1 reporter gene in LβT2 cells in response to GnRH (data not shown), which was similar to 
results shown in Figure 3.2. In addition, the GnRH-induced transcriptional response on a GRE-
reporter gene was also confirmed (data not shown). However, all of these investigations were 
performed under normal growth conditions, whereas in the Flot-1 knockdown GRE-reporter 
experiments the cells grew for two extra days, as this was shown to be optimal for Flot-1 
knockdown. In addition, Dex and GnRH co-stimulation still induced a synergistic transcriptional 
response (Figure 3.9C), suggesting that the reagents and the oligonucleotides do not interfere 
with GnRH signaling. Therefore, the exact source of the problem is still unknown, but it appears 
that cell culture conditions are involved. This suggests that the GnRHR signaling pathway is 
sensitive to the cellular conditions. It is possible that expression of the GnRHR is decreased upon 
increased cell densities and cell-cell contacts, which would result in the slightly weaker GnRH 
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response. This would result in decreased activation of the GR by this weaker GnRH signaling as 
compared to normal cell culture conditions, which could result in the lack of a GnRH response. 
 
4.4 Physiological implications in the pituitary 
 
The localization of the GnRHR with Flot-1 at the plasma membrane of LβT2 cells could indicate 
that Flot-1 is involved in the intra-cellular trafficking and degradation of the GnRHR. This could 
suggest that Flot-1 is directly involved in maintaining gonadotropin-sensitivity for GnRH and 
regulation of reproduction through controlling gonadotropin-release indirectly. Furthermore, the 
finding that Flot-1 appeared to be mostly cytoplasmic upon co-stimulation with Dex and GnRH 
suggests the presence of a novel Flot-1 internalization pathway regulated by GR and GnRHR 
crosstalk. This finding is similar to a recent report showing the EGF-induced internalization of 
Flot-1 and -2 in HeLa cells (Riento et al., 2009), and supports a role for Flot-1 in trafficking of 
the GnRHR in LβT2 cells.  
 
The novel finding that the GR localizes to lipid rafts through a physical interaction with Flot-1, 
indicates that the GR could exist in a multi-protein complex at the plasma membrane of LβT2 
cells. This is similar to a previous study showing the unliganded GR associating with caveolae 
via a physical interaction with Cav-1 in A549 cells (Matthews et al., 2008). The important 
finding of GR and Flot-1 existing in the same complex suggests a mechanism for rapid effects of 
GCs, resulting in the activation of various intra-cellular signaling pathways. This finding also 
suggests a mechanism for the GnRHR to modulate GR activity and GR-responsive genes via a 
direct or indirect interaction with GR in a complex, possibly through the activation of specific 
signaling molecules like kinases, which could modulate GR activity. The finding that lipid raft 
association of the GR is independent of ligands could be mechanism that maintains cellular 
sensitivity to hormones, by ensuring the localization of the unliganded GR at the plasma 
membrane, which upon hormone stimulation could result in the reciprocal modulation of the GR 
and other signaling pathways. In addition, the localization of the GR with the GnRHR to lipid 
rafts could indicate a possible mechanism for fine-tuning the interplay between stress and 
reproductive processes by the reciprocal modulation of signaling pathways in the pituitary. 
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Another important aspect will be to investigate the function of the GR in reproduction with the 
aid of knockout mice. In the literature there are a few references that reported effects of 
dimerization of the GR in mice and show that the GR is still able to translocate to the nucleus and 
affect transcription (Reichardt et al., 1998). A more recent study used the same system to show 
that lactation, milk protein synthesis and fertility were unaffected in the GR knockout mice 
(Reichardt et al., 2001). The latter effect on fertility suggests that dimerisation of the GR is not a 
requirement for fertility. This could be relevant to cross talk between the GR and GnRHR, and 
may be consistent with a model whereby the modulation of GnRH signaling in pituitary 
gonadotropes by the GR does not require transactivation by the GR, but rather a tethering model.  
However, none of these studies looked at the direct effect of GR knockout on gonadotropin 




The present study demonstrated the GnRH-induced activation of the GR resulting in 
transactivation of a GRE-reporter gene and the synergistic transcriptional response when LβT2 
cells were co-stimulated with Dex and GnRH. It was established that GR and GnRHR signaling 
pathways crosstalk on a minimal AP-1- but not on an NF-κB- reporter gene in these cells, 
indicating that the crosstalk mechanisms between the GR and GnRHR is promoter-specific. In 
addition, the study reported the novel finding that GnRH induced degradation of the GR after 24 
h stimulation in LβT2 cells, further supporting the crosstalk mechanism of GnRH activating the 
unliganded GR. The present study is the first report demonstrating that the endogenous GnRHR 
co-localizes with Flot-1 at the plasma membrane of LβT2 cells by immunoflorescence, while a 
small population of the GR appeared to localize with Flot-1 at the plasma membrane, 
independent of hormone treatment. This is the first report demonstrating that both the GR and the 
GnRHR appear to co-localize to lipid rafts containing Flot-1, and that this co-localization is 
unaffected by 30 min treatment with Dex, GnRH or both together. These findings are important 
and could suggest a possible mechanism for the crosstalk between the GR and GnRHR in LβT2 
cells. In addition, the present study is the first report showing by co-immunoprecipitation assays 
that Flot-1 and GR interact in a complex independent of ligand, further supporting the lipid raft 
association of the GR. The results suggest that the GR exists in a pre-formed multi-protein 
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signaling complex in LβT2 cells, which includes the GnRHR. This novel finding suggests that 
the lipid raft-associated GR could mediate the rapid non-genomic actions of GCs reported in 
other cell types, i.e. the activation of Akt in A549 cells. A functional role for lipid rafts in GR and 
GnRHR signaling could not be established using the cholesterol depletion experiments, which 
proved to be inconclusive. However, siRNA-mediated knockdown of Flot-1 protein expression 
suggests Flot-1 is required for transactivation of a GRE-reporter gene via the GR in response to 
Dex and of Dex with GnRH in LβT2 cells. This finding suggests that the association of the GR 
and GnRHR with Flot-1 is important for signaling by these receptors to result in the 
transactivation of a GRE in LβT2 cells.  In conclusion, the mechanism of crosstalk between the 
GR and GnRHR involves the co-localization of both receptors with Flot-1 to lipid rafts at the 
plasma membrane of LβT2 cells and Flot-1 is required for transactivation of a GRE-reporter gene 
in response to Dex as well as Dex and GnRH in combination in LβT2 cells. 
 
4.6 Future perspectives 
 
Using a reporter gene to elucidate molecular mechanisms of transcription is a valuable approach, 
but the DNA is not integrated into the genome making it is possible for the results to be different 
from an endogenous GRE-containing gene, which is in the context of chromatin and histones. 
Thus, it is important to verify the result of GnRH-induced activation of the GR to transactivate 
via a GRE on an endogenous GRE-containing gene in LβT2 cells. Similarly, investigation of the 
synergistic transcriptional response with co-stimulation by Dex and GnRH on an endogenous 
GRE-containing gene in these cells would also be of importance. After confirmation of the results 
on an endogenous gene in LβT2 cells, verification of the above results in primary gonadotrope 
cells will provide physiologically relevant evidence. This is required because it is possible that  
immortalized gonadotrope cell lines could behave slightly different to primary gonadotrope cells. 
Confirmation of these results in primary cells could be performed by the isolation of the anterior 
pituitaries from mature mice, followed by enrichment for gonadotrope cells by fluorescent-
activated cell sorting (FACS). The isolated gonadotrope cells could then be incubated with 
ligands as described for the GRE-reporter assays in the present study, followed by RNA isolation 




An important question is how GnRH activates the GR to induce transactivation of a GRE-
reporter gene in LβT2 cells. One possible mechanism that could be investigated is that GnRH 
activation of the GnRHR results in activation of enzymes within the lipid raft complex that are in 
close proximity to the GR, resulting in post-translational modifications of the GR. This 
modification could then activate the GR in the absence of GCs, i.e. induce a conformational 
change in the GR, similar in some respects to that induced by the GC ligand. Such post-
translational modifications could include phosphorylation by kinases, acetylation by acetylases or 
even addition of lipid modifications such as palmitoylation, myristoylation or GPI-anchoring 
(Neumann-Giesen et al., 2004; Faus et al., 2006; Zhou and Cidlowski, 2005; Kumar and 
Thompson, 2005; Lee et al., 2005; Allen et al., 2007). The study by Kotitschke et al. 
demonstrated that GnRH treatment resulted in a differential phosphorylation pattern of the GR 
compared to Dex (Kotitschke et al., 2009). The effect of these phosphorylation sites on the 
transcriptional activity of the GR could be investigated with a GRE-reporter assay and over-
expression of phosphorylation deficient GR mutants in cells that have a low level of endogenous 
GR, such as COS-7 cells. It would be interesting to investigate other serine phosphorylation sites 
of the mouse GR in response to GnRH as several reports have indicated the importance of 
receptor phosphorylation in regulating transcription (Avenant et al., 2010a, b; Webster et al., 
1997; Chen et al., 2008; Kino et al., 2007; Galliher-Beckley and Cidlowski, 2009). In addition, 
other post-translational modifications of the GR could be investigated, including the acetylation 
status of the GR and several lipid modifications, by using the same strategy as for the 
phosphorylation GR mutants. Furthermore, to determine if GR dimerization is required for the 
GnRH response on a GRE-reporter gene, a dimerization-deficient GR mutant can be used as 
above in COS-7.  
 
The Dex-mediated increase of the GnRH-induced transcriptional activity of the AP-1-reporter 
gene was interesting as usually AP-1-containing genes are repressed by the GC-activated GR (De 
Bosscher and Haegeman, 2009). To explore if this increase is also mediated by a genomic 
mechanism, the co-factor recruitment of the GR in the presence of Dex and GnRH could be 
investigated by ChIP-assays in LβT2 cells. It is possible that the GR has a differential 
phosphorylation pattern in the presence of Dex and GnRH on residues not yet investigated, which 
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favors interaction of the receptor with co-activators over co-repressors. This could be investigated 
by using different GR phosphorylation mutants and ChIP-assays on AP-1 regulated genes in 
COS-7 cells. 
 
In addition to a genomic mechanism described above, it is also possible that the Dex-mediated 
increase of the GnRH-induced transcriptional activity of the AP-1-reporter gene involves a non-
genomic mechanism. This could be mediated via modulation of signaling proteins involved in the 
GnRH-induced activation of the GnRHR signaling pathway that specifically targets AP-1. 
Furthermore, it could be investigated whether specific proteins such as various G- proteins, ERK-
1/2 and protein kinase A and C are involved in the synergistic response with Dex and GnRH on 
an AP-1-reporter gene (Grundker and Emons, 2003; Fink et al., 2010). This could be achieved by 
siRNA-mediated knockdown experiments.  
 
It is well established that the GC-activated GR is down-regulated at the protein level (Wallace et 
al., 2010; Avenant et al., 2010b). The increased degradation of the GR that occurs to the same 
extent in response to GnRH as compared to Dex supports the finding that GnRH activates the 
GR. The GnRH-induced degradation of the GR could possibly be mediated via increased 
ubiquitination of the receptor. Ubiquitination of the human GR at S419A was previously shown 
to be involved in the GC-dependent degradation of the receptor (Wallace et al., 2010). To 
investigate if the mechanism underlying the GnRH-induced degradation of the GR is similar to 
that for Dex-mediated degradation, the ability of GnRH to induce degradation of wild type and 
S419A mutant GR proteins could be investigated in COS-7 cells. The proteases involved in the 
GnRH-induced degradation could be identified with specific inhibitors, such as MG132 for the 
ubiquitin-proteasome pathway. Alternatively, the expression of specific protease proteins, such as 
the calpain family, could be reduced by specific siRNA-mediated knockdown. 
 
The second part of the present study demonstrated the co-localization of the GR and GnRHR to 
lipid rafts containing Flot-1 under all hormonal conditions investigated. An additional control 
would be helpful to evaluate the purity of the lipid rafts isolated. The localization of the 
transferrin receptor (which localizes to plasma membrane, but is excluded from lipid rafts) by 
immunoflorescence would distinguish the bulk plasma membrane from the lipid rafts. 
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Furthermore, probing for the transferrin receptor on the Western blot of the lipid raft gradient 
fractions would indicate the degree of plasma membrane contaminants.  
 
A time-course experiment to identify the time of stimulation that results in maximum lipid raft 
association of the GR would be interesting, as this could indicate the optimal time-point for 
investigating the co-localization of the GR and GnRHR in LβT2 cells. It would be important to 
further characterize the lipid rafts for the presence of other signaling molecules such as G-
proteins, MAPKs, RTKs, src kinase family members and Akt, which have previously been shown 
to localize to lipid rafts (Ha et al., 2003; Slaughter et al., 2003; Moffett et al., 2000; Zajchowski 
and Robbins, 2002). Although there is no differential localization of the GR to lipid rafts after 30 
min treatment with Dex, GnRH, or both together, it is possible that other signaling molecules in 
lipid rafts are activated by hormone treatment. This could result in activation of specific signaling 
pathways initiated by either dissociation or formation of a specific signaling complex within the 
lipid rafts of the activated receptors.   
 
The present study established by immunoflorescence analysis and Western blotting of lipid rafts 
isolated with density-gradients in LβT2 cells that both the GnRHR and a small amount of GR co-
localize with Flot-1. These findings suggest that the GnRHR and GR also co-localize, but is not 
conclusive evidence. Thus, an important experiment would be to investigate if the GR co-localize 
with the GnRHR at the plasma membrane of LβT2 cells by immunoflorescence analysis. 
Furthermore, an important experiment would be to determine if the GnRHR is also present in the 
novel GR-Flot-1 complex in LβT2 cells by immunoprecipitation assays. 
 
It would be interesting to investigate the mechanism of lipid raft association for the GR, as this 
would give insight into the proteins responsible for targeting the GR to lipid rafts. A recent report 
suggested that a highly conserved nine amino acid motif in the LBD of ERα and β, PR-A and B, 
and the AR is involved in plasma membrane targeting of these receptors. This domain was shown 
to contain palmitoylation sites that are important for membrane localization of these receptors 
(Pedram et al., 2007). Since members of the steroid receptor family share a highly conserved 
structure, it is likely that the GR could also contain this highly conserved nine amino acid 
domain. Thus, it is possible that palmitoylation could play a role in targeting the GR to lipid rafts. 
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The importance of this nine amino acid domain and the palmitoylation sites in the lipid raft 
association of the GR could be investigated by mutational studies of this domain. In addition, 
specific inhibitors of palmitoylation or myristoylation could be used to investigate the importance 
of these post-translational modifications on GR membrane-association. 
 
The present study reported a mechanism for the lipid raft association of the GR through a 
physical interaction in a complex with Flot-1 under all conditions investigated. This suggests that 
the GR already exists in a signaling complex in the absence of ligand, which could fine-tune 
hormonal responses by modulating the resulting downstream signaling cascades. Thus, to 
understand the complex signaling pathways required to fine-tune the hormonal responses in LβT2 
cells, characterization of this signaling complex, in terms of kinases and other signaling 
molecules, is important. It would be interesting to investigate the domains of the GR that are 
important for the Flot-1 interaction, as this could potentially give insight into the functional role 
of Flot-1 in GR signaling. An important experiment will be to investigate if the endogenous 
GnRHR is also present in the complex and if this association might be dependent on ligand.  
 
The cholesterol depletion experiments were inconclusive since MβCD treatment had no effect on 
the GnRH-induced activation of ERK-1/2. These results suggested that the lipid rafts were not 
disrupted in LβT2 cells. Thus, it would be important to investigate more directly if the lipid rafts 
were disrupted by the MβCD and Filipin-III treatments. This could be performed by live-cell 
imaging where the cells are stained with GM1, followed by addition of cholesterol depletion 
agents to the live cells. If the agents disrupted lipid rafts, it would be evident by the dissociation 
of GM1 from the plasma membrane. An alternative strategy that could be used to prevent the 
formation of lipid rafts in cells, involves reducing the synthesis of cholesterol by inhibiting the 3-
hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase enzyme by siRNA-mediated 
knockdown or specific inhibitors.  
 
The Flot-1 knockdown experiment showed that Flot-1 is required for the Dex and the synergistic 
transcriptional responses on a GRE-reporter gene in LβT2 cells. It would be important to identify 
the mechanism involved for this repression of GR transactivation in the absence of Flot-1, as this 
could give insight into the mechanism of transcriptional regulation by the GR. It would be 
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interesting to examine if GR phosphorylation is altered by decreased Flot-1 protein levels, as 
phosphorylation has previously been shown to be important in the transcriptional activity of the 
GR (Avenant et al., 2010a, b). In addition, a very important experiment would be to determine 
what effect decreased Flot-1 protein levels will have on the GnRH response on a GRE-containing 
gene in LβT2 cells. This is a difficult experiment to perform and should perhaps rather be 
performed on an endogenous GRE-containing gene. Showing the effect on endogenous gene 
expression does not require the additional transfection of cells with a GRE-reporter plasmid, 









Figure A: No difference in proliferation or morphology of LβT2 cells between uncoated or 
laminin coated glass slides, while cells growing on poly-L-ornithine have significant changes 
in cell morphology with a decreased rate of proliferation 
Cover slips were coated with 5 μg laminin or 2.5 μg poly-L-ornithine and incubated for 1 h at 
room temperature. Both cover slips were washed with PBS and only the poly-L-ornithine-coated 
cover slip was allowed to dry. LβT2 cells were seeded at a density of 3 X 10
5
 cells per well in 
DMEM with 10% FCS and antibiotics as described elsewhere. Cells were cultured for two days 
before visualization with an inverted light microscope. 
 
Uncoated Laminin Poly-L-ornithine 
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Figure B: Isolation of lipid rafts from LβT2 cells with a non-detergent method resulted in 
ineffective fractionation of Flot-1, whereas a method employing 0.05% Triton X-100 
resulted in more effective fractionation of Flot-1 as compared to 1% Triton X-100, which 
increased the solubility of Flot-1 resulting in its fractionation into the higher density 
fractions 
i. LβT2 cells were washed with PBS and the cells collected and resuspended in homogenization 
buffer (HB, 250 mM sucrose, 3 mM imidazole (pH 7.4), 2 mM EDTA and 1 mM PMSF), 
followed by lysis in a Dounce homogenizer. Unbroken cells and nuclei were removed by low-
speed centrifugation, followed by equilibrium flotation through a discontinuous sucrose-density 
gradient. Twelve fractions were collected from the top of the gradient and equal amounts of 
fractions were loaded on an 8% SDS-PAGE gel, transferred onto nitrocellulose membrane and 
probed with a specific antibody against Flot-1. The arrow indicates the expected position of the 
lipid raft fraction. ii. LβT2 cells were washed with PBS and the cells collected and resuspended 
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DTT and 1 mM PMSF, 5 μg/mL leupeptin and 2 μg/mL aprotinin), followed by lysis in a Dounce 
homogenizer. Unbroken cells and nuclei were removed by low-speed centrifugation and a crude 
membrane fraction was obtained by centrifugation. The membrane pellet was washed with ELB 
and resuspended in solubilization buffer (SB) (25 mM Tris-Cl (pH 7.5), 150 mM NaCl, 5 mM 
EDTA, 1 mM DTT, 1 mM PMSF, 5 μg/mL leupeptin and 2 μg/mL aprotinin) containing 1% or 
0.05% Triton X-100. After incubation for 45 min on ice, the crude membrane fraction was 
subjected to equilibrium flotation through a discontinuous sucrose-density gradient. Ten fractions 
were collected from the top of the gradient and equal amounts of fractions were loaded on an 8% 
SDS-PAGE gel, transferred onto nitrocellulose membrane and probed with a specific antibody 










Biii: Lipid raft-associated GR appears to be degraded when using a crude membrane 
fraction as the starting material for the isolation of lipid rafts from LβT2 cells 
LβT2 cells were washed with PBS and the cells collected and resuspended in extraction lysis 
buffer (ELB) (10 mM Hepes (pH 7.9), 10 mM NaCl, 3 mM MgCl2, 1 mM DTT, 1 mM PMSF, 5 
μg/mL leupeptin and 2 μg/mL aprotinin), followed by lysis in a Dounce homogenizer. Unbroken 
cells and nuclei were removed by low-speed centrifugation and a crude membrane fraction was 
obtained by centrifugation. The membrane pellet was washed with ELB and resuspended in 
solubilization buffer (SB), 25 mM Tris-Cl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1 mM DTT, 1 
mM PMSF, 5 μg/mL leupeptin and 2 μg/mL aprotinin) containing 0.05% Triton X-100. After 
incubation for 45 min on ice, the crude membrane fraction was subjected to equilibrium flotation 
through a discontinuous sucrose-density gradient. Ten fractions were collected from the top of 





onto nitrocellulose membrane and probed with specific antibodies against Flot-1 and GR. The 



















Figure C: Cholesterol depletion of cells with the continuous treatment with MβCD 
abolishes luciferase and constitutive β-galactosidase expression and results in death of LβT2 
cells 
LβT2 were seeded in 24-well plates at a density of 1 X 10
5
 cells per well in DMEM with 10% 
FCS and antibiotics as described elsewhere. The cells were cultured for two days and transfected 
with 250 ng of TAT-GRE-luciferase construct and 25 ng pSV β-galactosidase plasmid. After 24 
h, the cells were incubated for 8 h with MβCD in serum-free medium in combination with 100 
nM Dex or 100 nM GnRH. The cells were harvested in 50 μL reporter lysis buffer per well and 
both the luciferase and β-galactosidase assays were performed with 10 μL of cell lysates. The 





































































Figure D1: No reproducible differences were detected in the amount of Flot-1 knockdown 
between four different siRNA oligonucleotides tested, while 72 h incubation with siRNA 
appears to result in a greater decrease in the expression of Flot-1 protein compared to 48 h 
in LβT2 cells 
LβT2 cells were transfected with non-silencing control or four different specific mouse Flot-1 
siRNA oligonucleotides at a final concentration of 20 nM and incubated for 48 h or 72 h. Equal 
amounts of samples were loaded on an 8% SDS-PAGE gel, transferred onto nitrocellulose 
membrane and probed with specific antibodies against Flot-1 and GM130 (loading control). The 


















Figure D2: A combination of all four Flot-1 siRNA oligonucleotides at a final concentration 
of 40 nM appears to induce a greater amount of Flot-1 knockdown in LβT2 cells as 
compared to 20 nM  
LβT2 cells were transfected with non-silencing control or a combination of four different specific 
mouse Flot-1 siRNA oligonucleotides at a final concentration of 20 nM or 40 nM and incubated 
for 72 h. Equal amounts of samples were loaded on an 8% SDS-PAGE gel, transferred onto 
nitrocellulose membrane and probed with specific antibodies against Flot-1 and GM130 (loading 





















Adams TE, Sakurai H, Adams BM (1999). Effect of stress-like concentrations of cortisol on 
estradiol-dependent expression of gonadotropin-releasing hormone receptor in orchidectomized 
sheep. Biol Reprod 60:(1) 164-168. 
 
Alarid ET, Bakopoulos N, Solodin N (1999). Proteasome-mediated proteolysis of estrogen 
receptor: a novel component in autologous down-regulation. Mol Endocrinol 13:(9) 1522-1534. 
 
Albertson AJ, Navratil A, Mignot M, Dufourny L, Cherrington B, Skinner DC (2008). 
Immunoreactive GnRH type I receptors in the mouse and sheep brain. J Chem Neuroanat 35:(4) 
326-333. 
 
Allen JA, Halverson-Tamboli RA, Rasenick MM (2007). Lipid raft microdomains and 
neurotransmitter signalling. Nat Rev Neurosci 8:(2) 128-140. 
 
An BS, Selva DM, Hammond GL, Rivero-Muller A, Rahman N, Leung PC (2006). Steroid 
receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in 
response to gonadotropin-releasing hormone treatment of pituitary cells. J Biol Chem 281:(30) 
20817-20824. 
 
An BS, Poon SL, So WK, Hammond GL, Leung PC (2009). Rapid effect of GNRH1 on follicle-
stimulating hormone beta gene expression in LbetaT2 mouse pituitary cells requires the 
progesterone receptor. Biol Reprod 81:(2) 243-249. 
 
Ando H, Hew CL, Urano A (2001). Signal transduction pathways and transcription factors 
involved in the gonadotropin-releasing hormone-stimulated gonadotropin subunit gene 
expression. Comp Biochem Physiol B Biochem Mol Biol 129:(2-3) 525-532. 
 
Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi 
OP, Trent JM, Meltzer PS (1997). AIB1, a steroid receptor coactivator amplified in breast and 
ovarian cancer. Science 277:(5328) 965-968. 
 
Avenant C (2009). Molecular mechanism of action of the glucocorticoid receptor: role of 
liganddependent receptor phosphorylation and half-life in determination of ligand-specific 
transcriptional activity. PhD thesis University of Cape Town, South Africa. 
 
Avenant C, Kotitschke A, Hapgood JP (2010a). Glucocorticoid receptor phosphorylation 
modulates transcription efficacy through GRIP-1 recruitment. Biochemistry 49:(5) 972-985. 
 
 122 
Avenant C, Ronacher K, Stubsrud E, Louw A, Hapgood JP (2010b). Role of ligand-dependent 
GR phosphorylation and half-life in determination of ligand-specific transcriptional activity. Mol 
Cell Endocrinol 327:(1-2) 72-88. 
 
Babuke T, Tikkanen R (2007). Dissecting the molecular function of reggie/flotillin proteins. Eur 
J Cell Biol 86:(9) 525-532. 
 
Babuke T, Ruonala M, Meister M, Amaddii M, Genzler C, Esposito A, Tikkanen R (2009). 
Hetero-oligomerization of reggie-1/flotillin-2 and reggie-2/flotillin-1 is required for their 
endocytosis. Cell Signal 21:(8) 1287-1297. 
 
Balbis A, Parmar A, Wang Y, Baquiran G, Posner BI (2007). Compartmentalization of signaling-
competent epidermal growth factor receptors in endosomes. Endocrinology 148:(6) 2944-2954. 
 
Balbis A, Posner BI (2010). Compartmentalization of EGFR in cellular membranes: role of 
membrane rafts. J Cell Biochem 109:(6) 1103-1108. 
 
Baldwin DM, Roser JF, Muyan M, Lasley B, Dybdal N (1991). Direct effects of free and 
conjugated steroids on GnRH stimulated LH release in cultured equine anterior pituitary cells. J 
Reprod Fertil Suppl 44 327-332. 
 
Bamberger CM, Bamberger AM, de Castro M, Chrousos GP (1995). Glucocorticoid receptor 
beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:(6) 
2435-2441. 
 
Banerjee A, Periyasamy S, Wolf IM, Hinds TD, Jr., Yong W, Shou W, Sanchez ER (2008). 
Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-
binding domain is mediated by distinct interactions with tetratricopeptide repeat proteins. 
Biochemistry 47:(39) 10471-10480. 
 
Barman S, Nayak DP (2000). Analysis of the transmembrane domain of influenza virus 
neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft association. J 
Virol 74:(14) 6538-6545. 
 
Bartholome B, Spies CM, Gaber T, Schuchmann S, Berki T, Kunkel D, Bienert M, Radbruch A, 
Burmester GR, Lauster R, Scheffold A, Buttgereit F (2004). Membrane glucocorticoid receptors 
(mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated 
after in vitro stimulation and in patients with rheumatoid arthritis. FASEB J 18:(1) 70-80. 
 
Bartis D, Boldizsar F, Szabo M, Palinkas L, Nemeth P, Berki T (2006). Dexamethasone induces 
rapid tyrosine-phosphorylation of ZAP-70 in Jurkat cells. J Steroid Biochem Mol Biol 98:(2-3) 
147-154. 
 
Bartis D, Boldizsar F, Kvell K, Szabo M, Palinkas L, Nemeth P, Monostori E, Berki T (2007). 
Intermolecular relations between the glucocorticoid receptor, ZAP-70 kinase, and Hsp-90. 
Biochem Biophys Res Commun 354:(1) 253-258. 
 
 123 
Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin 
JE, Saltiel AR (2000). CAP defines a second signalling pathway required for insulin-stimulated 
glucose transport. Nature 407:(6801) 202-207. 
 
Beck K, Hunter I, Engel J (1990). Structure and function of laminin: anatomy of a multidomain 
glycoprotein. FASEB J 4:(2) 148-160. 
 
Berry NB, Fan M, Nephew KP (2008). Estrogen receptor-alpha hinge-region lysines 302 and 303 
regulate receptor degradation by the proteasome. Mol Endocrinol 22:(7) 1535-1551. 
 
Bickel PE, Scherer PE, Schnitzer JE, Oh P, Lisanti MP, Lodish HF (1997). Flotillin and 
epidermal surface antigen define a new family of caveolae-associated integral membrane 
proteins. J Biol Chem 272:(21) 13793-13802. 
 
Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks 
DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE (2002). Crystal 
structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor 
dimerization and coactivator recognition. Cell 110:(1) 93-105. 
 
Bledsoe RK, Stewart EL, Pearce KH (2004). Structure and function of the glucocorticoid 
receptor ligand binding domain. Vitam Horm 68 49-91. 
 
Blind RD, Garabedian MJ (2008). Differential recruitment of glucocorticoid receptor phospho-
isoforms to glucocorticoid-induced genes. J Steroid Biochem Mol Biol 109:(1-2) 150-157. 
 
Bliss SP, Navratil AM, Breed M, Skinner DC, Clay CM, Roberson MS (2007). Signaling 
complexes associated with the type I gonadotropin-releasing hormone (GnRH) receptor: 
colocalization of extracellularly regulated kinase 2 and GnRH receptor within membrane rafts. 
Mol Endocrinol 21:(2) 538-549. 
 
Bloom FE, Battenberg EL, Rivier J, Vale W (1982). Corticotropin releasing factor (CRF): 
immunoreactive neurones and fibers in rat hypothalamus. Regul Pept 4:(1) 43-48. 
 
Bodin S, Giuriato S, Ragab J, Humbel BM, Viala C, Vieu C, Chap H, Payrastre B (2001). 
Production of phosphatidylinositol 3,4,5-trisphosphate and phosphatidic acid in platelet rafts: 
evidence for a critical role of cholesterol-enriched domains in human platelet activation. 
Biochemistry 40:(50) 15290-15299. 
 
Bonfil D, Chuderland D, Kraus S, Shahbazian D, Friedberg I, Seger R, Naor Z (2004). 
Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in 
gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-
stimulating hormone beta-subunit promoter. Endocrinology 145:(5) 2228-2244. 
 
Borner GH, Sherrier DJ, Weimar T, Michaelson LV, Hawkins ND, Macaskill A, Napier JA, 
Beale MH, Lilley KS, Dupree P (2005). Analysis of detergent-resistant membranes in 
Arabidopsis. Evidence for plasma membrane lipid rafts. Plant Physiol 137:(1) 104-116. 
 
 124 
Bouvier C, Lagace G, Collu R (1991). G protein modulation by estrogens. Mol Cell Endocrinol 
79:(1-3) 65-73. 
 
Brann DW, Mahesh VB (1991). Role of corticosteroids in female reproduction. FASEB J 5:(12) 
2691-2698. 
 
Breen KM, Karsch FJ (2004). Does cortisol inhibit pulsatile luteinizing hormone secretion at the 
hypothalamic or pituitary level? Endocrinology 145:(2) 692-698. 
 
Brooks J, Taylor PL, Saunders PT, Eidne KA, Struthers WJ, McNeilly AS (1993). Cloning and 
sequencing of the sheep pituitary gonadotropin-releasing hormone receptor and changes in 
expression of its mRNA during the estrous cycle. Mol Cell Endocrinol 94:(2) R23-27. 
 
Brothers SP, Cornea A, Janovick JA, Conn PM (2004). Human loss-of-function gonadotropin-
releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: 
molecular basis of the dominant-negative effect. Mol Endocrinol 18:(7) 1787-1797. 
 
Brown DA, Rose JK (1992). Sorting of GPI-anchored proteins to glycolipid-enriched membrane 
subdomains during transport to the apical cell surface. Cell 68:(3) 533-544. 
 
Brown DA, London E (1997). Structure of detergent-resistant membrane domains: does phase 
separation occur in biological membranes? Biochem Biophys Res Commun 240:(1) 1-7. 
 
Brown DA, London E (1998). Functions of lipid rafts in biological membranes. Annu Rev Cell 
Dev Biol 14 111-136. 
 
Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Krausslich HG (2006). The HIV 
lipidome: a raft with an unusual composition. Proc Natl Acad Sci U S A 103:(8) 2641-2646. 
 
Burnstein KL, Jewell CM, Sar M, Cidlowski JA (1994). Intragenic sequences of the human 
glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger 
RNA down-regulation through multiple mechanisms. Mol Endocrinol 8:(12) 1764-1773. 
 
Buttgereit F, Scheffold A (2002). Rapid glucocorticoid effects on immune cells. Steroids 67:(6) 
529-534. 
 
Buttgereit F, Straub RH, Wehling M, Burmester GR (2004). Glucocorticoids in the treatment of 
rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum 50:(11) 3408-3417. 
 
Caelles C, Gonzalez-Sancho JM, Munoz A (1997). Nuclear hormone receptor antagonism with 
AP-1 by inhibition of the JNK pathway. Genes Dev 11:(24) 3351-3364. 
 
Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, 
Gustafsson JA, Van der Saag PT (1995). Negative cross-talk between RelA and the 
glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. 
Mol Endocrinol 9:(4) 401-412. 
 
 125 
Calof AL, Lander AD (1991). Relationship between neuronal migration and cell-substratum 
adhesion: laminin and merosin promote olfactory neuronal migration but are anti-adhesive. J Cell 
Biol 115:(3) 779-794. 
 
Carapeti M, Aguiar RC, Chase A, Goldman JM, Cross NC (1998). Assignment of the steroid 
receptor coactivator-1 (SRC-1) gene to human chromosome band 2p23. Genomics 52:(2) 242-
244. 
 
Carter GC, Bernstone L, Sangani D, Bee JW, Harder T, James W (2009). HIV entry in 
macrophages is dependent on intact lipid rafts. Virology 386:(1) 192-202. 
 
Cecchi C, Nichino D, Zampagni M, Bernacchioni C, Evangelisti E, Pensalfini A, Liguri G, 
Gliozzi A, Stefani M, Relini A (2009). A protective role for lipid raft cholesterol against 
amyloid-induced membrane damage in human neuroblastoma cells. Biochim Biophys Acta 
1788:(10) 2204-2216. 
 
Chang WJ, Ying YS, Rothberg KG, Hooper NM, Turner AJ, Gambliel HA, De Gunzburg J, 
Mumby SM, Gilman AG, Anderson RG (1994). Purification and characterization of smooth 
muscle cell caveolae. J Cell Biol 126:(1) 127-138. 
 
Chazal N, Gerlier D (2003). Virus entry, assembly, budding, and membrane rafts. Microbiol Mol 
Biol Rev 67:(2) 226-237, table of contents. 
 
Chen A, Ganor Y, Rahimipour S, Ben-Aroya N, Koch Y, Levite M (2002). The neuropeptides 
GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene 
expression, adhesion, chemotaxis and homing to specific organs. Nat Med 8:(12) 1421-1426. 
 
Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans 
RM (1997). Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a 
multimeric activation complex with P/CAF and CBP/p300. Cell 90:(3) 569-580. 
 
Chen J, An BS, Cheng L, Hammond GL, Leung PC (2009). Gonadotropin-releasing hormone-
mediated phosphorylation of estrogen receptor-alpha contributes to fosB expression in mouse 
gonadotrophs. Endocrinology 150:(10) 4583-4593. 
 
Chen W, Dang T, Blind RD, Wang Z, Cavasotto CN, Hittelman AB, Rogatsky I, Logan SK, 
Garabedian MJ (2008). Glucocorticoid receptor phosphorylation differentially affects target gene 
expression. Mol Endocrinol 22:(8) 1754-1766. 
 
Chen X, Resh MD (2002). Cholesterol depletion from the plasma membrane triggers ligand-
independent activation of the epidermal growth factor receptor. J Biol Chem 277:(51) 49631-
49637. 
 
Cheng CK, Leung PC (2005). Molecular biology of gonadotropin-releasing hormone (GnRH)-I, 
GnRH-II, and their receptors in humans. Endocr Rev 26:(2) 283-306. 
 
 126 
Cheung LW, Wong AS (2008). Gonadotropin-releasing hormone: GnRH receptor signaling in 
extrapituitary tissues. FEBS J 275:(22) 5479-5495. 
 
Cheung TC, Hearn JP (2003). Developmental expression and subcellular localization of wallaby 
gonadotropin-releasing hormone receptor and its splice variants. Gen Comp Endocrinol 133:(1) 
88-99. 
 
Chi L, Zhou W, Prikhozhan A, Flanagan C, Davidson JS, Golembo M, Illing N, Millar RP, 
Sealfon SC (1993). Cloning and characterization of the human GnRH receptor. Mol Cell 
Endocrinol 91:(1-2) R1-6. 
 
Chintagari NR, Gou D, Liu L (2008). Knockdown of flotillin-2 inhibits lung surfactant secretion 
by alveolar type II cells. Cell Res 18:(6) 701-703. 
 
Cho YJ, Chema D, Moskow JJ, Cho M, Schroeder WT, Overbeek P, Buchberg AM, Duvic M 
(1995). Epidermal surface antigen (MS17S1) is highly conserved between mouse and human. 
Genomics 27:(2) 251-258. 
 
Choi JR, Park DW, Choi DS, Min CK (2006). Role of integrin, FAK (focal adhesion kinase) and 
ERK (extracellular signal regulated kinase) on the suppressed cell proliferation of endometrial 
cancer cells by GnRH (gonadotropin-releasing hormone). Korean J Fertil Steril 33:(115-123). 
 
Chrousos GP (1995). The hypothalamic-pituitary-adrenal axis and immune-mediated 
inflammation. N Engl J Med 332:(20) 1351-1362. 
 
Chun M, Liyanage UK, Lisanti MP, Lodish HF (1994). Signal transduction of a G protein-
coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc 
Natl Acad Sci U S A 91:(24) 11728-11732. 
 
Ciechanowska M, Lapot M, Mateusiak K, Przekop F (2010). Neuroendocrine regulation of 
GnRH release and expression of GnRH and GnRH receptor genes in the hypothalamus-pituitary 
unit in different physiological states. Reprod Biol 10:(2) 85-124. 
 
Clark E, Hoare C, Tanianis-Hughes J, Carlson GL, Warhurst G (2005). Interferon gamma 
induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-
mediated process. Gastroenterology 128:(5) 1258-1267. 
 
Cohen AW, Hnasko R, Schubert W, Lisanti MP (2004). Role of caveolae and caveolins in health 
and disease. Physiol Rev 84:(4) 1341-1379. 
 
Comings DE, Muhleman D, Dietz G, Sherman M, Forest GL (1995). Sequence of human 
tryptophan 2,3-dioxygenase (TDO2): presence of a glucocorticoid response-like element 
composed of a GTT repeat and an intronic CCCCT repeat. Genomics 29:(2) 390-396. 
 
Committee NRN (1999). A unified nomenclature system for the nuclear receptor superfamily. 
Cell 97:(2) 161-163. 
 
 127 
Conn PM, Crowley WF, Jr. (1994). Gonadotropin-releasing hormone and its analogs. Annu Rev 
Med 45 391-405. 
 
Croxtall JD, Choudhury Q, Flower RJ (2000). Glucocorticoids act within minutes to inhibit 
recruitment of signalling factors to activated EGF receptors through a receptor-dependent, 
transcription-independent mechanism. Br J Pharmacol 130:(2) 289-298. 
 
Cuadras MA, Greenberg HB (2003). Rotavirus infectious particles use lipid rafts during 
replication for transport to the cell surface in vitro and in vivo. Virology 313:(1) 308-321. 
 
D'Agostino J, Valadka RJ, Schwartz NB (1990). Differential effects of in vitro glucocorticoids on 
luteinizing hormone and follicle-stimulating hormone secretion: dependence on sex of pituitary 
donor. Endocrinology 127:(2) 891-899. 
 
Dahlman-Wright K, Wright A, Gustafsson JA, Carlstedt-Duke J (1991). Interaction of the 
glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short 
segment of five amino acids. J Biol Chem 266:(5) 3107-3112. 
 
Davies TH, Ning YM, Sanchez ER (2002). A new first step in activation of steroid receptors: 
hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 277:(7) 4597-
4600. 
 
De Bosscher K, Haegeman G (2009). Minireview: latest perspectives on antiinflammatory 
actions of glucocorticoids. Mol Endocrinol 23:(3) 281-291. 
 
Deininger SO, Rajendran L, Lottspeich F, Przybylski M, Illges H, Stuermer CA, Reuter A 
(2003). Identification of teleost Thy-1 and association with the microdomain/lipid raft reggie 
proteins in regenerating CNS axons. Mol Cell Neurosci 22:(4) 544-554. 
 
Deng GM, Tsokos GC (2008). Cholera toxin B accelerates disease progression in lupus-prone 
mice by promoting lipid raft aggregation. J Immunol 181:(6) 4019-4026. 
 
Dermine JF, Duclos S, Garin J, St-Louis F, Rea S, Parton RG, Desjardins M (2001). Flotillin-1-
enriched lipid raft domains accumulate on maturing phagosomes. J Biol Chem 276:(21) 18507-
18512. 
 
Deroo BJ, Rentsch C, Sampath S, Young J, DeFranco DB, Archer TK (2002). Proteasomal 
inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. 
Mol Cell Biol 22:(12) 4113-4123. 
 
Dessy C, Kelly RA, Balligand JL, Feron O (2000). Dynamin mediates caveolar sequestration of 
muscarinic cholinergic receptors and alteration in NO signaling. EMBO J 19:(16) 4272-4280. 
 
Dhungana S, Merrick BA, Tomer KB, Fessler MB (2009). Quantitative proteomics analysis of 
macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-
mediated ERK activation in response to lipopolysaccharide. Mol Cell Proteomics 8:(1) 201-213. 
 
 128 
Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR (1990). Transcription factor interactions: 
selectors of positive or negative regulation from a single DNA element. Science 249:(4974) 
1266-1272. 
 
Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM (1999). Activation of 
nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:(6736) 
601-605. 
 
Dobkin-Bekman M, Naidich M, Rahamim L, Przedecki F, Almog T, Lim S, Melamed P, Liu P, 
Wohland T, Yao Z, Seger R, Naor Z (2009). A preformed signaling complex mediates GnRH-
activated ERK phosphorylation of paxillin and FAK at focal adhesions in L beta T2 gonadotrope 
cells. Mol Endocrinol 23:(11) 1850-1864. 
 
Dong L, Hu S, Chen F, Lei X, Tu W, Yu Y, Yang L, Sun W, Yamaguchi T, Masaki Y, Umehara 
H (2010). Increased expression of ganglioside GM1 in peripheral CD4+ T cells correlates soluble 
form of CD30 in Systemic Lupus Erythematosus patients. J Biomed Biotechnol 2010 569053. 
 
Dong Y, Poellinger L, Gustafsson JA, Okret S (1988). Regulation of glucocorticoid receptor 
expression: evidence for transcriptional and posttranslational mechanisms. Mol Endocrinol 2:(12) 
1256-1264. 
 
Doppler W, Windegger M, Soratroi C, Tomasi J, Lechner J, Rusconi S, Cato AC, Almlof T, 
Liden J, Okret S, Gustafsson JA, Richard-Foy H, Starr DB, Klocker H, Edwards D, Geymayer S 
(2001). Expression level-dependent contribution of glucocorticoid receptor domains for 
functional interaction with STAT5. Mol Cell Biol 21:(9) 3266-3279. 
 
Drouin J, Maira M, Philips A (1998). Novel mechanism of action for Nur77 and antagonism by 
glucocorticoids: a convergent mechanism for CRH activation and glucocorticoid repression of 
POMC gene transcription. J Steroid Biochem Mol Biol 65:(1-6) 59-63. 
 
Dschietzig T, Bartsch C, Wessler S, Baumann G, Stangl K (2009). Autoregulation of human 
relaxin-2 gene expression critically involves relaxin and glucocorticoid receptor binding to 
glucocorticoid response half-sites in the relaxin-2 promoter. Regul Pept 155:(1-3) 163-173. 
 
Dvorak Z, Modriansky M, Ulrichova J, Maurel P, Vilarem MJ, Pascussi JM (2005). Disruption of 
microtubules leads to glucocorticoid receptor degradation in HeLa cell line. Cell Signal 17:(2) 
187-196. 
 
Eberharter A, Becker PB (2002). Histone acetylation: a switch between repressive and permissive 
chromatin. Second in review series on chromatin dynamics. EMBO Rep 3:(3) 224-229. 
 
Edgar AJ, Polak JM (2001). Flotillin-1: gene structure: cDNA cloning from human lung and the 
identification of alternative polyadenylation signals. Int J Biochem Cell Biol 33:(1) 53-64. 
 
Eicke N, Gunthert AR, Emons G, Grundker C (2006). GnRH-II agonist [D-Lys6]GnRH-II 
inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer 
cells. Int J Oncol 29:(5) 1223-1229. 
 129 
 
Eidne KA, Sellar RE, Couper G, Anderson L, Taylor PL (1992). Molecular cloning and 
characterisation of the rat pituitary gonadotropin-releasing hormone (GnRH) receptor. Mol Cell 
Endocrinol 90:(1) R5-9. 
 
Elbi C, Walker DA, Romero G, Sullivan WP, Toft DO, Hager GL, DeFranco DB (2004). 
Molecular chaperones function as steroid receptor nuclear mobility factors. Proc Natl Acad Sci U 
S A 101:(9) 2876-2881. 
 
Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M (2000). Multiple actions of 
steroid hormones--a focus on rapid, nongenomic effects. Pharmacol Rev 52:(4) 513-556. 
 
Fan NC, Jeung EB, Peng C, Olofsson JI, Krisinger J, Leung PC (1994). The human 
gonadotropin-releasing hormone (GnRH) receptor gene: cloning, genomic organization and 
chromosomal assignment. Mol Cell Endocrinol 103:(1-2) R1-6. 
 
Faurholm B, Millar RP, Katz AA (2001). The genes encoding the type II gonadotropin-releasing 
hormone receptor and the ribonucleoprotein RBM8A in humans overlap in two genomic loci. 
Genomics 78:(1-2) 15-18. 
 
Faus H, Haendler B (2006). Post-translational modifications of steroid receptors. Biomed 
Pharmacother 60:(9) 520-528. 
 
Fernandez-Vazquez G, Kaiser UB, Albarracin CT, Chin WW (1996). Transcriptional activation 
of the gonadotropin-releasing hormone receptor gene by activin A. Mol Endocrinol 10:(4) 356-
366. 
 
Feron O, Smith TW, Michel T, Kelly RA (1997). Dynamic targeting of the agonist-stimulated m2 
muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem 272:(28) 17744-
17748. 
 
Finch AR, Sedgley KR, Armstrong SP, Caunt CJ, McArdle CA (2010). Trafficking and 
signalling of gonadotrophin-releasing hormone receptors: an automated imaging approach. Br J 
Pharmacol 159:(4) 751-760. 
 
Fink G (1988). The G. W. Harris lecture. Steroid control of brain and pituitary function. Q J Exp 
Physiol 73:(3) 257-293. 
 
Fink MY, Pincas H, Choi SG, Nudelman G, Sealfon SC (2010). Research resource: 
gonadotropin-releasing hormone receptor-mediated signaling network in LbetaT2 cells: a 
pathway-based web-accessible knowledgebase. Mol Endocrinol 24:(9) 1863-1871. 
 
Fonte C, Trousson A, Grenier J, Schumacher M, Massaad C (2007). Opposite effects of CBP and 
p300 in glucocorticoid signaling in astrocytes. J Steroid Biochem Mol Biol 104:(3-5) 220-227. 
 
 130 
Ford J, McEwan IJ, Wright AP, Gustafsson JA (1997). Involvement of the transcription factor 
IID protein complex in gene activation by the N-terminal transactivation domain of the 
glucocorticoid receptor in vitro. Mol Endocrinol 11:(10) 1467-1475. 
 
Fra AM, Williamson E, Simons K, Parton RG (1994). Detergent-insoluble glycolipid 
microdomains in lymphocytes in the absence of caveolae. J Biol Chem 269:(49) 30745-30748. 
 
Fra AM, Williamson E, Simons K, Parton RG (1995). De novo formation of caveolae in 
lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci U S A 92:(19) 8655-8659. 
 
Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP (2004). Genetic ablation of 
caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 24:(1) 98-
105. 
 
Freedman LP, Luisi BF, Korszun ZR, Basavappa R, Sigler PB, Yamamoto KR (1988). The 
function and structure of the metal coordination sites within the glucocorticoid receptor DNA 
binding domain. Nature 334:(6182) 543-546. 
 
Freedman ND, Yamamoto KR (2004). Importin 7 and importin alpha/importin beta are nuclear 
import receptors for the glucocorticoid receptor. Mol Biol Cell 15:(5) 2276-2286. 
 
Freitas MS, Gaspar LP, Lorenzoni M, Almeida FC, Tinoco LW, Almeida MS, Maia LF, Degreve 
L, Valente AP, Silva JL (2007). Structure of the Ebola fusion peptide in a membrane-mimetic 
environment and the interaction with lipid rafts. J Biol Chem 282:(37) 27306-27314. 
 
Fryer CJ, Archer TK (1998). Chromatin remodelling by the glucocorticoid receptor requires the 
BRG1 complex. Nature 393:(6680) 88-91. 
 
Fu M, Wang C, Zhang X, Pestell R (2003). Nuclear receptor modifications and endocrine cell 
proliferation. J Steroid Biochem Mol Biol 85:(2-5) 133-138. 
 
Furuchi T, Anderson RG (1998). Cholesterol depletion of caveolae causes hyperactivation of 
extracellular signal-related kinase (ERK). J Biol Chem 273:(33) 21099-21104. 
 
Gagescu R, Demaurex N, Parton RG, Hunziker W, Huber LA, Gruenberg J (2000). The recycling 
endosome of Madin-Darby canine kidney cells is a mildly acidic compartment rich in raft 
components. Mol Biol Cell 11:(8) 2775-2791. 
 
Galbiati F, Volonte D, Gil O, Zanazzi G, Salzer JL, Sargiacomo M, Scherer PE, Engelman JA, 
Schlegel A, Parenti M, Okamoto T, Lisanti MP (1998a). Expression of caveolin-1 and -2 in 
differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in 
response to cell injury. Proc Natl Acad Sci U S A 95:(17) 10257-10262. 
 
Galbiati F, Volonte D, Goltz JS, Steele Z, Sen J, Jurcsak J, Stein D, Stevens L, Lisanti MP 
(1998b). Identification, sequence and developmental expression of invertebrate flotillins from 
Drosophila melanogaster. Gene 210:(2) 229-237. 
 
 131 
Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H, Jr., Kneitz B, 
Edelmann W, Lisanti MP (2001). Caveolin-3 null mice show a loss of caveolae, changes in the 
microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J 
Biol Chem 276:(24) 21425-21433. 
 
Galliher-Beckley AJ, Williams JG, Collins JB, Cidlowski JA (2008). Glycogen synthase kinase 
3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene 
expression profiles. Mol Cell Biol 28:(24) 7309-7322. 
 
Galliher-Beckley AJ, Cidlowski JA (2009). Emerging roles of glucocorticoid receptor 
phosphorylation in modulating glucocorticoid hormone action in health and disease. IUBMB Life 
61:(10) 979-986. 
 
Gametchu B, Watson CS, Wu S (1993). Use of receptor antibodies to demonstrate membrane 
glucocorticoid receptor in cells from human leukemic patients. FASEB J 7:(13) 1283-1292. 
 
Gametchu B, Chen F, Sackey F, Powell C, Watson CS (1999). Plasma membrane-resident 
glucocorticoid receptors in rodent lymphoma and human leukemia models. Steroids 64:(1-2) 
107-119. 
 
Garcia J, Curtidor H, Pinzon CG, Vanegas M, Moreno A, Patarroyo ME (2009). Identification of 
conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-
associated protein family. Vaccine 27:(30) 3953-3962. 
 
Garside H, Waters C, Berry A, Rice L, Ardley HC, White A, Robinson PA, Ray D (2006). 
UbcH7 interacts with the glucocorticoid receptor and mediates receptor autoregulation. J 
Endocrinol 190:(3) 621-629. 
 
Gault PM, Morgan K, Pawson AJ, Millar RP, Lincoln GA (2004). Sheep exhibit novel variations 
in the organization of the mammalian type II gonadotropin-releasing hormone receptor gene. 
Endocrinology 145:(5) 2362-2374. 
 
Gharib SD, Wierman ME, Shupnik MA, Chin WW (1990). Molecular biology of the pituitary 
gonadotropins. Endocr Rev 11:(1) 177-199. 
 
Gkantiragas I, Brugger B, Stuven E, Kaloyanova D, Li XY, Lohr K, Lottspeich F, Wieland FT, 
Helms JB (2001). Sphingomyelin-enriched microdomains at the Golgi complex. Mol Biol Cell 
12:(6) 1819-1833. 
 
Glebov OO, Bright NA, Nichols BJ (2006). Flotillin-1 defines a clathrin-independent endocytic 
pathway in mammalian cells. Nat Cell Biol 8:(1) 46-54. 
 
Glenney JR, Jr. (1992). The sequence of human caveolin reveals identity with VIP21, a 
component of transport vesicles. FEBS Lett 314:(1) 45-48. 
 
Godowski PJ, Rusconi S, Miesfeld R, Yamamoto KR (1987). Glucocorticoid receptor mutants 
that are constitutive activators of transcriptional enhancement. Nature 325:(6102) 365-368. 
 132 
 
Goel A, Janknecht R (2004). Concerted activation of ETS protein ER81 by p160 coactivators, the 
acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu. J Biol Chem 279:(15) 14909-
14916. 
 
Gomez-Mouton C, Abad JL, Mira E, Lacalle RA, Gallardo E, Jimenez-Baranda S, Illa I, Bernad 
A, Manes S, Martinez AC (2001). Segregation of leading-edge and uropod components into 
specific lipid rafts during T cell polarization. Proc Natl Acad Sci U S A 98:(17) 9642-9647. 
 
Gorodinsky A, Harris DA (1995). Glycolipid-anchored proteins in neuroblastoma cells form 
detergent-resistant complexes without caveolin. J Cell Biol 129:(3) 619-627. 
 
Grafer CM, Thomas R, Lambrakos L, Montoya I, White S, Halvorson LM (2009). GnRH 
stimulates expression of PACAP in the pituitary gonadotropes via both the PKA and PKC 
signaling systems. Mol Endocrinol 23:(7) 1022-1032. 
 
Griekspoor A, Zwart W, Neefjes J, Michalides R (2007). Visualizing the action of steroid 
hormone receptors in living cells. Nucl Recept Signal 5 e003. 
 
Gronemeyer H, Gustafsson JA, Laudet V (2004). Principles for modulation of the nuclear 
receptor superfamily. Nat Rev Drug Discov 3:(11) 950-964. 
 
Grosse R, Schmid A, Schoneberg T, Herrlich A, Muhn P, Schultz G, Gudermann T (2000). 
Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by exclusively 
coupling to G(q/11) proteins. J Biol Chem 275:(13) 9193-9200. 
 
Grossmann C, Husse B, Mildenberger S, Schreier B, Schuman K, Gekle M (2010). 
Colocalization of mineralocorticoid and EGF receptor at the plasma membrane. Biochim Biophys 
Acta 1803:(5) 584-590. 
 
Grundker C, Volker P, Emons G (2001). Antiproliferative signaling of luteinizing hormone-
releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-
mediated activation of phosphotyrosine phosphatase. Endocrinology 142:(6) 2369-2380. 
 
Grundker C, Gunthert AR, Westphalen S, Emons G (2002). Biology of the gonadotropin-
releasing hormone system in gynecological cancers. Eur J Endocrinol 146:(1) 1-14. 
 
Grundker C, Emons G (2003). Role of gonadotropin-releasing hormone (GnRH) in ovarian 
cancer. Reprod Biol Endocrinol 1 65. 
 
Guerrero HE, Stein P, Asch RH, de Fried EP, Tesone M (1993). Effect of a gonadotropin-
releasing hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells. 
Fertil Steril 59:(4) 803-808. 
 
Gunthert AR, Grundker C, Olota A, Lasche J, Eicke N, Emons G (2005). Analogs of GnRH-I and 
GnRH-II inhibit epidermal growth factor-induced signal transduction and resensitize resistant 
human breast cancer cells to 4OH-tamoxifen. Eur J Endocrinol 153:(4) 613-625. 
 133 
 
Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, Borg M, Lindroth M, Peterson KH, 
Magnusson KE, Stralfors P (1999). Localization of the insulin receptor in caveolae of adipocyte 
plasma membrane. FASEB J 13:(14) 1961-1971. 
 
Ha H, Kwak HB, Lee SK, Na DS, Rudd CE, Lee ZH, Kim HH (2003). Membrane rafts play a 
crucial role in receptor activator of nuclear factor kappaB signaling and osteoclast function. J 
Biol Chem 278:(20) 18573-18580. 
 
Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh 
CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao 
JK (2002). Acute cardiovascular protective effects of corticosteroids are mediated by non-
transcriptional activation of endothelial nitric oxide synthase. Nat Med 8:(5) 473-479. 
 
Haglund K, Ivankovic-Dikic I, Shimokawa N, Kruh GD, Dikic I (2004). Recruitment of Pyk2 
and Cbl to lipid rafts mediates signals important for actin reorganization in growing neurites. J 
Cell Sci 117:(Pt 12) 2557-2568. 
 
Hamilos DL, Leung DY, Muro S, Kahn AM, Hamilos SS, Thawley SE, Hamid QA (2001). 
GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory 
effects of intranasal fluticasone. J Allergy Clin Immunol 108:(1) 59-68. 
 
Hanson RW, Reshef L (1997). Regulation of phosphoenolpyruvate carboxykinase (GTP) gene 
expression. Annu Rev Biochem 66 581-611. 
 
Hapgood JP, Sadie H, van Biljon W, Ronacher K (2005). Regulation of expression of 
mammalian gonadotrophin-releasing hormone receptor genes. J Neuroendocrinol 17:(10) 619-
638. 
 
Harder T, Simons K (1997). Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol 
microdomains. Curr Opin Cell Biol 9:(4) 534-542. 
 
Harder T, Scheiffele P, Verkade P, Simons K (1998). Lipid domain structure of the plasma 
membrane revealed by patching of membrane components. J Cell Biol 141:(4) 929-942. 
 
Harr MW, Rong Y, Bootman MD, Roderick HL, Distelhorst CW (2009). Glucocorticoid-
mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by 
down-regulating inositol 1,4,5-trisphosphate receptors. J Biol Chem 284:(46) 31860-31871. 
 
Hawes BE, Marzen JE, Waters SB, Conn PM (1992). Sodium fluoride provokes gonadotrope 
desensitization to gonadotropin-releasing hormone (GnRH) and gonadotrope sensitization to 
A23187: evidence for multiple G proteins in GnRH action. Endocrinology 130:(5) 2465-2475. 
 
Hawes BE, Barnes S, Conn PM (1993). Cholera toxin and pertussis toxin provoke differential 
effects on luteinizing hormone release, inositol phosphate production, and gonadotropin-releasing 
hormone (GnRH) receptor binding in the gonadotrope: evidence for multiple guanyl nucleotide 
binding proteins in GnRH action. Endocrinology 132:(5) 2124-2130. 
 134 
 
Hazarika P, McCarty MF, Prieto VG, George S, Babu D, Koul D, Bar-Eli M, Duvic M (2004). 
Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression 
of the thrombin receptor protease activated receptor 1. Cancer Res 64:(20) 7361-7369. 
 
Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P, Cato AC (1994). A distinct 
modulating domain in glucocorticoid receptor monomers in the repression of activity of the 
transcription factor AP-1. EMBO J 13:(17) 4087-4095. 
 
Heery DM, Kalkhoven E, Hoare S, Parker MG (1997). A signature motif in transcriptional co-
activators mediates binding to nuclear receptors. Nature 387:(6634) 733-736. 
 
Heitzer MD, Wolf IM, Sanchez ER, Witchel SF, DeFranco DB (2007). Glucocorticoid receptor 
physiology. Rev Endocr Metab Disord 8:(4) 321-330. 
 
Hershko A, Ciechanover A (1998). The ubiquitin system. Annu Rev Biochem 67 425-479. 
 
Hinds TD, Jr., Ramakrishnan S, Cash HA, Stechschulte LA, Heinrich G, Najjar SM, Sanchez ER 
(2010). Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Mol 
Endocrinol 24:(9) 1715-1727. 
 
Hoeck W, Rusconi S, Groner B (1989). Down-regulation and phosphorylation of glucocorticoid 
receptors in cultured cells. Investigations with a monospecific antiserum against a bacterially 
expressed receptor fragment. J Biol Chem 264:(24) 14396-14402. 
 
Hoehne M, de Couet HG, Stuermer CA, Fischbach KF (2005). Loss- and gain-of-function 
analysis of the lipid raft proteins Reggie/Flotillin in Drosophila: they are posttranslationally 
regulated, and misexpression interferes with wing and eye development. Mol Cell Neurosci 
30:(3) 326-338. 
 
Holmstrom S, Van Antwerp ME, Iniguez-Lluhi JA (2003). Direct and distinguishable inhibitory 
roles for SUMO isoforms in the control of transcriptional synergy. Proc Natl Acad Sci U S A 
100:(26) 15758-15763. 
 
Housley PR, Pratt WB (1983). Direct demonstration of glucocorticoid receptor phosphorylation 
by intact L-cells. J Biol Chem 258:(7) 4630-4635. 
 
Huang C, Hepler JR, Chen LT, Gilman AG, Anderson RG, Mumby SM (1997). Organization of 
G proteins and adenylyl cyclase at the plasma membrane. Mol Biol Cell 8:(12) 2365-2378. 
 
Huang CS, Zhou J, Feng AK, Lynch CC, Klumperman J, DeArmond SJ, Mobley WC (1999). 
Nerve growth factor signaling in caveolae-like domains at the plasma membrane. J Biol Chem 
274:(51) 36707-36714. 
 
Huang J, Motto DG, Bundle DR, Sadler JE (2010). Shiga toxin B subunits induce VWF secretion 




Ikezu T, Ueda H, Trapp BD, Nishiyama K, Sha JF, Volonte D, Galbiati F, Byrd AL, Bassell G, 
Serizawa H, Lane WS, Lisanti MP, Okamoto T (1998). Affinity-purification and characterization 
of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial 
and astroglial cell types. Brain Res 804:(2) 177-192. 
 
Illing N, Jacobs GF, Becker, II, Flanagan CA, Davidson JS, Eales A, Zhou W, Sealfon SC, Millar 
RP (1993). Comparative sequence analysis and functional characterization of the cloned sheep 
gonadotropin-releasing hormone receptor reveal differences in primary structure and ligand 
specificity among mammalian receptors. Biochem Biophys Res Commun 196:(2) 745-751. 
 
Imai A, Ohno T, Iida K, Fuseya T, Furui T, Tamaya T (1994). Gonadotropin-releasing hormone 
receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types. Cancer 
74:(9) 2555-2561. 
 
Imai A, Tamaya T (2000). GnRH receptor and apoptotic signaling. Vitam Horm 59 1-33. 
 
Inokuchi J (2006). Insulin resistance as a membrane microdomain disorder. Biol Pharm Bull 
29:(8) 1532-1537. 
 
Ishizaka N, Griendling KK, Lassegue B, Alexander RW (1998). Angiotensin II type 1 receptor: 
relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32:(3) 459-
466. 
 
Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, Adcock IM (2006). Histone 
deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB 
suppression. J Exp Med 203:(1) 7-13. 
 
Itoh M, Adachi M, Yasui H, Takekawa M, Tanaka H, Imai K (2002). Nuclear export of 
glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol 
Endocrinol 16:(10) 2382-2392. 
 
Iwasaki Y, Aoki Y, Katahira M, Oiso Y, Saito H (1997). Non-genomic mechanisms of 
glucocorticoid inhibition of adrenocorticotropin secretion: possible involvement of GTP-binding 
protein. Biochem Biophys Res Commun 235:(2) 295-299. 
 
Jacobson JD, Crofford LJ, Sun L, Wilder RL (1998). Cyclical expression of GnRH and GnRH 
receptor mRNA in lymphoid organs. Neuroendocrinology 67:(2) 117-125. 
 
Jain S, Li Y, Kumar A, Sehgal PB (2005). Transcriptional signaling from membrane raft-
associated glucocorticoid receptor. Biochem Biophys Res Commun 336:(1) 3-8. 
 
Janes PW, Ley SC, Magee AI (1999). Aggregation of lipid rafts accompanies signaling via the T 
cell antigen receptor. J Cell Biol 147:(2) 447-461. 
 
 136 
Japiassu AM, Salluh JI, Bozza PT, Bozza FA, Castro-Faria-Neto HC (2009). Revisiting steroid 
treatment for septic shock: molecular actions and clinical effects--a review. Mem Inst Oswaldo 
Cruz 104:(4) 531-548. 
 
Jorgensen JS, Quirk CC, Nilson JH (2004). Multiple and overlapping combinatorial codes 
orchestrate hormonal responsiveness and dictate cell-specific expression of the genes encoding 
luteinizing hormone. Endocr Rev 25:(4) 521-542. 
 
Kaether C, Haass C (2004). A lipid boundary separates APP and secretases and limits amyloid 
beta-peptide generation. J Cell Biol 167:(5) 809-812. 
 
Kaiser UB, Zhao D, Cardona GR, Chin WW (1992). Isolation and characterization of cDNAs 
encoding the rat pituitary gonadotropin-releasing hormone receptor. Biochem Biophys Res 
Commun 189:(3) 1645-1652. 
 
Kaiser UB, Jakubowiak A, Steinberger A, Chin WW (1993). Regulation of rat pituitary 
gonadotropin-releasing hormone receptor mRNA levels in vivo and in vitro. Endocrinology 
133:(2) 931-934. 
 
Kakar SS, Musgrove LC, Devor DC, Sellers JC, Neill JD (1992). Cloning, sequencing, and 
expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res 
Commun 189:(1) 289-295. 
 
Kamel F, Kubajak CL (1987). Modulation of gonadotropin secretion by corticosterone: 
interaction with gonadal steroids and mechanism of action. Endocrinology 121:(2) 561-568. 
 
Kanasaki H, Miyazaki K (2006). [GnRH pulse frequency-dependent regulation of gonadotropin 
gene expression]. Nippon Rinsho 64 Suppl 4 141-148. 
 
Karman J, Tedstone JL, Gumlaw NK, Zhu Y, Yew N, Siegel C, Guo S, Siwkowski A, Ruzek M, 
Jiang C, Cheng SH (2010). Reducing glycosphingolipid biosynthesis in airway cells partially 
ameliorates disease manifestations in a mouse model of asthma. Int Immunol 22:(7) 593-603. 
 
Kassel O, Schneider S, Heilbock C, Litfin M, Gottlicher M, Herrlich P (2004). A nuclear isoform 
of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at 
AP-1- and NF-kappaB-regulated promoters. Genes Dev 18:(20) 2518-2528. 
 
Kassel O, Herrlich P (2007). Crosstalk between the glucocorticoid receptor and other 
transcription factors: molecular aspects. Mol Cell Endocrinol 275:(1-2) 13-29. 
 
Kelly A, Bowen H, Jee Y-K, Mahfiche N, Soh C, Lee T, Hawrylowicz C, Lavender P (2008). 
The Glucocorticoid Receptor ß Isoform Can Mediate Transcriptional Repression by Recruiting 
Histone Deacetylases. J Allergy Clin Immunol 121 203-208. 
 
Kerppola TK, Luk D, Curran T (1993). Fos is a preferential target of glucocorticoid receptor 
inhibition of AP-1 activity in vitro. Mol Cell Biol 13:(6) 3782-3791. 
 
 137 
Kilen SM, Szabo M, Strasser GA, McAndrews JM, Ringstrom SJ, Schwartz NB (1996). 
Corticosterone selectively increases follicle-stimulating hormone beta-subunit messenger 
ribonucleic acid in primary anterior pituitary cell culture without affecting its half-life. 
Endocrinology 137:(9) 3802-3807. 
 
Kilsdonk EP, Yancey PG, Stoudt GW, Bangerter FW, Johnson WJ, Phillips MC, Rothblat GH 
(1995). Cellular cholesterol efflux mediated by cyclodextrins. J Biol Chem 270:(29) 17250-
17256. 
 
Kim JH, Li H, Stallcup MR (2003). CoCoA, a nuclear receptor coactivator which acts through an 
N-terminal activation domain of p160 coactivators. Mol Cell 12:(6) 1537-1549. 
 
Kim YS, Kim J, Kim Y, Lee YH, Kim JH, Lee SJ, Shin SY, Ko J (2008). The role of calpains in 
ligand-induced degradation of the glucocorticoid receptor. Biochem Biophys Res Commun 
374:(2) 373-377. 
 
Kimura A, Baumann CA, Chiang SH, Saltiel AR (2001). The sorbin homology domain: a motif 
for the targeting of proteins to lipid rafts. Proc Natl Acad Sci U S A 98:(16) 9098-9103. 
 
Kino T, Tiulpakov A, Ichijo T, Chheng L, Kozasa T, Chrousos GP (2005). G protein beta 
interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. 
J Cell Biol 169:(6) 885-896. 
 
Kino T, Ichijo T, Amin ND, Kesavapany S, Wang Y, Kim N, Rao S, Player A, Zheng YL, 
Garabedian MJ, Kawasaki E, Pant HC, Chrousos GP (2007). Cyclin-dependent kinase 5 
differentially regulates the transcriptional activity of the glucocorticoid receptor through 
phosphorylation: clinical implications for the nervous system response to glucocorticoids and 
stress. Mol Endocrinol 21:(7) 1552-1568. 
 
Kioka N, Ueda K, Amachi T (2002). Vinexin, CAP/ponsin, ArgBP2: a novel adaptor protein 
family regulating cytoskeletal organization and signal transduction. Cell Struct Funct 27:(1) 1-7. 
 
Knollman PE, Janovick JA, Brothers SP, Conn PM (2005). Parallel regulation of membrane 
trafficking and dominant-negative effects by misrouted gonadotropin-releasing hormone receptor 
mutants. J Biol Chem 280:(26) 24506-24514. 
 
Kogo H, Fujimoto T, Park MK, Mori T (1999). Gonadotropin-releasing hormone receptor mRNA 
expression in the ovaries of neonatal and adult rats. Cells Tissues Organs 164:(1) 14-22. 
 
Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F (2001). Low cholesterol stimulates the 
nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U 
S A 98:(10) 5815-5820. 
 
Kokubo H, Helms JB, Ohno-Iwashita Y, Shimada Y, Horikoshi Y, Yamaguchi H (2003). 
Ultrastructural localization of flotillin-1 to cholesterol-rich membrane microdomains, rafts, in rat 
brain tissue. Brain Res 965:(1-2) 83-90. 
 
 138 
Koshizuka T, Kawaguchi Y, Nozawa N, Mori I, Nishiyama Y (2007). Herpes simplex virus 
protein UL11 but not UL51 is associated with lipid rafts. Virus Genes 35:(3) 571-575. 
 
Kotitschke A, Sadie-Van Gijsen H, Avenant C, Fernandes S, Hapgood JP (2009). Genomic and 
nongenomic cross talk between the gonadotropin-releasing hormone receptor and glucocorticoid 
receptor signaling pathways. Mol Endocrinol 23:(11) 1726-1745. 
 
Kottler ML, Starzec A, Carre MC, Lagarde JP, Martin A, Counis R (1997). The genes for 
gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic 
disease and cancer. Int J Cancer 71:(4) 595-599. 
 
Kouzarides T (2000). Acetylation: a regulatory modification to rival phosphorylation? EMBO J 
19:(6) 1176-1179. 
 
Kowase T, Walsh HE, Darling DS, Shupnik MA (2007). Estrogen enhances gonadotropin-
releasing hormone-stimulated transcription of the luteinizing hormone subunit promoters via 
altered expression of stimulatory and suppressive transcription factors. Endocrinology 148:(12) 
6083-6091. 
 
Kraus S, Naor Z, Seger R (2001). Intracellular signaling pathways mediated by the gonadotropin-
releasing hormone (GnRH) receptor. Arch Med Res 32:(6) 499-509. 
 
Kumar R, Thompson EB (2005). Gene regulation by the glucocorticoid receptor: 
structure:function relationship. J Steroid Biochem Mol Biol 94:(5) 383-394. 
 
Kusumi A, Koyama-Honda I, Suzuki K (2004). Molecular dynamics and interactions for creation 
of stimulation-induced stabilized rafts from small unstable steady-state rafts. Traffic 5:(4) 213-
230. 
 
Lafont F, Simons K (2001). Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-
triggered cell signaling. Proc Natl Acad Sci U S A 98:(6) 3180-3184. 
 
Lahtinen U, Honsho M, Parton RG, Simons K, Verkade P (2003). Involvement of caveolin-2 in 
caveolar biogenesis in MDCK cells. FEBS Lett 538:(1-3) 85-88. 
 
Lamharzi N, Halmos G, Jungwirth A, Schally AV (1998a). Decrease in the level and mRNA 
expression of LH-RH and EGF receptors after treatment with LH-RH antagonist cetrorelix in 
DU-145 prostate tumor xenografts in nude mice. Int J Oncol 13:(3) 429-435. 
 
Lamharzi N, Schally AV, Koppan M (1998b). Luteinizing hormone-releasing hormone (LH-RH) 
antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate 
carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors. 
Regul Pept 77:(1-3) 185-192. 
 
Lang DM, Lommel S, Jung M, Ankerhold R, Petrausch B, Laessing U, Wiechers MF, Plattner H, 
Stuermer CA (1998). Identification of reggie-1 and reggie-2 as plasmamembrane-associated 
 139 
proteins which cocluster with activated GPI-anchored cell adhesion molecules in non-caveolar 
micropatches in neurons. J Neurobiol 37:(4) 502-523. 
 
Lange CA, Shen T, Horwitz KB (2000). Phosphorylation of human progesterone receptors at 
serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. 
Proc Natl Acad Sci U S A 97:(3) 1032-1037. 
 
Langhorst MF, Reuter A, Stuermer CA (2005). Scaffolding microdomains and beyond: the 
function of reggie/flotillin proteins. Cell Mol Life Sci 62:(19-20) 2228-2240. 
 
Langhorst MF, Jaeger FA, Mueller S, Sven Hartmann L, Luxenhofer G, Stuermer CA (2008). 
Reggies/flotillins regulate cytoskeletal remodeling during neuronal differentiation via 
CAP/ponsin and Rho GTPases. Eur J Cell Biol 87:(12) 921-931. 
 
Lariviere S, Garrel G, Simon V, Soh JW, Laverriere JN, Counis R, Cohen-Tannoudji J (2007). 
Gonadotropin-releasing hormone couples to 3',5'-cyclic adenosine-5'-monophosphate pathway 
through novel protein kinase Cdelta and -epsilon in LbetaT2 gonadotrope cells. Endocrinology 
148:(3) 1099-1107. 
 
Le Drean Y, Mincheneau N, Le Goff P, Michel D (2002). Potentiation of glucocorticoid receptor 
transcriptional activity by sumoylation. Endocrinology 143:(9) 3482-3489. 
 
Le Lay S, Krief S, Farnier C, Lefrere I, Le Liepvre X, Bazin R, Ferre P, Dugail I (2001). 
Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression 
in adipocytes. J Biol Chem 276:(20) 16904-16910. 
 
Lee DK, Chang C (2003). Endocrine mechanisms of disease: Expression and degradation of 
androgen receptor: mechanism and clinical implication. J Clin Endocrinol Metab 88:(9) 4043-
4054. 
 
Lee SJ, Liyanage U, Bickel PE, Xia W, Lansbury PT, Jr., Kosik KS (1998). A detergent-
insoluble membrane compartment contains A beta in vivo. Nat Med 4:(6) 730-734. 
 
Lee YH, Koh SS, Zhang X, Cheng X, Stallcup MR (2002). Synergy among nuclear receptor 
coactivators: selective requirement for protein methyltransferase and acetyltransferase activities. 
Mol Cell Biol 22:(11) 3621-3632. 
 
Lee YH, Coonrod SA, Kraus WL, Jelinek MA, Stallcup MR (2005). Regulation of coactivator 
complex assembly and function by protein arginine methylation and demethylimination. Proc 
Natl Acad Sci U S A 102:(10) 3611-3616. 
 
Lerner L, Henriksen MA, Zhang X, Darnell JE, Jr. (2003). STAT3-dependent enhanceosome 
assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-
macroglobulin gene. Genes Dev 17:(20) 2564-2577. 
 




Li Q, Su A, Chen J, Lefebvre YA, Hache RJ (2002). Attenuation of glucocorticoid signaling 
through targeted degradation of p300 via the 26S proteasome pathway. Mol Endocrinol 16:(12) 
2819-2827. 
 
Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, Lisanti MP 
(1995). Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J 
Biol Chem 270:(26) 15693-15701. 
 
Li X, Qiu J, Wang J, Zhong Y, Zhu J, Chen Y (2001). Corticosterone-induced rapid 
phosphorylation of p38 and JNK mitogen-activated protein kinases in PC12 cells. FEBS Lett 
492:(3) 210-214. 
 
Limonta P, Moretti RM, Marelli MM, Motta M (2003). The biology of gonadotropin hormone-
releasing hormone: role in the control of tumor growth and progression in humans. Front 
Neuroendocrinol 24:(4) 279-295. 
 
Lingwood D, Kaiser HJ, Levental I, Simons K (2009). Lipid rafts as functional heterogeneity in 
cell membranes. Biochem Soc Trans 37:(Pt 5) 955-960. 
 
Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF, 
Sargiacomo M (1994). Characterization of caveolin-rich membrane domains isolated from an 
endothelial-rich source: implications for human disease. J Cell Biol 126:(1) 111-126. 
 
Lisanti P, Scherer P, Tang Z, Kiibler E, Koleske A, Sargiacomo M (1995). Caveolae and human 
disease: functional roles in transcytosis, potocytosis, signalling, and cell polarity. Semin Dev Biol 
6 47-50. 
 
Liu F, Usui I, Evans LG, Austin DA, Mellon PL, Olefsky JM, Webster NJ (2002a). Involvement 
of both G(q/11) and G(s) proteins in gonadotropin-releasing hormone receptor-mediated 
signaling in L beta T2 cells. J Biol Chem 277:(35) 32099-32108. 
 
Liu F, Austin DA, Mellon PL, Olefsky JM, Webster NJ (2002b). GnRH activates ERK1/2 
leading to the induction of c-fos and LHbeta protein expression in LbetaT2 cells. Mol Endocrinol 
16:(3) 419-434. 
 
Liu F, Austin DA, Webster NJ (2003). Gonadotropin-releasing hormone-desensitized LbetaT2 
gonadotrope cells are refractory to acute protein kinase C, cyclic AMP, and calcium-dependent 
signaling. Endocrinology 144:(10) 4354-4365. 
 
Liu J, Oh P, Horner T, Rogers RA, Schnitzer JE (1997). Organized endothelial cell surface signal 
transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein 
microdomains. J Biol Chem 272:(11) 7211-7222. 
 
Liu J, Deyoung SM, Zhang M, Dold LH, Saltiel AR (2005). The 
stomatin/prohibitin/flotillin/HflK/C domain of flotillin-1 contains distinct sequences that direct 
 141 
plasma membrane localization and protein interactions in 3T3-L1 adipocytes. J Biol Chem 
280:(16) 16125-16134. 
 
Liu JL, Papachristou DN, Patel YC (1994). Glucocorticoids activate somatostatin gene 
transcription through co-operative interaction with the cyclic AMP signalling pathway. Biochem 
J 301 ( Pt 3) 863-869. 
 
Liu P, Ying Y, Ko YG, Anderson RG (1996). Localization of platelet-derived growth factor-
stimulated phosphorylation cascade to caveolae. J Biol Chem 271:(17) 10299-10303. 
 
Lopez-Casas PP, del Mazo J (2003). Regulation of flotillin-1 in the establishment of NIH-3T3 
cell-cell interactions. FEBS Lett 555:(2) 223-228. 
 
Losel R, Wehling M (2003). Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 
4:(1) 46-56. 
 
Loumaye E, Catt KJ (1982). Homologous regulation of gonadotropin-releasing hormone 
receptors in cultured pituitary cells. Science 215:(4535) 983-985. 
 
Lowenberg M, Tuynman J, Bilderbeek J, Gaber T, Buttgereit F, van Deventer S, Peppelenbosch 
M, Hommes D (2005). Rapid immunosuppressive effects of glucocorticoids mediated through 
Lck and Fyn. Blood 106:(5) 1703-1710. 
 
Lowenberg M, Tuynman J, Scheffer M, Verhaar A, Vermeulen L, van Deventer S, Hommes D, 
Peppelenbosch M (2006a). Kinome analysis reveals nongenomic glucocorticoid receptor-
dependent inhibition of insulin signaling. Endocrinology 147:(7) 3555-3562. 
 
Lowenberg M, Verhaar AP, Bilderbeek J, Marle J, Buttgereit F, Peppelenbosch MP, van 
Deventer SJ, Hommes DW (2006b). Glucocorticoids cause rapid dissociation of a T-cell-
receptor-associated protein complex containing LCK and FYN. EMBO Rep 7:(10) 1023-1029. 
 
Lowenberg M, Stahn C, Hommes DW, Buttgereit F (2008). Novel insights into mechanisms of 
glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 
73:(9-10) 1025-1029. 
 
Lu NZ, Cidlowski JA (2004). The origin and functions of multiple human glucocorticoid receptor 
isoforms. Ann N Y Acad Sci 1024 102-123. 
 
Lu NZ, Cidlowski JA (2005). Translational regulatory mechanisms generate N-terminal 
glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 18:(3) 331-
342. 
 
Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, 
Renoir JM, Weigel NL, Wilson EM, McDonnell DP, Cidlowski JA (2006). International Union 
of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor 
superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol 
Rev 58:(4) 782-797. 
 142 
 
Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB (1991). 
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 
352:(6335) 497-505. 
 
Malcher-Lopes R, Franco A, Tasker JG (2008). Glucocorticoids shift arachidonic acid 
metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch. Eur J 
Pharmacol 583:(2-3) 322-339. 
 
Malkoski SP, Dorin RI (1999). Composite glucocorticoid regulation at a functionally defined 
negative glucocorticoid response element of the human corticotropin-releasing hormone gene. 
Mol Endocrinol 13:(10) 1629-1644. 
 
Mandai K, Nakanishi H, Satoh A, Takahashi K, Satoh K, Nishioka H, Mizoguchi A, Takai Y 
(1999). Ponsin/SH3P12: an l-afadin- and vinculin-binding protein localized at cell-cell and cell-
matrix adherens junctions. J Cell Biol 144:(5) 1001-1017. 
 
Manes S, del Real G, Lacalle RA, Lucas P, Gomez-Mouton C, Sanchez-Palomino S, Delgado R, 
Alcami J, Mira E, Martinez AC (2000). Membrane raft microdomains mediate lateral assemblies 
required for HIV-1 infection. EMBO Rep 1:(2) 190-196. 
 
Marelli MM, Moretti RM, Dondi D, Motta M, Limonta P (1999). Luteinizing hormone-releasing 
hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in 
androgen-independent prostate cancer cells. Endocrinology 140:(1) 329-334. 
 
Martinez-Fuentes AJ, Hu L, Krsmanovic LZ, Catt KJ (2004). Gonadotropin-releasing hormone 
(GnRH) receptor expression and membrane signaling in early embryonic GnRH neurons: role in 
pulsatile neurosecretion. Mol Endocrinol 18:(7) 1808-1817. 
 
Mason SA, Housley PR (1993). Site-directed mutagenesis of the phosphorylation sites in the 
mouse glucocorticoid receptor. J Biol Chem 268:(29) 21501-21504. 
 
Mathew R, Huang J, Shah M, Patel K, Gewitz M, Sehgal PB (2004). Disruption of endothelial-
cell caveolin-1alpha/raft scaffolding during development of monocrotaline-induced pulmonary 
hypertension. Circulation 110:(11) 1499-1506. 
 
Matthews L, Berry A, Ohanian V, Ohanian J, Garside H, Ray D (2008). Caveolin mediates rapid 
glucocorticoid effects and couples glucocorticoid action to the antiproliferative program. Mol 
Endocrinol 22:(6) 1320-1330. 
 
Mattson MP (2004). Pathways towards and away from Alzheimer's disease. Nature 430:(7000) 
631-639. 
 
Maudsley S, Davidson L, Pawson AJ, Freestone SH, Lopez de Maturana R, Thomson AA, Millar 
RP (2006). Gonadotropin-releasing hormone functionally antagonizes testosterone activation of 
the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5. 
Neuroendocrinology 84:(5) 285-300. 
 143 
 
Mayor S, Rao M (2004). Rafts: scale-dependent, active lipid organization at the cell surface. 
Traffic 5:(4) 231-240. 
 
McAndrews JM, Ringstrom SJ, Dahl KD, Schwartz NB (1994). Corticosterone in vivo increases 
pituitary follicle-stimulating hormone (FSH)-beta messenger ribonucleic acid content and serum 
FSH bioactivity selectively in female rats. Endocrinology 134:(1) 158-163. 
 
McGuire TF, Corey SJ, Sebti SM (1993). Lovastatin inhibits platelet-derived growth factor 
(PDGF) stimulation of phosphatidylinositol 3-kinase activity as well as association of p85 
subunit to tyrosine-phosphorylated PDGF receptor. J Biol Chem 268:(30) 22227-22230. 
 
McKenna NJ, Lanz RB, O'Malley BW (1999). Nuclear receptor coregulators: cellular and 
molecular biology. Endocr Rev 20:(3) 321-344. 
 
Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL, Weiner RI (1990). 
Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 
5:(1) 1-10. 
 
Meyer T, Gustafsson JA, Carlstedt-Duke J (1997). Glucocorticoid-dependent transcriptional 
repression of the osteocalcin gene by competitive binding at the TATA box. DNA Cell Biol 
16:(8) 919-927. 
 
Millar R, Lowe S, Conklin D, Pawson A, Maudsley S, Troskie B, Ott T, Millar M, Lincoln G, 
Sellar R, Faurholm B, Scobie G, Kuestner R, Terasawa E, Katz A (2001). A novel mammalian 
receptor for the evolutionarily conserved type II GnRH. Proc Natl Acad Sci U S A 98:(17) 9636-
9641. 
 
Millar RP (2003). GnRH II and type II GnRH receptors. Trends Endocrinol Metab 14:(1) 35-43. 
 
Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, Maudsley SR (2004). Gonadotropin-
releasing hormone receptors. Endocr Rev 25:(2) 235-275. 
 
Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, Thompson EB (2005). p38 
Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis 
of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of 
the human glucocorticoid receptor at serine 211. Mol Endocrinol 19:(6) 1569-1583. 
 
Mineo C, James GL, Smart EJ, Anderson RG (1996). Localization of epidermal growth factor-
stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem 271:(20) 11930-11935. 
 
Mineo C, Gill GN, Anderson RG (1999). Regulated migration of epidermal growth factor 
receptor from caveolae. J Biol Chem 274:(43) 30636-30643. 
 
Miyamoto K, Koshiba S, Inoue M, Kigawa T, Yokoyama S (2004). Solution structure of the band 
7 domain of the mouse flotillin 2 protein. Protein Data Bank ID1WIN. 
 
 144 
Moffett S, Brown DA, Linder ME (2000). Lipid-dependent targeting of G proteins into rafts. J 
Biol Chem 275:(3) 2191-2198. 
 
Montagnani Marelli M, Moretti RM, Mai S, Procacci P, Limonta P (2007). Gonadotropin-
releasing hormone agonists reduce the migratory and the invasive behavior of androgen-
independent prostate cancer cells by interfering with the activity of IGF-I. Int J Oncol 30:(1) 261-
271. 
 
Moral-Naranjo MT, Montenegro MF, Munoz-Delgado E, Campoy FJ, Vidal CJ (2010). The 
levels of both lipid rafts and raft-located acetylcholinesterase dimers increase in muscle of mice 
with muscular dystrophy by merosin deficiency. Biochim Biophys Acta 1802:(9) 754-764. 
 
Morales P (1998). Gonadotropin-releasing hormone increases ability of the spermatozoa to bind 
to the human zona pellucida. Biol Reprod 59:(2) 426-430. 
 
Moretti RM, Marelli MM, Dondi D, Poletti A, Martini L, Motta M, Limonta P (1996). 
Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of 
epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145. J Clin 
Endocrinol Metab 81:(11) 3930-3937. 
 
Morgan K, Conklin D, Pawson AJ, Sellar R, Ott TR, Millar RP (2003). A transcriptionally active 
human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the 
antisense orientation on chromosome 1q.12. Endocrinology 144:(2) 423-436. 
 
Morrow IC, Rea S, Martin S, Prior IA, Prohaska R, Hancock JF, James DE, Parton RG (2002). 
Flotillin-1/reggie-2 traffics to surface raft domains via a novel golgi-independent pathway. 
Identification of a novel membrane targeting domain and a role for palmitoylation. J Biol Chem 
277:(50) 48834-48841. 
 
Morrow IC, Parton RG (2005). Flotillins and the PHB domain protein family: rafts, worms and 
anaesthetics. Traffic 6:(9) 725-740. 
 
Mulvaney JM, Zhang T, Fewtrell C, Roberson MS (1999). Calcium influx through L-type 
channels is required for selective activation of extracellular signal-regulated kinase by 
gonadotropin-releasing hormone. J Biol Chem 274:(42) 29796-29804. 
 
Munderloh C, Solis GP, Bodrikov V, Jaeger FA, Wiechers M, Malaga-Trillo E, Stuermer CA 
(2009). Reggies/flotillins regulate retinal axon regeneration in the zebrafish optic nerve and 
differentiation of hippocampal and N2a neurons. J Neurosci 29:(20) 6607-6615. 
 
Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, Simons K (1995). VIP21/caveolin 
is a cholesterol-binding protein. Proc Natl Acad Sci U S A 92:(22) 10339-10343. 
 
Nader N, Ng SS, Lambrou GI, Pervanidou P, Wang Y, Chrousos GP, Kino T (2010). AMPK 
regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor 
through p38 MAPK. Mol Endocrinol 24:(9) 1748-1764. 
 
 145 
Naidich M, Shterntal B, Furman R, Pawson AJ, Jabbour HN, Morgan K, Millar RP, Jia J, Tomic 
M, Stojilkovic S, Stern N, Naor Z (2010). Elucidation of mechanisms of the reciprocal cross talk 
between gonadotropin-releasing hormone and prostaglandin receptors. Endocrinology 151:(6) 
2700-2712. 
 
Naor Z, Benard O, Seger R (2000). Activation of MAPK cascades by G-protein-coupled 
receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab 11:(3) 
91-99. 
 
Naor Z, Jabbour HN, Naidich M, Pawson AJ, Morgan K, Battersby S, Millar MR, Brown P, 
Millar RP (2007). Reciprocal cross talk between gonadotropin-releasing hormone (GnRH) and 
prostaglandin receptors regulates GnRH receptor expression and differential gonadotropin 
secretion. Mol Endocrinol 21:(2) 524-537. 
 
Naor Z (2009). Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor. 
Front Neuroendocrinol 30:(1) 10-29. 
 
Navratil AM, Bliss SP, Berghorn KA, Haughian JM, Farmerie TA, Graham JK, Clay CM, 
Roberson MS (2003). Constitutive localization of the gonadotropin-releasing hormone (GnRH) 
receptor to low density membrane microdomains is necessary for GnRH signaling to ERK. J Biol 
Chem 278:(34) 31593-31602. 
 
Neill JD (2002). GnRH and GnRH receptor genes in the human genome. Endocrinology 143:(3) 
737-743. 
 
Neill JD, Musgrove LC, Duck LW (2004). Newly recognized GnRH receptors: function and 
relative role. Trends Endocrinol Metab 15:(8) 383-392. 
 
Nelson SB, Eraly SA, Mellon PL (1998). The GnRH promoter: target of transcription factors, 
hormones, and signaling pathways. Mol Cell Endocrinol 140:(1-2) 151-155. 
 
Neumann-Giesen C, Falkenbach B, Beicht P, Claasen S, Luers G, Stuermer CA, Herzog V, 
Tikkanen R (2004). Membrane and raft association of reggie-1/flotillin-2: role of myristoylation, 
palmitoylation and oligomerization and induction of filopodia by overexpression. Biochem J 
378:(Pt 2) 509-518. 
 
Neumann-Giesen C, Fernow I, Amaddii M, Tikkanen R (2007). Role of EGF-induced tyrosine 
phosphorylation of reggie-1/flotillin-2 in cell spreading and signaling to the actin cytoskeleton. J 
Cell Sci 120:(Pt 3) 395-406. 
 
Nguyen DH, Hildreth JE (2000). Evidence for budding of human immunodeficiency virus type 1 
selectively from glycolipid-enriched membrane lipid rafts. J Virol 74:(7) 3264-3272. 
 
Ning G, Jurecic V, Baldini A, Xu J (1999). Structure and chromosomal locations of mouse 
steroid receptor coactivator gene family. In Vitro Cell Dev Biol Anim 35:(8) 481-486. 
 
 146 
Nishi M (2010). Imaging of transcription factor trafficking in living cells: lessons from 
corticosteroid receptor dynamics. Methods Mol Biol 647 199-212. 
 
Niu SL, Mitchell DC, Litman BJ (2002). Manipulation of cholesterol levels in rod disk 
membranes by methyl-beta-cyclodextrin: effects on receptor activation. J Biol Chem 277:(23) 
20139-20145. 
 
Nordeen SK, Suh BJ, Kuhnel B, Hutchison CA, 3rd (1990). Structural determinants of a 
glucocorticoid receptor recognition element. Mol Endocrinol 4:(12) 1866-1873. 
 
Norwitz ER, Jeong KH, Chin WW (1999). Molecular mechanisms of gonadotropin-releasing 
hormone receptor gene regulation. J Soc Gynecol Investig 6:(4) 169-178. 
 
Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA (1999). The dominant negative 
activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. 
J Biol Chem 274:(39) 27857-27866. 
 
Ohtani Y, Irie T, Uekama K, Fukunaga K, Pitha J (1989). Differential effects of alpha-, beta- and 
gamma-cyclodextrins on human erythrocytes. Eur J Biochem 186:(1-2) 17-22. 
 
Okret S, Poellinger L, Dong Y, Gustafsson JA (1986). Down-regulation of glucocorticoid 
receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding 
sequence within a receptor cDNA clone. Proc Natl Acad Sci U S A 83:(16) 5899-5903. 
 
Orti E, Mendel DB, Smith LI, Munck A (1989). Agonist-dependent phosphorylation and nuclear 
dephosphorylation of glucocorticoid receptors in intact cells. J Biol Chem 264:(17) 9728-9731. 
 
Ostrom RS, Violin JD, Coleman S, Insel PA (2000). Selective enhancement of beta-adrenergic 
receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and 
adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol 57:(5) 1075-1079. 
 
Ostrom RS, Gregorian C, Drenan RM, Xiang Y, Regan JW, Insel PA (2001). Receptor number 
and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol 
Chem 276:(45) 42063-42069. 
 
Ostrom RS, Liu X, Head BP, Gregorian C, Seasholtz TM, Insel PA (2002). Localization of 
adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: 
expression in caveolin-rich and noncaveolin domains. Mol Pharmacol 62:(5) 983-992. 
 
Park SK, Yang WS, Han NJ, Lee SK, Ahn H, Lee IK, Park JY, Lee KU, Lee JD (2004). 
Dexamethasone regulates AP-1 to repress TNF-alpha induced MCP-1 production in human 
glomerular endothelial cells. Nephrol Dial Transplant 19:(2) 312-319. 
 
Parpal S, Karlsson M, Thorn H, Stralfors P (2001). Cholesterol depletion disrupts caveolae and 
insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for 
mitogen-activated protein kinase control. J Biol Chem 276:(13) 9670-9678. 
 
 147 
Parton RG, Simons K (1995). Digging into caveolae. Science 269:(5229) 1398-1399. 
 
Parton RG (1996). Caveolae and caveolins. Curr Opin Cell Biol 8:(4) 542-548. 
 
Patra SK (2008). Ras regulation of DNA-methylation and cancer. Exp Cell Res 314:(6) 1193-
1201. 
 
Pawson AJ, Morgan K, Maudsley SR, Millar RP (2003). Type II gonadotrophin-releasing 
hormone (GnRH-II) in reproductive biology. Reproduction 126:(3) 271-278. 
 
Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER (2007). A conserved 
mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282:(31) 
22278-22288. 
 
Picard D, Yamamoto KR (1987). Two signals mediate hormone-dependent nuclear localization 
of the glucocorticoid receptor. EMBO J 6:(11) 3333-3340. 
 
Pike LJ, Miller JM (1998). Cholesterol depletion delocalizes phosphatidylinositol bisphosphate 
and inhibits hormone-stimulated phosphatidylinositol turnover. J Biol Chem 273:(35) 22298-
22304. 
 
Pike LJ, Casey L (2002). Cholesterol levels modulate EGF receptor-mediated signaling by 
altering receptor function and trafficking. Biochemistry 41:(32) 10315-10322. 
 
Pike LJ (2004). Lipid rafts: heterogeneity on the high seas. Biochem J 378:(Pt 2) 281-292. 
 
Pike LJ (2006). Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell 
Function. J Lipid Res 47:(7) 1597-1598. 
 
Powell CE, Watson CS, Gametchu B (1999). Immunoaffinity isolation of native membrane 
glucocorticoid receptor from S-49++ lymphoma cells: biochemical characterization and 
interaction with Hsp 70 and Hsp 90. Endocrine 10:(3) 271-280. 
 
Pratt WB, Toft DO (1997). Steroid receptor interactions with heat shock protein and 
immunophilin chaperones. Endocr Rev 18:(3) 306-360. 
 
Puri C, Tosoni D, Comai R, Rabellino A, Segat D, Caneva F, Luzzi P, Di Fiore PP, Tacchetti C 
(2005). Relationships between EGFR signaling-competent and endocytosis-competent membrane 
microdomains. Mol Biol Cell 16:(6) 2704-2718. 
 
Qi AQ, Qiu J, Xiao L, Chen YZ (2005). Rapid activation of JNK and p38 by glucocorticoids in 
primary cultured hippocampal cells. J Neurosci Res 80:(4) 510-517. 
 
Raga F, Casan EM, Kruessel JS, Wen Y, Huang HY, Nezhat C, Polan ML (1998). Quantitative 
gonadotropin-releasing hormone gene expression and immunohistochemical localization in 
human endometrium throughout the menstrual cycle. Biol Reprod 59:(3) 661-669. 
 
 148 
Rani CS, Elango N, Wang SS, Kobayashi K, Strong R (2009). Identification of an activator 
protein-1-like sequence as the glucocorticoid response element in the rat tyrosine hydroxylase 
gene. Mol Pharmacol 75:(3) 589-598. 
 
Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell 
RG, Li M, Pestell RG, Di Vizio D, Hou H, Jr., Kneitz B, Lagaud G, Christ GJ, Edelmann W, 
Lisanti MP (2001). Caveolin-1 null mice are viable but show evidence of hyperproliferative and 
vascular abnormalities. J Biol Chem 276:(41) 38121-38138. 
 
Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H, Jr., 
Christ GJ, Edelmann W, Lisanti MP (2002). Caveolin-2-deficient mice show evidence of severe 
pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 22:(7) 2329-2344. 
 
Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, 
Herrlich P, Angel P, Schutz G (1998). DNA binding of the glucocorticoid receptor is not 
essential for survival. Cell 93:(4) 531-541. 
 
Reichardt HM, Horsch K, Grone HJ, Kolbus A, Beug H, Hynes N, Schutz G (2001). Mammary 
gland development and lactation are controlled by different glucocorticoid receptor activities. Eur 
J Endocrinol 145:(4) 519-527. 
 
Reinhart J, Mertz LM, Catt KJ (1992). Molecular cloning and expression of cDNA encoding the 
murine gonadotropin-releasing hormone receptor. J Biol Chem 267:(30) 21281-21284. 
 
Reuter A, Malaga-Trillo E, Binkle U, Rivera-Milla E, Beltre R, Zhou Y, Bastmeyer M, Stuermer 
CA (2004). Evolutionary analysis and expression of teleost Thy-1. Zebrafish 1:(3) 191-201. 
 
Rhen T, Cidlowski JA (2005). Antiinflammatory action of glucocorticoids-new mechanisms for 
old drugs. N Engl J Med 353:(16) 1711-1723. 
 
Ribon V, Herrera R, Kay BK, Saltiel AR (1998). A role for CAP, a novel, multifunctional Src 
homology 3 domain-containing protein in formation of actin stress fibers and focal adhesions. J 
Biol Chem 273:(7) 4073-4080. 
 
Riddell DR, Christie G, Hussain I, Dingwall C (2001). Compartmentalization of beta-secretase 
(Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol 11:(16) 1288-1293. 
 
Riento K, Frick M, Schafer I, Nichols BJ (2009). Endocytosis of flotillin-1 and flotillin-2 is 
regulated by Fyn kinase. J Cell Sci 122:(Pt 7) 912-918. 
 
Ringerike T, Blystad FD, Levy FO, Madshus IH, Stang E (2002). Cholesterol is important in 
control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae. J 
Cell Sci 115:(Pt 6) 1331-1340. 
 
Rivera-Milla E, Stuermer CA, Malaga-Trillo E (2006). Ancient origin of reggie (flotillin), reggie-




Rivier C, Rivest S (1991). Effect of stress on the activity of the hypothalamic-pituitary-gonadal 
axis: peripheral and central mechanisms. Biol Reprod 45:(4) 523-532. 
 
Roberson MS, Zhang T, Li HL, Mulvaney JM (1999). Activation of the p38 mitogen-activated 
protein kinase pathway by gonadotropin-releasing hormone. Endocrinology 140:(3) 1310-1318. 
 
Roepstorff K, Thomsen P, Sandvig K, van Deurs B (2002). Sequestration of epidermal growth 
factor receptors in non-caveolar lipid rafts inhibits ligand binding. J Biol Chem 277:(21) 18954-
18960. 
 
Rogatsky I, Logan SK, Garabedian MJ (1998). Antagonism of glucocorticoid receptor 
transcriptional activation by the c-Jun N-terminal kinase. Proc Natl Acad Sci U S A 95:(5) 2050-
2055. 
 
Rogatsky I, Zarember KA, Yamamoto KR (2001). Factor recruitment and TIF2/GRIP1 
corepressor activity at a collagenase-3 response element that mediates regulation by phorbol 
esters and hormones. EMBO J 20:(21) 6071-6083. 
 
Rogatsky I, Luecke HF, Leitman DC, Yamamoto KR (2002). Alternate surfaces of transcriptional 
coregulator GRIP1 function in different glucocorticoid receptor activation and repression 
contexts. Proc Natl Acad Sci U S A 99:(26) 16701-16706. 
 
Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, Darimont BD, 
Garabedian MJ, Yamamoto KR (2003). Target-specific utilization of transcriptional regulatory 
surfaces by the glucocorticoid receptor. Proc Natl Acad Sci U S A 100:(24) 13845-13850. 
 
Rogatsky I, Ivashkiv LB (2006). Glucocorticoid modulation of cytokine signaling. Tissue 
Antigens 68:(1) 1-12. 
 
Ronacher K, Matsiliza N, Nkwanyana N, Pawson AJ, Adam T, Flanagan CA, Millar RP, Katz 
AA (2004). Serine Residues 338 and 339 in the carboxyl-terminal tail of the type II 
gonadotropin-releasing hormone receptor are critical for b-arrestin-independent internalization. 
Endocrinology 145 4480–4488. 
 
Ronacher K, Hadley K, Avenant C, Stubsrud E, Simons SS, Jr., Louw A, Hapgood JP (2009). 
Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of 
cofactor interaction. Mol Cell Endocrinol 299:(2) 219-231. 
 
Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attie T, Gubler MC, Antignac C (2002). 
Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160:(1) 131-139. 
 
Rosen H, Dalkin A, Haisenleder D, Friberg RD, Ortolano G, Barkan A (1991). Dexamethasone 
alters responses of pituitary gonadotropin-releasing hormone (GnRH) receptors, gonadotropin 
subunit messenger ribonucleic acids, and gonadotropins to pulsatile GnRH in male rats. 
Endocrinology 128:(2) 654-660. 
 
 150 
Ruf F, Fink MY, Sealfon SC (2003). Structure of the GnRH receptor-stimulated signaling 
network: insights from genomics. Front Neuroendocrinol 24:(3) 181-199. 
 
Rybin VO, Xu X, Lisanti MP, Steinberg SF (2000). Differential targeting of beta -adrenergic 
receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally 
regulate the cAMP signaling pathway. J Biol Chem 275:(52) 41447-41457. 
 
Sakamoto Y, Harada T, Horie S, Iba Y, Taniguchi F, Yoshida S, Iwabe T, Terakawa N (2003). 
Tumor necrosis factor-alpha-induced interleukin-8 (IL-8) expression in endometriotic stromal 
cells, probably through nuclear factor-kappa B activation: gonadotropin-releasing hormone 
agonist treatment reduced IL-8 expression. J Clin Endocrinol Metab 88:(2) 730-735. 
 
Santamaria A, Castellanos E, Gomez V, Benedit P, Renau-Piqueras J, Morote J, Reventos J, 
Thomson TM, Paciucci R (2005). PTOV1 enables the nuclear translocation and mitogenic 
activity of flotillin-1, a major protein of lipid rafts. Mol Cell Biol 25:(5) 1900-1911. 
 
Sarabdjitsingh RA, Meijer OC, de Kloet ER (2010). Specificity of glucocorticoid receptor 
primary antibodies for analysis of receptor localization patterns in cultured cells and rat 
hippocampus. Brain Res 1331 1-11. 
 
Sargiacomo M, Sudol M, Tang Z, Lisanti MP (1993). Signal transducing molecules and glycosyl-
phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J 
Cell Biol 122:(4) 789-807. 
 
Sasson R, Shinder V, Dantes A, Land A, Amsterdam A (2003). Activation of multiple signal 
transduction pathways by glucocorticoids: protection of ovarian follicular cells against apoptosis. 
Biochem Biophys Res Commun 311:(4) 1047-1056. 
 
Sasson R, Luu SH, Thackray VG, Mellon PL (2008). Glucocorticoids induce human glycoprotein 
hormone alpha-subunit gene expression in the gonadotrope. Endocrinology 149:(7) 3643-3655. 
 
Savory JG, Hsu B, Laquian IR, Giffin W, Reich T, Hache RJ, Lefebvre YA (1999). 
Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid 
receptor. Mol Cell Biol 19:(2) 1025-1037. 
 
Scheiffele P, Roth MG, Simons K (1997). Interaction of influenza virus haemagglutinin with 
sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J 16:(18) 
5501-5508. 
 
Scheiffele P, Rietveld A, Wilk T, Simons K (1999). Influenza viruses select ordered lipid 
domains during budding from the plasma membrane. J Biol Chem 274:(4) 2038-2044. 
 
Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP (1996). Identification, 




Schmid E, Schmid W, Jantzen M, Mayer D, Jastorff B, Schutz G (1987). Transcription activation 
of the tyrosine aminotransferase gene by glucocorticoids and cAMP in primary hepatocytes. Eur 
J Biochem 165:(3) 499-506. 
 
Schmidt MV, Sterlemann V, Wagner K, Niederleitner B, Ganea K, Liebl C, Deussing JM, Berger 
S, Schutz G, Holsboer F, Muller MB (2009). Postnatal glucocorticoid excess due to pituitary 
glucocorticoid receptor deficiency: differential short- and long-term consequences. 
Endocrinology 150:(6) 2709-2716. 
 
Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, Oh P (1995). Separation of caveolae from 
associated microdomains of GPI-anchored proteins. Science 269:(5229) 1435-1439. 
 
Schoneveld OJ, Gaemers IC, Lamers WH (2004). Mechanisms of glucocorticoid signalling. 
Biochim Biophys Acta 1680:(2) 114-128. 
 
Schroeder R, London E, Brown D (1994a). Interactions between saturated acyl chains confer 
detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-
anchored proteins in liposomes and cells show similar behavior. Proc Natl Acad Sci U S A 
91:(25) 12130-12134. 
 
Schroeder WT, Stewart-Galetka S, Mandavilli S, Parry DA, Goldsmith L, Duvic M (1994b). 
Cloning and characterization of a novel epidermal cell surface antigen (ESA). J Biol Chem 
269:(31) 19983-19991. 
 
Schulte T, Paschke KA, Laessing U, Lottspeich F, Stuermer CA (1997). Reggie-1 and reggie-2, 
two cell surface proteins expressed by retinal ganglion cells during axon regeneration. 
Development 124:(2) 577-587. 
 
Schwencke C, Yamamoto M, Okumura S, Toya Y, Kim SJ, Ishikawa Y (1999). 
Compartmentation of cyclic adenosine 3',5'-monophosphate signaling in caveolae. Mol 
Endocrinol 13:(7) 1061-1070. 
 
Sealfon SC, Weinstein H, Millar RP (1997). Molecular mechanisms of ligand interaction with the 
gonadotropin-releasing hormone receptor. Endocr Rev 18:(2) 180-205. 
 
Segaloff DL, Ascoli M (1993). The lutropin/choriogonadotropin receptor ... 4 years later. Endocr 
Rev 14:(3) 324-347. 
 
Selkoe DJ (2001). Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:(2) 741-766. 
 
Seminara SB, Hayes FJ, Crowley WF, Jr. (1998). Gonadotropin-releasing hormone deficiency in 
the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): 
pathophysiological and genetic considerations. Endocr Rev 19:(5) 521-539. 
 
Seno K, Kishimoto M, Abe M, Higuchi Y, Mieda M, Owada Y, Yoshiyama W, Liu H, Hayashi F 
(2001). Light- and guanosine 5'-3-O-(thio)triphosphate-sensitive localization of a G protein and 
 152 
its effector on detergent-resistant membrane rafts in rod photoreceptor outer segments. J Biol 
Chem 276:(24) 20813-20816. 
 
Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RG, Michel T 
(1996). Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol 
Chem 271:(11) 6518-6522. 
 
Sheflin L, Keegan B, Zhang W, Spaulding SW (2000). Inhibiting proteasomes in human HepG2 
and LNCaP cells increases endogenous androgen receptor levels. Biochem Biophys Res Commun 
276:(1) 144-150. 
 
Shenoy-Scaria AM, Dietzen DJ, Kwong J, Link DC, Lublin DM (1994). Cysteine3 of Src family 
protein tyrosine kinase determines palmitoylation and localization in caveolae. J Cell Biol 
126:(2) 353-363. 
 
Shin DM, Yang CS, Lee JY, Lee SJ, Choi HH, Lee HM, Yuk JM, Harding CV, Jo EK (2008). 
Mycobacterium tuberculosis lipoprotein-induced association of TLR2 with protein kinase C zeta 
in lipid rafts contributes to reactive oxygen species-dependent inflammatory signalling in 
macrophages. Cell Microbiol 10:(9) 1893-1905. 
 
Silverstein AM, Galigniana MD, Kanelakis KC, Radanyi C, Renoir JM, Pratt WB (1999). 
Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid 
receptor, hsp90, and cytoplasmic dynein. J Biol Chem 274:(52) 36980-36986. 
 
Simoni M, Gromoll J, Nieschlag E (1997). The follicle-stimulating hormone receptor: 
biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18:(6) 739-773. 
 
Simons K, Ikonen E (1997). Functional rafts in cell membranes. Nature 387:(6633) 569-572. 
 
Simons K, Toomre D (2000). Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:(1) 31-
39. 
 
Simons K, Ehehalt R (2002). Cholesterol, lipid rafts, and disease. J Clin Invest 110:(5) 597-603. 
 
Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998). Cholesterol 
depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U 
S A 95:(11) 6460-6464. 
 
Singer SJ, Nicolson GL (1972). The fluid mosaic model of the structure of cell membranes. 
Science 175:(23) 720-731. 
 
Singh VB, Moudgil VK (1985). Phosphorylation of rat liver glucocorticoid receptor. J Biol Chem 
260:(6) 3684-3690. 
 
Slaughter N, Laux I, Tu X, Whitelegge J, Zhu X, Effros R, Bickel P, Nel A (2003). The flotillins 
are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: 
implications for T-cell activation. Clin Immunol 108:(2) 138-151. 
 153 
 
Smart EJ, Ying YS, Mineo C, Anderson RG (1995). A detergent-free method for purifying 
caveolae membrane from tissue culture cells. Proc Natl Acad Sci U S A 92:(22) 10104-10108. 
 
Snyers L, Umlauf E, Prohaska R (1998). Oligomeric nature of the integral membrane protein 
stomatin. J Biol Chem 273:(27) 17221-17226. 
 
So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR (2007). Determinants of cell- and gene-
specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet 3:(6) e94. 
 
Solis GP, Malaga-Trillo E, Plattner H, Stuermer CA (2010). Cellular roles of the prion protein in 
association with reggie/flotillin microdomains. Front Biosci 15 1075-1085. 
 
Solito E, Mulla A, Morris JF, Christian HC, Flower RJ, Buckingham JC (2003). Dexamethasone 
induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human 
folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid 
receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. 
Endocrinology 144:(4) 1164-1174. 
 
Sowa G, Pypaert M, Fulton D, Sessa WC (2003). The phosphorylation of caveolin-2 on serines 
23 and 36 modulates caveolin-1-dependent caveolae formation. Proc Natl Acad Sci U S A 
100:(11) 6511-6516. 
 
Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai 
SY, Tsai MJ, O'Malley BW (1997). Steroid receptor coactivator-1 is a histone acetyltransferase. 
Nature 389:(6647) 194-198. 
 
Stahn C, Lowenberg M, Hommes DW, Buttgereit F (2007). Molecular mechanisms of 
glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 275:(1-
2) 71-78. 
 
Stanislaus D, Janovick JA, Brothers S, Conn PM (1997). Regulation of G(q/11)alpha by the 
gonadotropin-releasing hormone receptor. Mol Endocrinol 11:(6) 738-746. 
 
Stanislaus D, Ponder S, Ji TH, Conn PM (1998). Gonadotropin-releasing hormone receptor 
couples to multiple G proteins in rat gonadotrophs and in GGH3 cells: evidence from 
palmitoylation and overexpression of G proteins. Biol Reprod 59:(3) 579-586. 
 
Stoecklin E, Wissler M, Moriggl R, Groner B (1997). Specific DNA binding of Stat5, but not of 
glucocorticoid receptor, is required for their functional cooperation in the regulation of gene 
transcription. Mol Cell Biol 17:(11) 6708-6716. 
 
Stojilkovic SS, Reinhart J, Catt KJ (1994). Gonadotropin-releasing hormone receptors: structure 
and signal transduction pathways. Endocr Rev 15:(4) 462-499. 
 
 154 
Stuermer CA, Lang DM, Kirsch F, Wiechers M, Deininger SO, Plattner H (2001). 
Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma 
membrane microdomains defined by reggie-1 and -2. Mol Biol Cell 12:(10) 3031-3045. 
 
Stuermer CA, Langhorst MF, Wiechers MF, Legler DF, Von Hanwehr SH, Guse AH, Plattner H 
(2004). PrPc capping in T cells promotes its association with the lipid raft proteins reggie-1 and 
reggie-2 and leads to signal transduction. FASEB J 18:(14) 1731-1733. 
 
Stuermer CA (2010). The reggie/flotillin connection to growth. Trends Cell Biol 20:(1) 6-13. 
 
Sugawara Y, Nishii H, Takahashi T, Yamauchi J, Mizuno N, Tago K, Itoh H (2007). The lipid 
raft proteins flotillins/reggies interact with Galphaq and are involved in Gq-mediated p38 
mitogen-activated protein kinase activation through tyrosine kinase. Cell Signal 19:(6) 1301-
1308. 
 
Sundaresan S, Colin IM, Pestell RG, Jameson JL (1996). Stimulation of mitogen-activated 
protein kinase by gonadotropin-releasing hormone: evidence for the involvement of protein 
kinase C. Endocrinology 137:(1) 304-311. 
 
Swanwick CC, Shapiro ME, Vicini S, Wenthold RJ (2010). Flotillin-1 mediates neurite 
branching induced by synaptic adhesion-like molecule 4 in hippocampal neurons. Mol Cell 
Neurosci 45:(3) 213-225. 
 
Takabe S, Mochizuki K, Goda T (2008). De-phosphorylation of GR at Ser203 in nuclei 
associates with GR nuclear translocation and GLUT5 gene expression in Caco-2 cells. Arch 
Biochem Biophys 475:(1) 1-6. 
 
Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP 
(1996). Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed 
predominantly in muscle. J Biol Chem 271:(4) 2255-2261. 
 
Tasker JG, Di S, Malcher-Lopes R (2006). Minireview: rapid glucocorticoid signaling via 
membrane-associated receptors. Endocrinology 147:(12) 5549-5556. 
 
Tavernarakis N, Driscoll M, Kyrpides NC (1999). The SPFH domain: implicated in regulating 
targeted protein turnover in stomatins and other membrane-associated proteins. Trends Biochem 
Sci 24:(11) 425-427. 
 
Taylor DR, Whitehouse IJ, Hooper NM (2009). Glypican-1 mediates both prion protein lipid raft 
association and disease isoform formation. PLoS Pathog 5:(11) e1000666. 
 
Teixeira A, Chaverot N, Schroder C, Strosberg AD, Couraud PO, Cazaubon S (1999). 
Requirement of caveolae microdomains in extracellular signal-regulated kinase and focal 




Teurich S, Angel P (1995). The glucocorticoid receptor synergizes with Jun homodimers to 
activate AP-1-regulated promoters lacking GR binding sites. Chem Senses 20:(2) 251-255. 
 
Tian S, Poukka H, Palvimo JJ, Janne OA (2002). Small ubiquitin-related modifier-1 (SUMO-1) 
modification of the glucocorticoid receptor. Biochem J 367:(Pt 3) 907-911. 
 
Tilbrook AJ, Turner AI, Clarke IJ (2000). Effects of stress on reproduction in non-rodent 
mammals: the role of glucocorticoids and sex differences. Rev Reprod 5:(2) 105-113. 
 
Tritel M, Resh MD (2001). The late stage of human immunodeficiency virus type 1 assembly is 
an energy-dependent process. J Virol 75:(12) 5473-5481. 
 
Troskie B, Illing N, Rumbak E, Sun YM, Hapgood J, Sealfon S, Conklin D, Millar R (1998). 
Identification of three putative GnRH receptor subtypes in vertebrates. Gen Comp Endocrinol 
112:(3) 296-302. 
 
Tsutsumi M, Zhou W, Millar RP, Mellon PL, Roberts JL, Flanagan CA, Dong K, Gillo B, 
Sealfon SC (1992). Cloning and functional expression of a mouse gonadotropin-releasing 
hormone receptor. Mol Endocrinol 6:(7) 1163-1169. 
 
Tsutsumi R, Mistry D, Webster NJ (2010). Signaling responses to pulsatile gonadotropin-
releasing hormone in LbetaT2 gonadotrope cells. J Biol Chem 285:(26) 20262-20272. 
 
Turgeon JL, Kimura Y, Waring DW, Mellon PL (1996). Steroid and pulsatile gonadotropin-
releasing hormone (GnRH) regulation of luteinizing hormone and GnRH receptor in a novel 
gonadotrope cell line. Mol Endocrinol 10:(4) 439-450. 
 
Urbach V, Walsh DE, Mainprice B, Bousquet J, Harvey BJ (2002). Rapid non-genomic 
inhibition of ATP-induced Cl- secretion by dexamethasone in human bronchial epithelium. J 
Physiol 545:(Pt 3) 869-878. 
 
Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, Alexander RW 
(2001). Cholesterol depletion inhibits epidermal growth factor receptor transactivation by 
angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal 
adhesions in angiotensin II signaling. J Biol Chem 276:(51) 48269-48275. 
 
Vainio S, Heino S, Mansson JE, Fredman P, Kuismanen E, Vaarala O, Ikonen E (2002). 
Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae. EMBO 
Rep 3:(1) 95-100. 
 
Vainio S, Bykov I, Hermansson M, Jokitalo E, Somerharju P, Ikonen E (2005). Defective insulin 
receptor activation and altered lipid rafts in Niemann-Pick type C disease hepatocytes. Biochem J 
391:(Pt 3) 465-472. 
 
van Biljon W, Wykes S, Scherer S, Krawetz SA, Hapgood J (2002). Type II gonadotropin-
releasing hormone receptor transcripts in human sperm. Biol Reprod 67:(6) 1741-1749. 
 
 156 
Van Bogaert T, De Bosscher K, Libert C (2010). Crosstalk between TNF and glucocorticoid 
receptor signaling pathways. Cytokine Growth Factor Rev. 
 
Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P, Gronemeyer H (1998). The coactivator TIF2 
contains three nuclear receptor-binding motifs and mediates transactivation through CBP 
binding-dependent and -independent pathways. EMBO J 17:(2) 507-519. 
 
Vogel U, Sandvig K, van Deurs B (1998). Expression of caveolin-1 and polarized formation of 
invaginated caveolae in Caco-2 and MDCK II cells. J Cell Sci 111 ( Pt 6) 825-832. 
 
Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T, Lisanti MP (1999). Flotillins/cavatellins 
are differentially expressed in cells and tissues and form a hetero-oligomeric complex with 
caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal 
antibody probe. J Biol Chem 274:(18) 12702-12709. 
 
Vottero A, Kino T, Combe H, Lecomte P, Chrousos GP (2002). A novel, C-terminal dominant 
negative mutation of the GR causes familial glucocorticoid resistance through abnormal 
interactions with p160 steroid receptor coactivators. J Clin Endocrinol Metab 87:(6) 2658-2667. 
 
Wada S, Morishima-Kawashima M, Qi Y, Misono H, Shimada Y, Ohno-Iwashita Y, Ihara Y 
(2003). Gamma-secretase activity is present in rafts but is not cholesterol-dependent. 
Biochemistry 42:(47) 13977-13986. 
 
Wakasugi K, Nakano T, Kitatsuji C, Morishima I (2004). Human neuroglobin interacts with 
flotillin-1, a lipid raft microdomain-associated protein. Biochem Biophys Res Commun 318:(2) 
453-460. 
 
Wallace AD, Cidlowski JA (2001). Proteasome-mediated glucocorticoid receptor degradation 
restricts transcriptional signaling by glucocorticoids. J Biol Chem 276:(46) 42714-42721. 
 
Wallace AD, Cao Y, Chandramouleeswaran S, Cidlowski JA (2010). Lysine 419 targets human 
glucocorticoid receptor for proteasomal degradation. Steroids. 
 
Wang X, DeFranco DB (2005). Alternative effects of the ubiquitin-proteasome pathway on 
glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase. 
Mol Endocrinol 19:(6) 1474-1482. 
 
Wang Y, Posner BI, Balbis A (2009). Compartmentalization of epidermal growth factor receptor 
in liver plasma membrane. J Cell Biochem 107:(1) 96-103. 
 
Wang Z, Frederick J, Garabedian MJ (2002). Deciphering the phosphorylation "code" of the 
glucocorticoid receptor in vivo. J Biol Chem 277:(29) 26573-26580. 
 
Wang Z, Chen W, Kono E, Dang T, Garabedian MJ (2007). Modulation of glucocorticoid 
receptor phosphorylation and transcriptional activity by a C-terminal-associated protein 
phosphatase. Mol Endocrinol 21:(3) 625-634. 
 
 157 
Way M, Parton RG (1995). M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 
376:(1-2) 108-112. 
 
Webster JC, Jewell CM, Bodwell JE, Munck A, Sar M, Cidlowski JA (1997). Mouse 
glucocorticoid receptor phosphorylation status influences multiple functions of the receptor 
protein. J Biol Chem 272:(14) 9287-9293. 
 
Weesner GD, Matteri RL (1994). Rapid communication: nucleotide sequence of luteinizing 
hormone-releasing hormone (LHRH) receptor cDNA in the pig pituitary. J Anim Sci 72:(7) 1911. 
 
Wiegers GJ, Reul JM (1998). Induction of cytokine receptors by glucocorticoids: functional and 
pathological significance. Trends Pharmacol Sci 19:(8) 317-321. 
 
Wissink S, van Heerde EC, Schmitz ML, Kalkhoven E, van der Burg B, Baeuerle PA, van der 
Saag PT (1997). Distinct domains of the RelA NF-kappaB subunit are required for negative 
cross-talk and direct interaction with the glucocorticoid receptor. J Biol Chem 272:(35) 22278-
22284. 
 
Wolf IM, Periyasamy S, Hinds T, Jr., Yong W, Shou W, Sanchez ER (2009). Targeted ablation 
reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor 
transcriptional activity. J Steroid Biochem Mol Biol 113:(1-2) 36-45. 
 
Wolozin B (2001). A fluid connection: cholesterol and Abeta. Proc Natl Acad Sci U S A 98:(10) 
5371-5373. 
 
Wu C, Butz S, Ying Y, Anderson RG (1997). Tyrosine kinase receptors concentrated in 
caveolae-like domains from neuronal plasma membrane. J Biol Chem 272:(6) 3554-3559. 
 
Wu JC, Sealfon SC, Miller WL (1994). Gonadal hormones and gonadotropin-releasing hormone 
(GnRH) alter messenger ribonucleic acid levels for GnRH receptors in sheep. Endocrinology 
134:(4) 1846-1850. 
 
Xiang Y, Rybin VO, Steinberg SF, Kobilka B (2002). Caveolar localization dictates physiologic 
signaling of beta 2-adrenoceptors in neonatal cardiac myocytes. J Biol Chem 277:(37) 34280-
34286. 
 
Yamada E (1955). The fine structure of the gall bladder epithelium of the mouse. J Biophys 
Biochem Cytol 1:(5) 445-458. 
 
Yasin M, Dalkin AC, Haisenleder DJ, Kerrigan JR, Marshall JC (1995). Gonadotropin-releasing 
hormone (GnRH) pulse pattern regulates GnRH receptor gene expression: augmentation by 
estradiol. Endocrinology 136:(4) 1559-1564. 
 
Yates C, Wells A, Turner T (2005). Luteinising hormone-releasing hormone analogue reverses 
the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. Br 
J Cancer 92:(2) 366-375. 
 
 158 
Young LS, Naik SI, Clayton RN (1984). Adenosine 3',5'-monophosphate derivatives increase 
gonadotropin-releasing hormone receptors in cultured pituitary cells. Endocrinology 114:(6) 
2114-2122. 
 
Yu BL, Wang SH, Peng DQ, Zhao SP (2010). HDL and immunomodulation: an emerging role of 
HDL against atherosclerosis. Immunol Cell Biol 88:(3) 285-290. 
 
Zajchowski LD, Robbins SM (2002). Lipid rafts and little caves. Compartmentalized signalling 
in membrane microdomains. Eur J Biochem 269:(3) 737-752. 
 
Zhang J, Pekosz A, Lamb RA (2000). Influenza virus assembly and lipid raft microdomains: a 
role for the cytoplasmic tails of the spike glycoproteins. J Virol 74:(10) 4634-4644. 
 
Zhang X, Clark AF, Yorio T (2008). FK506-binding protein 51 regulates nuclear transport of the 
glucocorticoid receptor beta and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci 49:(3) 
1037-1047. 
 
Zhong J, Troppmair J, Rapp UR (2001). Independent control of cell survival by Raf-1 and Bcl-2 
at the mitochondria. Oncogene 20:(35) 4807-4816. 
 
Zhou J, Cidlowski JA (2005). The human glucocorticoid receptor: one gene, multiple proteins 
and diverse responses. Steroids 70:(5-7) 407-417. 
 
Zhou W, Sealfon SC (1994). Structure of the mouse gonadotropin-releasing hormone receptor 
gene: variant transcripts generated by alternative processing. DNA Cell Biol 13:(6) 605-614. 
 
 
 
 
